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Abstract
Tyrosine Phosphorylation linked to Cardiac Arrhythmias via HCN Pacemaker Channel
Yen-Chang Lin
Cardiac sudden death (CSD) is the leading cause of death in the United States. Although the
causes of CSD are not understood completely, cardiac arrhythmias have been indicated as the
major contribution to CSD. The main purpose of this thesis is to investigate the mechanisms
underlying cardiac arrhythmias, therefore providing scientific basis for clinical applications in
the future to lower the rate of CSD.
My thesis contains four chapters. Chapter 1 aims to examine a novel role of tyrosine
phosphorylation in the arrhythmogenesis. To achieve this goal, a rat arrhythmia model was
established without structural remodeling, and the Src tyrosine kinase and protein tyrosine
phosphatase were evaluated in the induction of cardiac arrhythmias by using electrocardiography
(ECG) technique (two manuscripts are in preparation).
In chapter 2, we elucidate the mechanism tyrosine phosphorylation used to modulate the cardiac
pacemaker channels that directly contribute to the regulation of heart rate and their potential new
role in cardiac arrhythmias (J Biol Chem 284: 30433-30440, 2009).
In chapter 3, we explore a novel role of Hyperpolarization-activated, cyclic nucleotide-gated
(HCN) channels serving as a regulatory protein to regulate the Ca2+ influx via inactivation of Ltype calcium channel (LTCC) (Am J Physiol Cell Physiol 298(5): C1029-37, 2010).
In chapter 4, the results that have not been published are summarized. These results represented
my efforts to explore previously unrecognized mechanisms that underlie the genesis and
development of cardiac arrhythmias that predispose the heart to CSD, claiming more than
300,000 lives each year in the US.
Collectively, our results indicate that tyrosine phosphorylation plays a critical role in the
regulation of cardiac rhythm, possibly via modulation the activities of HCN pacemaker channels.
Furthermore, we also found that HCN channels can limit the Ca2+ influx via induction of fast
inactivation of LTCC. These results not only help us to better understand the mechanisms of
cardiac arrhythmias, but can also be applied to the future drug development for the prevention of
CSD caused by cardiac arrhythmias.
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Introduction
Cardiac sudden death (CSD) affects approximately 300,000 people in the United Stated
every year, and is estimated to account for nearly 50 percent of all death from
cardiovascular causes (Myerburg et al., 1997). Major cardiac diseases such as ischemia,
heart failure, and cardiac hypertrophy have been reported to cause CSD via ion channel
remodeling and changes in ion influx or efflux (Heman et al., 1996; Hynes et al., 2002;
Mammarella et al., 2000; Wolfe et al., 1991). However, there are also cases where
people, especially young adults, died of sudden CSD in the absence of defective heart
structure including hypertrophy (Heman et al., 1996; Hynes et al., 2002; Mammarella et
al., 2000; Wolfe et al., 1991). This indicates that our knowledge of CSD is not a complete
picture. From a pathological point of view, it is commonly accepted that the underlying
cause of CSD is tachycardia-induced arrhythmias (Kannel et al., 1987; Willich et al.,
1987). Therefore, to obtain a comprehensive understanding of arrhythmias is the key to
understand the causes of CSD. However, the underlying mechanisms of cardiac
arrhythmias still remain obscure due to lack of a good animal model system with
inducible and controlled real-time ventricular arrhythmias, which the first part of my
thesis is focused on.
To provide an ionic basis of cardiac arrhythmias that I observed in the new arrhythmic
animal model described in the first part, the second part of this thesis concentrates on two
ion channels: Hyperpolarization-activated and cyclic nucleotide-gated (HCN) channels
and L-type calcium channels (LTCCs). Ion channels can directly cause diseases. The
term “channelopathy” represents the diseases directly caused by the malfunction of the
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channels (Robert et al., 2005). Mutations in the channel proteins or abnormal regulation
of the channel contribute to the channelopathy (Hunter et al., 1994; Zhou et al., 2009). In
the past decade, numerous mutations in ion channels have been identified in patients and
directly linked to a variety of arrhythmias (Dai et al., 2005; Peter et al., 2007). Therefore,
my study aims to provide the molecular and cellular basis of how regulation of ion
channels of interest (HCN channels and LTCCs) can serve as good strategies for the
therapeutic purposes of cardiac arrhythmias.
1. Mechanisms of cardiac arrhythmias:
Ion channels are major players to regulate the flow of ions across biological membranes
and to maintain cellular homeostasis in the physiological condition. They provide a
molecular basis of action potential propagation during the cell excitation. In the resting
state, the more negative charges intracellularly make the resting membrane potential
around -70mV in neurons and -90mV in myocytes. Once the action potential arrives, the
cells are depolarized by making the intracellular cell membrane more positive via the
flow of ions across the channels (Hodgkin et al., 1952; Noble et al., 1960). In heart, the
action potential is generated in the “primary pacemaker” sinoatrial node (SA node) in the
right atrium and then conducts along atria, the atrial-ventricular node (AV node), Bundles
of His, Purkinje fibers, and ventricles. Regulation of SA node rate is critical in
understanding of mechanisms, leading to better management of cardiac arrhythmias such
as atrial fibrillation and ventricular tachycardia.
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1.1 Abnormal impulse initiation
Cardiac arrhythmias are defined as abnormal cardiac electrical properties attributed to
two factors: the abnormality in impulse initiation and impulse conduction. Normal
impulse initiation is associated with automatic foci determined by the slope of phase 4
depolarization, which establishes the time required to reach threshold potential and
generate a spontaneous action potential. The sinus node is the primary pacemaker to
initiate and coordinate the electrical impulse which then conducts to the atrium and
ventricle. If the sinus node firing rate is slower than atrial cells, the electrical impulse can
be initiated and coordinated by atrial cells instead of the sinus node and ectopic activities
occurred. The function of If currents (mediated by HCN channels) contributed to the
phase 4 of sinus node or atrial or Purkinje action potential and make the “U” turn of the
maximal diastolic potential. However, when the slope of phase 4 is accelerated by the
increase of HCN channel expressions, the ectopic impulse or the tachycardia induced
arrhythmias will be generated (Hoffman et al., 1981). Cardiac remodeling caused by
atrial tachycardia or heart failure (failing ventricles) has been demonstrated to be
associated with the enhancement of HCN channel expressions (Nattel S et al., 2007).
Different from the mechanism in phase 4, delayed after depolarizations (DADs) and early
after depolarizations (EADs) are caused by abnormalities in cellular Ca2+ handling.
DADs are represented by spontaneous hump-shaped depolarizations after repolarization,
which will increase more Ca2+ load and trigger sustained tachycardia (Chen et al., 2001;
Coutu et al., 2006; Stambler et al., 2003). EADs occur when action potentials become
abnormally prolonged due to increased Ca2+ influx via LTCCs and generate abnormal
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depolarization at plateau phases, which are characterized in Purkinje fibers and long-QT
syndrome (Burashnikov et al., 2003; Nattel et al., 1988; Satoh et al., 1998).
1.2 Abnormal impulse conduction
Abnormal impulse conduction causes reentrant excitation. Reentry occurred when an
ectopic impulse was blocked by refractory tissues while propagating in one direction and
will then propagate in the other direction where the tissues have faster recovering from
refractory periods. For the maintaining of reentry, the time of conducting has to be longer
than the refractory period in the circuit (to make sure the impulse can re-excite all points
of the entire circuit). The time of conduction is determined by conduction velocity and
circuit path length. Slower conduction velocity and longer circuit path length create the
environment in which reentry can be maintained. Refractory period of action potential is
also a critical determinant for reentry. Short refractory period increases the opportunity
that tissues are available to be reactivated by the reentering pulse (Hoffman et al., 1981).
Previous studies have demonstrated that atrial remodeling caused by ischemia or heart
failure increases the risk of reentrant excitation by increase of circuit path spaces and
decrease of refractory periods (For example, decrease inward calcium currents via
LTCCs), which potentially results in atrial fibrillation (Cha et al., 2006; Yue et al., 1997).
2. HCN channels
2.1 Properties of HCN channels
Hyperpolarization-activated, cyclic nucleotide-modulated (HCN) channels are the major
contributor to SA node pacemaker activity (Brown et al., 1982; DiFrancesco, 1993;
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Irisawa et al., 1978). Exploring the new mechanisms that control the HCN channel
properties by tyrosine phosphorylation constitutes the majority of my thesis work.
HCN channels form tetramers on the cell membrane and each subunit consists of six
transmembrane domains including the voltage sensor S4 domain, P loop with the GYG
motif for the selectivity of the K+ ion flow, and the cyclic nucleotide-binding domain
(CNBD) on the C-terminus (Fig 1). There are four isoforms (HCN1-4) of HCN channels.
Despite their similarity in structure, different HCN isoforms do not express uniformly in
the heart. HCN4 is the dominant isoform in SA node whereas HCN2 is mainly expressed
in ventricles. HCN1 transcripts are expressed at low levels in SA node, and cannot be
detected in ventricles (Shi et al., 1999).
Unlike most other voltage-gated ion channels that are activated by membrane
depolarization,

the

Na+/K+

permeable HCN channels can
only be activated by membrane
hyperpolarization, generating a
voltage- and time- dependent
inward current, called If in heart
and Ih in neurons. If contributes
to the termination of the repolarization and generation of the diastolic depolarization to
the threshold for firing an action potential (Brown et al., 1982; DiFrancesco, 1993;
Irisawa et al., 1978).
HCN channels are regulated by autonomic nervous system. The activation of βadrenergic receptors by adrenaline (i.e. norepinephrine) or isoproterenol can cause the
5

increase of intracellular cAMP. In a phosphorylation-independent regulation manner,
cAMP can interact with HCN channels at the cyclic nucleotide-binding domain (CNBD)
on their C-terminal tail. This triggers conformational change of HCN channels, resulting
in the net positive charge influx, to generate voltage and time dependent inward currents.
As a result, the activation curve will shift to more positive voltages (increase of the
channel sensitivity in response to the voltage stimulation), contributing to an increase in
the heart rate (Accili et al., 1997; Altomare et al., 2001; DiFrancesco et al., 1999).
On the contrary, the activation of muscarinic acetylcholine receptors (type II) by
acetylcholine can cause the decrease of cAMP and make activation curve shift to more
negative voltages (decrease of the channel sensitivity in response to the voltage
stimulation), leading to an decrease in the heart rate for physiological effect (Accili et al.,
1997; Altomare et al., 2001; DiFrancesco et al., 1999).
2.2 Tyrosine Phosphorylation of HCN channels in the heart
One of the important regulations of HCN channels is via tyrosine phosphorylation. In
2000, the If has been found to be reduced by approximately 30% after applying genistein,
a tyrosine kinase inhibitor, with epidermal growth factor (EGF) when compared with
EGF alone in rabbit sinus node myocytes. In accordance with the results in rat ventricular
myocytes, not only was If enhanced, but its activation threshold was also positively shift
by nearly +20mv after washout of genistein, demonstrating that tyrosine phosphorylation
is critical in the regulation of HCN channels function (Wu et al., 2000).
To further investigate the phosphorylation-related regulation of the different subtypes of
HCN channels, genistein was applied in Xenopus Oocytes overexpressing HCN1, HCN2,
6

or HCN4. It has been demonstrated that the conductance of HCN2 and HCN4 were both
reduced; whereas V1/2 (the voltage where the 50% channels can be activated) of HCN2
but not HCN4 was shifted to more negative charge after applying genistein. However,
neither the conductance nor V1/2 was affected by genistein for HCN1 channels,
suggesting that different subtypes of HCNs respond differently to tyrosine
phosphorylation. These results strongly indicate that HCN channels, especially HCN2
and HCN4, can be tightly regulated by tyrosine phosphorylation (Yu et al., 2004).
To search for the intracellular tyrosine kinases that can provide tyrosine phosphorylation
regulation of HCN channels, tyrosine kinase Src was studied. The Src family is
composed of nine members, three of which are ubiquitously expressed in heart- Src, Yes,
and Fyn. Structurally, these proteins are highly homologous and consist of an aminoterminal site, SH domains, and a carboxyl-terminal regulatory region. Functionally, they
can phosphorylate the proteins in the signal transduction cascade (Thomas et al., 1997).
Interestingly, previous study indicated that Src529, a constitutively active Src tyrosine
kinase, was capable of enhancing current densities and positively shifting the V1/2 and
activation threshold after co-expression with HCN4 channels in HEK 293 cells. In
contrast, Src296, a dominant negative Src tyrosine kinase, caused the reduction of current
densities and decreased the gating properties of HCN4 channels. This suggests that the
regulation of HCN is probably via Src-mediated tyrosine phosphorylation (Arinsburg et
al., 2006).
In 2008, by using a specific Src kinase inhibitor, PP2 (4-amino-5-(4-chlorophenyl)-7-(tbutyl)pyrazolo[3,4-d]pyramidine), it has been revealed that the conductance of HCN4
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channels was significantly decreased and the activation threshold was also negatively
shifted due to the reduction of tyrosine phosphorylation. Immunoprecipitation results
demonstrate the possible association between the kinase Src and HCN4 channels. By
employing PP2 and whole-cell patch clamp technique, our lab also found that Y531 is the
main residue for the Src-mediated tyrosine phosphorylation (Li et al., 2008).
Recently, a tyrosine phosphatase inhibitor, phenylarsine oxide (PAO), has also been
demonstrated to enhance the If density of HCN4 channels and positively shift the
threshold of activation about +40mV in adult ventricular myocytes. To further identify
the specific tyrosine phosphatase that contributed to the PAO effects on If, we
investigated the potential modulation of receptor protein tyrosine phosphates (RPTP).
Receptor Protein Tyrosine Phosphatase α (RPTPα), a member of receptor-type tyrosine
phosphatase, was cotransfected with HCN2 or HCN4 channels in HEK 293 cells.
Interestingly, HCN2 or HCN4 currents were totally eliminated by RPTPα two days after
transient co-transfection HCN2 or HCN4 with RPTPα. Biochemical approach further
indicates that tyrosine dephosphorylation by RPTPα impairs membrane trafficking of
HCN2 channels, possibly due to an association between RPTPα and HCN2 channels.
This may explain why the If density was significantly reduced in rat ventricle by applying
a tyrosine phosphatase inhibitor PAO (Huang et al., 2008).
2.3 HCN4 mutants in Human Cardiac Arrhythmias
HCN4 channels are closely related to the initiation of cardiac pacemaker activity. Defects
in the HCN4 channels including gene knockout have caused death in embryo, and severe
cardiac arrhythmias (Stieber et al., 2003).
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Several gene mutations of HCN4 channels have been reported to be implicated to the
cardiac arrhythmia and to impair the cardiac function such as HCN4-573X, S672R,
G480R, and D553N mutations.
HCN4-573X is a single base pair mutation, which leads to a premature stop codon
resulting in the protein truncation of C-terminal including the CNBD domain of the
channels. This leads to loss of interaction with cAMP and alteration of deactivation
kinetics in channels (Schulze et al., 2003).
S672R missense mutation is located in the β roll of the CNBD domain. This mutant
channel causes a shift of the activation threshold towards the more hyperpolarizing
direction (which reduces If in sinoatrial node at a given hyperpolarized voltage), therefore
slows down the heart rate. This mutant also decreases the sensitivity of the channels in
response to the membrane hyperpolarization. However, the cAMP modulation is not
changed in this single base mutation (Milanesi et al., 2006).
G480R is located in the pore region of HCN4 channels and has been reported to be
associated with reduction of pacemaker currents and HR. Previous studies by using
Xenopus oocytes and HEK293 cells revealed that reduction of current expression is
attributed to a more negative voltage dependence of channel activation as well as
decrease of membrane expression of this mutant (Nof et al., 2007).
The relevant one to my own study is the D553N missense mutation in the C-linker of
HCN4 channels. This mutant was found in a patient who suffers from a severe cardiac
arrhythmia including sinus node dysfunction-induced bradycardia (lower heart rate), long
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QT

syndrome,

and

ventricular

tachycardia

polymorphisms

indicated

by

electrocardiogram (ECG) (Ueda et al., 2004). By employing the electrophysiology and
imaging, further investigation also implicated that this mutant is a dominant negative
mutant and causes the membrane trafficking defect of the channels. Not only the current
densities are significantly reduced, this mutant can also alter the kinetics of activation and
deactivation of the channel. As the trafficking defect of this mutant results in cardiac
arrhythmia, my main goal is to test the hypothesis that the Src kinases-mediated tyrosine
phosphorylation can rescue the defective trafficking of this mutant.
3. L-type calcium channels (LTCCs):
3.1 Properties of LTCCs:
LTCCs are pivotal to control the extracellular calcium influx into the cell and in turn to
regulate the calcium-dependent physiological functions of the cell. LTCCs consist of the
pore-forming α1 subunit with several accessory subunits such as α2δ, β, and γ subunits
surrounding this pore subunit (Arikkath et al., 2003; McCleskey et al., 1994; Tsien et al.,
1995; Yasuda et al., 2004). The pore-forming α1 subunit has four repeats and each one
has six transmembrane domains, which is capable of mediating the biophysical and
pharmacological properties of the channels, while its accessory subunits are critical to
regulate the gating and trafficking of the channels (Arikkath et al., 2003; Yasuda et al.,
2004). It is generally accepted that LTCCs require association of the pore-forming α1
subunit with its accessory β and α2δ subunits to generate the functional calcium currents
in response to depolarization.
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In the heart, cardiac contractions of the atrium and ventricle occur via activation of
LTCCs. In a resting condition, the intracellular calcium concentration is maintained at
approximately 0.1µM, which is nearly 1/10000 of the extracellular free calcium
concentration (1mM) (Bers, 2002). During action potential, in cardiomyocytes calcium
enters the cell through depolarization-activated calcium channels as inward calcium
current, which can trigger calcium release from the sarcoplasmic reticulum (calcium
induced calcium release), and then switches on the contractile machinery (Bers, 2000).
Therefore, the physiological function of the heart is controlled by this excitationcontraction coupling (EC-coupling) (Bers, 2002).
Abnormal pacemaking or conduction can lead to cardiac arrhythmia, such as long QT
syndromes (LQTS), a precursor of sudden cardiac arrest. On the other hand, once the EC
coupling is impaired by disruptive Ca2+ homeostasis, the ventricular pacing will not be
controlled by sinus node rate, making the ventricle prone to arrhythmias (Splawski et al.,
2004; 2005).
Long QT syndrome is caused by either an increase in inward currents (causing the
prolonged plateau phase of ventricular action potential) or a decrease of outward currents
(causing the delayed repolarization of plateau phase of ventricular action potential)
(Morita et al., 2008). As L-type calcium current is one of the main inward currents
(Splawski et al., 2004; 2005), it is commonly believed that by modulating the inactivation
of LTCCs, Ca2+ influx can be controlled, thus rescue diseases like long QT.
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3.2 Role of LTCC inactivation in calcium homeostasis
Calcium influx regulation is critical for the normal function of cardiac cells. The amount
of Ca2+ ions can be delicately regulated by the activation and inactivation of calcium
channels. The inactivation process of LTCCs has been extensively studies in Xenopus
oocytes or HEK 293 cells (Kim et al., 2004; Zuhlke et al., 1998). The C-terminus of α1
subunit locates intracellularly and contains motifs including the IQ motif and EF hand.
Although the potential inactivation mechanisms for LTCCs are controversial, it is
generally believed that the IQ motif and the EF hand upstream the IQ motif on the α1
subunit C-terminal region are where calmodulin (CaM) is pre-associated with; and these
domains combined with I-II loop are responsible for mediating the calcium-dependent
fast inactivation (CDI) (using Ca2+ as the charge carrier) as well as the voltage-dependent
slow inactivation (VDI) (using Ba2+ as the charge carrier) of the calcium channels (Cens
et al., 2006; Kim et al., 2004; Pitt et al., 2001; Zuhlke et al., 1998).
Calcium influx is a pivotal second messenger for intracellular signal transduction to
maintain cell physiological function such as cell contraction, neurotransmitter release,
and cardiac cell excitability (Adams et al., 1986; Dewaard et al., 1998; Forder et al.,
1985). On the other hand, high intracellular calcium concentration is also toxic and
causes cell damage, which has been demonstrated in myocardial ischemia (Fleckenstein
et al., 1974) and muscle dystrophy (Wrogemann et al., 1976). Moreover, the abnormal
calcium influx is directly linked to cardiac arrhythmias (Novotny et al., 1986; Williams et
al., 1984). In my thesis work, I identified a novel role of HCN channel to control
inactivation of LTCCs.
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General materials and methods
Whole animal preparation and drugs administration
2% isoflurane mixed with oxygen at the flow rate of 2 liter/min inhaled by adult SpragueDawley (SD) rats was used for anesthetization in accordance with Animal Care and Use
Committee guidelines for implantation of catheters.
The catheter (polyurethane, 1 French size) was inserted into the jugular vein for different
doses of drug administration. ECG was measured by using two leads vector. The arterial
catheter was connected to a heparin filled pressure transducer for at least 20 minutes
before measurements are made.
In part I of chapter 1, different doses of Na3VO4 were applied for the induction of
ventricular arrhythmias. At the beginning, 3.8 mg/kg of Na3VO4 was administrated via
the catheter injection which catheter has been placed in jugular vein to induce
arrhythmias. For more severe arrhythmias induction, a relatively higher dose of Na3VO4
(5.5 mg/kg) was applied.
In part II of chapter 1, different doses of PP2, ZD7288, PP3, and isoproterenol were
applied via jugular vein to see effects on HRV. High dose of PP2 (0.3 mg/kg) or ZD7288
(0.7 mg/kg) as well as low dose of PP2 or ZD7288 (0.2 mg/kg) were applied whereas the
dose of 0.2 mg/kg was applied in PP3 (negative control of PP2). For isoproterenol, 0.4
µg/kg was applied as the positive control.
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The data were recorded and analyzed using cardiovascular continuous monitoring
software (PowerLab/4SP, ADInstruments, Colorado Springs, CO). Values for
hemodynamic measures are derived by 1KHz sampling rate. All the results are repeated
by at least 10~12 times (n=10~12).
cDNA plasmid preparation
For HCN4 and HCN4-D553N cDNA plasmids, the human version of HCN4-pcDNA1.1
was kindly provided by Dr. U. B. Kaupp and subcloned into pcDNA3.1 vector. HCN4D553N-pcDNA3 was made by substituting aspartic acid with asparagine using PCR.
HCN4-D553N-DsRed was made by subcloning HCN4-D553N into the DsRed vector.
RPTPα was a generous gift from Dr. Jan Sap (University of Copenhagen, Copenhagen,
Denmark). The constitutively active form of Fyn, FynY531F, in pcDNA3.1 vector, was
kindly provided by Dr. Shigeru Kanda (Nagasaki University, Nagasaki, Japan). The
constitutively active form of Yes (YesY537F) was kindly provided by Dr. Arkadiusz
Welman (Edinburgh Cancer Research Center), and we subcloned it into the pcDNA3.1
vector. Src529 (SrcY529F) was purchased from Upstate Biotechnology (Millipore). For
simplicity, we also use Src, Fyn, and Yes and Src529, Fyn531, and Yes537 in the text for
interchangeable use with the constitutively active form of each kinase: SrcY529F,
FynY531F, and YesY537F.
For HCN2 DNA plasmids, mouse HCN2 cDNA in an oocyte expression vector, pGH,
was initially obtained from Drs. Bina Santoro/Steve Siegelbaum (Columbia University).
We subcloned it into the EcoRI/XbaI sites of pcDNA3.1 mammalian expression vector
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(Invitrogen) for functional expression in mammalian cells. RPRPα inserted in pRK5
vector was kindly provided by Dr. Jan Sap (University of Copenhagen, Denmark).
Cell culture and plasmids transfection
For the study of HCN currents, HEK293 cells were grown in Dulbecco's modified Eagle's
medium (Invitrogen), supplemented with 10% fetal bovine serum, 100 IU/ml penicillin,
and 100 g/liter streptomycin. Cells with 50–70% confluence in 6-well plates were used
for plasmid transfection (2-5 μg for each plasmid transfection) using Lipofectamine2000
(Invitrogen). For the study of LTCC inactivation, an HEK293 cell line stably expressing
α2δ/β1 was kindly provided by Dr. Richard Tsien (Stanford University). Culture of these
cells was similar to that described above except for addition of antibiotics, G418 (0.5
mM/ml) and 5 mM L-glutamine, to the DMEM. Primary embryonic day 18 rat
hippocampus neurons were used for studying the interaction between α1C and HCN2.
Neuron culture and plasmid transfection were completed following the instruction manual
(Invitrogen).

Whole-cell patch technique
For recording IHCN4, day 1 (24–30 h) up to day 4 (90–98 h) post-transfection HEK293
cells with green fluorescence were selected for patch clamp studies. The HEK293 cells
were placed in a Lucite bath in which the temperature was maintained at 25 ± 1 °C by a
temperature controller (Cell MicroControls). IHCN4 currents were recorded using the
whole cell patch clamp technique with an Axopatch-200B amplifier. The current
amplitude of HCN4 or D553N current is defined as the amplitude of the onset timedependent inward current elicited by the hyperpolarizing pulse, excluding the instant
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jump at the beginning of the pulse. The current density is the current amplitude divided
by the cell capacitance measured in each cell studied. The pipettes had a resistance of 2–4
MΩ when filled with internal solution: 6 mM NaCl, 130 mM potassium aspartate, 2 mM
MgCl2, 5 mM CaCl2, 11 mM EGTA, and 10 mM HEPES; pH was adjusted to 7.2 by
KOH. The external solution contained 120 mM NaCl, 1 mM MgCl2, 5 mM HEPES, 30
mM KCl, 1.8 mM CaCl2; pH was adjusted to 7.4 by NaOH. The Ito blocker, 4aminopyridine (2 mM), was added to the external solution to inhibit the endogenous
transient potassium current, which can overlap with and obscure IHCN4 tail currents
recorded at +20 mV. The data were acquired by CLAMPEX and analyzed by
CLAMPFIT (pClamp 8; Axon).
For IHCN4 analysis, the data are shown as the means ± S.E. The threshold activation of
IHCN4 is defined as the first hyperpolarizing voltage at which the first time-dependent
inward current can be observed. Student's t test was used for statistical analysis with p <
0.05 being considered statistically significant. Time constants were obtained by using
Boltzmann best fit with one exponential function on current traces that reach steady state.
HCN4 activates slowly, and the cells would not tolerate pulses sufficiently long to reach
the steady state. We therefore used the following approach to obtain an accurate estimate
of the steady state activation (Arinsburg et al., 2006). The onset current traces were fitted
with a single exponential function to 30–40 s to allow estimates of steady state current
levels. The fitted current amplitudes were then divided by the driving force (the
difference between test pulses and the reversal potential that was measured in each cell)
to obtain the conductance at each test pulse. The activation curves were constructed by
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normalizing the conductance to its maximal value in response to the most negative test
pulse.
For recording IHCN2, day 1 (24–30 h) up to day 4 (90–98 h) post-transfection, HEK293
cells with green fluorescence were selected for patch clamp studies. The HEK293 cells
were placed in a Lucite bath in which the temperature was maintained at 25 ± 1 °C by a
temperature controller (Cell MicroControls, Virginia Beach, VA).
IHCN2 were recorded using the whole-cell patch clamp technique with an Axopatch-200B
amplifier. The pipettes had a resistance of 2–4 megohms when filled with internal
solution (mM) as follows: NaCl 6, potassium aspartate 130, MgCl2 2, CaCl2 5, EGTA 11,
and HEPES 10; pH adjusted to 7.2 by KOH. The external solution contained (mM) the
following: NaCl 120, MgCl2 1, HEPES 5, KCl 30, CaCl2 1.8, and pH was adjusted to 7.4
by NaOH. The Ito blocker, 4-aminopyridine (2 mM), was added to the external solution to
inhibit the endogenous transient potassium current, which can overlap with and obscure
IHCN2 tail currents recorded at 20 mV. Data were acquired by CLAMPEX and analyzed
by CLAMPFIT (pClamp 8, Axon Instruments).
For IHCN2 analysis, data are shown as mean ± S.E. The threshold activation of If is defined
as the first hyperpolarizing voltage at which the time-dependent inward current can be
observed. Student's t test was used for statistical analysis with p < 0.05 being considered
as statistically significant. Time constants were obtained by using Boltzmann best fit with
one exponential function on current traces that reach steady state.
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For the study of LTCC inactivation, patch-clamp recordings are the same as previously
reported (Huang et al., 2008). The pipettes had a resistance of 2–5 M when filled (in
mM): 108 CsCl, 4 MgCl2, 9 EGTA, and 9 HEPES. The bath solution contained (in mM)
2 BaCl2, 1 MgCl2, 10 HEPES, 40 tetraethylammonium, 10 glucoses, and 65 CsCl. Both
solutions were adjusted with CsOH to pH 7.2. Unless specifically mentioned in the text,
the Ba2+ currents (IBa) were recorded at +10 mV from a holding potential of –90 mV. IBa
current inactivation was sometimes normalized for better comparison of kinetics in
different combinations of plasmids coexpressed in different HEK-293 cells.
Normalization is indicated without vertical scales; where vertical scales are present, P/4
protocols were used to remove the leak currents. The capacitive currents were minimized
with 75–85% series resistance compensation.

Confocal fluorescent imaging
HEK293 cells transfected with HCN4-DsRed or HCN4-DsRed-D553N or ER marker
KKXX or stained by FMI34 (cell membrane dye) were incubated on coverslips and fixed
in 4% paraformaldehyde/PBS for 15 min and then washed with PBS (10 mM phosphate
buffer, 150 mM NaCl, pH 7.4) for 5 min for three times, followed by blocking in 1%
bovine serum albumin/PBS, pH 7.4, for 60 min. After washing six times in PBS, the
coverslips were mounted on slide glasses using Fluoromount G (Southern
Biotechnology). The cells were imaged by a LSM510 confocal microscopy using a PlanNeofluar 40×/0.75 objective or a Plan-Apochromat 63×/1.4 Oil differential interference
contrast M27 objective. For DsRed imaging, a 1.2-milliwatt 543-nm HeNe laser was used
for excitation, and a 560–615-nm BP emission filter was used for emission.
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For hippocampal neurons, live-cell images of hippocampal neurons were visualized using
an inverted Nikon TE2000S epifluorescent microscope with Prior filter wheels and a
Photometrics Coolsnap HQ charge-coupled device camera.
Fluorescence recovery after photobleaching (FRAP)
HEK 293 cells transfected with different combinations of plasmids were placed under
LSM510 microscope and stimulated by the laser beam. 480nm was used for GFP.
Briefly, FRAP parameters in Capture Preferences was set followed by searching a region
to be FRAPed using Focus Window (Eric et al., 2001; Brian et al., 2005). The region of
interests was then photobleached by Laser beam. The data were then analyzed by Igor
software for the calculation of decay time.
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Chapter1
Establishment of a Rat Arrhythmia Model without Structural
Remodeling for Studying Ventricular Arrhythmias
The goal of the work presented in this chapter is to explore the potential role of tyrosine
phosphorylation in cardiac arrhythmias. Two parts are included. Part I summarizes the
role of tyrosine phosphorylation in ventricular arrhythmias. Part II summarizes the role of
tyrosine phosphorylation in heart rate variability.
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Part I: Inhibition of Tyrosine Phosphatase activity induces ventricular
arrhythmias
Abstract
Using a small molecule, sodium orthovanadate (Na3VO4) to inhibit the cellular tyrosine
phosphatase activity, we have reproducibly detected several major ventricular
arrhythmias. At the dose of 3.8 mg/kg, frequent premature ventricular contractions
(PVCs) can be induced leading to ventricular tachycardia (VT). Fragmented QRS, a
strong marker of abnormal conduction in the ventricle, also appeared. At the higher dose
(5.5 mg/kg), the most severe ventricular arrhythmia, ventricular fibrillation, occurred.
Our goal is to develop a rat model with controllable occurrence of ventricular
arrhythmias without cardiac structural remodeling, providing a reliable small animal
model to study the novel mechanisms of ventricular arrhythmias and to develop new
antiarrhythmic drug for treatment of patients without structural heart disease.
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Introduction
Major heart diseases (ischemia, hypertrophy, heart failure) are associated with ventricular
arrhythmias leading to sudden cardiac death (Hernan et al., 1996; Hynes et al., 2002;
Mammarella et al., 2000; Wolfe et al., 1991). Ventricular arrhythmias also cause cardiac
death without cardiac structural remodeling. The underlying mechanisms are unknown,
and are hard to study due to lack of a good animal model with inducible and controlled
ventricular arrhythmias.
Previous animal models for studying arrhythmias frequently used (Hynes et al., 2002)
aorta bandage to create ischemic condition (Billman, 2002; 2005), (2) fast pacing to
induce heart failure (Shinbane et al., 1997; Moe et al., 1998; Kashem et al., 2003; Timek
et al., 2003), (3) genetic ablation (Benkusky et al., 2007). Significant progress has been
made regarding the underlying mechanisms of a variety of cardiac arrhythmias. All these
studies have led to the ion channel remodeling under each condition. These studies
created either a structural change in heart (ischemia, heart failure) or an altered
expression level of a specific protein. However, it remains as a puzzle as to how heart
stop beating without structural changes and unaltered expression levels of relevant
proteins. In fact, an ion channel protein has multiple functions. For example, the
selectivity of a channel is controlled by the amino acids lining in the pore regions
between S5 and S6 domains. The activation, inactivation and deactivation of a channel
can be controlled by amino acids in the N- or C-terminal regions (Staes et al., 2001;
Gustina et al., 2011; Takahiro et al., 2007). In addition, the gating kinetics of a channel
can be controlled by amino acids in other transmembrane domains (Hanlon et al., 2002).
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These biophysical studies have led to the recent discoveries of many single amino acid
mutations of channels identified in patients with arrhythmias such as long QT (Moss et
al., 2005; Hedley et al., 2009).
To explore new mechanisms independent of cardiac structural changes, seen in ischemia
and heart failure, or mutations in ion channels, we established an inducible rat arrhythmia
model to investigate how altered state of tyrosine phosphorylation might be relevant to
the arrhythmogenesis.
Tyrosine phosphorylation has recently been demonstrated to be involved in the regulation
of gating properties and surface expressions of pacemaker channels, which may in turn
result in the alteration of cardiac tune (Huang et al., 2008; Lin et al., 2009). Inhibition of
tyrosine phosphatases may associate with the enhancement of tyrosine kinase-mediated
tyrosine phosphorylation and thus change the ventricular activity.
Our results showed that sodium orthovanadate, a tyrosine phosphatase inhibitor (Gordon,
1991), can reliably induce several types of ventricular arrhythmias at relatively low
doses. These results indicated our initial success in the establishment of a valid in vivo rat
model for studying the novel mechanisms (such as tyrosine phosphorylation) of
ventricular arrhythmias in the absence of cardiac structural remodeling and channel
mutations.
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Results
In this study, two different doses of sodium orthovanadate were administrated via jugular
vein injection. In order to investigate whether ventricular arrhythmias can be induced, I
applied the dose of sodium orthovanadate at 3.8 mg/kg. PVC, fragmented QRS (Fig 2),
and ventricular tachycardia (VT) (Fig 3) can be induced by this dose in comparison with
the basal (Fig 1). It is worth to notice here that Torsades de pointes, a rapid, polymorphic
ventricular tachycardia, followed by frequent VT can also be recorded at the dose of 3.8
mg/kg (Fig 3).
For the more serious ventricular arrhythmias induction, an increasing dose up to 5.5
mg/kg sodium orthovanadate was applied. The reliable induction of ventricular
fibrillation can be recorded by this dose (Fig 4).
These results suggested that different types of ventricular arrhythmias can be reliably
induced depending upon different doses of sodium orthovanadate administration. Thus,
this established animal model can be served as a good model to study ventricular
arrhythmias mediated by the alteration of tyrosine phosphorylation state.
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0.5 mv

ECG (mv)

0.5 mv

ECG (mv)

2.5 s

0.25 s

Fig 1. Normal ECG in anesthetized SD rats.
Upper panel indicates the overview of the measurement of ECG. Lower panel indicates
the enlarged scope from the upper panel. X-axis represents the time scale (sec), Y-axis
represents the amplitude (mv) of ECG.
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0.5 mv

ECG (mv)

0.2 mv

ECG (mv)

0.05 s

0.03 s

Fig 2. PVC and fragmented QRS were induced by Na3VO4 at the dose of 3.8 mg/kg.
Upper panel represents multiple PVCs (black arrow) whereas lower panel indicates
fragmented QRS (black arrow) which were induced in a dose of 3.8 mg/kg.
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Fig 3. Ventricular tachycardia (VT) was induced by Na3VO4 at the dose of 3.8
mg/kg.
Torsades de pointes, a rapid, polymorphic ventricular tachycardia, followed by frequent
VT (black arrow in upper panel) can also be recorded by applying Na3VO4 at the dose of
3.8 mg/kg. Red line enclosed traces indicates the enlarged scope of VT from the upper
panel.
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1 mv

ECG (mv)

1 mv

ECG (mv)

15 s

1s

Fig 4. Ventricular Fibrillation (VF) was induced by Na3VO4 at the dose of 5.5
mg/kg. Upper panel indicates the overview of VF (black arrow) whereas red line
enclosed traces represents the enlarged scope from the upper panel.
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Discussion
Several cardiac diseases such as ischemia, hypertrophy, and cardiac sudden death are
associated with ventricular arrhythmias. However, the underlying mechanism of how
ventricular arrhythmias occur is still obscure due to lack of a feasible animal model with
the controlled ventricular arrhythmias. By using sodium orthovanadate, a tyrosine
phosphatase inhibitor, we established a valid small-molecule inducible rat model to study
the mechanisms of ventricular arrhythmias without cardiac structural remodeling.
Sodium orthovanadate is a small molecule which can rapidly enter the cell to inhibit
cellular tyrosine phosphatase activity. Our previous studies demonstrated that tyrosine
phosphorylation was involved in the regulation of surface expression and gating
properties of HCN channels, which may consequently lead to the alteration of ventricular
activities (Huang et al., 2008; Lin et al., 2009). Thus, reduced tyrosine phosphatase
activity may be involved in tyrosine kinase activity increasing and tachycardia-mediated
ventricular arrhythmias. Surprisingly, by using two different doses of sodium
orthovanadate, our results demonstrated that different dose-based types of ventricular
arrhythmias can be reliably induced, possibly through increasing HCN channel activities
(either increase surface expressions or gating properties) mediated by increased tyrosine
phosphorylation.
This model will help us understand how tyrosine phosphorylation contributes to
ventricular arrhythmogenesis and is useful in effort to test small molecules to delay and
ultimately inhibit the incidents of ventricular arrhythmias which in most situations are
lethal.
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Part II: Inhibition of Src kinase activity reduces heart rate without
significant alteration of heart rate variability
Abstract
Heart rate variability (HRV) is the cardiac index representing the oscillation of the
intervals between consecutive heartbeats (RR intervals in the ECG). It reflects the
influences of the autonomic nervous system (ANS) on the sinus node. In order to
investigate the involvement of tyrosine phosphorylation in cardiac function of the whole
rat system and its effect on HRV, we employed a potent selective inhibitor of Src family
kinases, PP2 (4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyramidine), to
inhibit the activity of Src kinases that include Src, Fyn, and Yes.
Heart rate was decreased 20% by PP2 at the dose of 0.2 mg/kg. PP3, a negative control
compound of PP2, which does not inhibit the activity of Src kinases decreased heart rate
by 8% (when at the identical dose of 0.2 mg/kg) when compared with the basal.
Interestingly, HRV was not significantly altered at a relatively low dose of PP2 (0.2
mg/kg) when compared with that of PP3 or the basal. Unlike that of PP2, HRV was
significantly decreased after application of 0.4 μg/kg isoproterenol. Similar to that of
PP2, ZD7288, a specific inhibitor of HCN channels, when at the low dose of 0.2 mg/kg,
was able to decrease the heart rate without significant change of HRV in comparison to
isoproterenol.
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Furthermore, atrial ventricular block (AV block) can be induced at the higher dose of PP2
(0.3 mg/kg) whereas in ZD7288, higher dose application (0.7 mg/kg) can elicit both
premature ventricular contraction (PVC) and AV block.
Although PP2 and ZD7288 slightly increased the short-term (SD1) and the long-term
(SD2) HRV, larger degree of increase in SD1 or SD2 was observed in isoproterenol. The
fractal scaling exponent alpha 1 (α1) in basal level was 0.640, which was comparable to
that of PP3 (0.605), but slightly decreased in PP2 (0.328) and ZD7288 (0.144) at the low
dose of 0.2 mg/kg.
Overall, PP2, like ZD7288, can serve as a potential candidate in the treatment of
tachycardia-induced arrhythmias via inhibition of Src-mediated tyrosine phosphorylation.
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Introduction
Sudden cardiac death caused by cardiac arrhythmias has affected nearly 300,000 people
in the United States every year and contributes to approximately 50% of all death of
cardiovascular causes (Myerburgh et al., 1997). Tachycardia, represented fast heart beat,
has been demonstrated to be the common reason to cause cardiac arrhythmias (Kannel et
al., 1987; Willich et al., 1987). However, the underlying mechanism of cardiac
arrhythmias is still obscure. In the previous study by using tyrosine phosphatase inhibitor
sodium orthovanadate in a whole animal rat model, we demonstrate that different degree
of ventricular arrhythmias can be reliably induced by decreasing endogenous tyrosine
phosphastase activity. Here we demonstrated that reduction of Src-mediated tyrosine
phosphorylation by its specific inhibitor PP2 decreased the heart rate to nearly 20% at
low dose of 0.2 mg/kg in comparison to the basal.
HRV is the cardiac index representing oscillation of RR interval of ECG, reflecting the
effect of autonomic system on the sinus node. Accumulating evidence indicates that there
is a strong association between the compromised autonomic nervous system and sudden
cardiac death (Jouven et al., 2005; Schwartz et al., 1992; 1998). HRV has been widely
used to measure alterations in the autonomic nervous system, which in turn influences the
rhythm of heart. Several studies have shown that decreased HRV can serve as a powerful
predictor for sudden cardiac death than established clinical predictors such as left
ventricular ejection fraction (Bauer et al., 2006; Makikallio et al., 2005; Scmiddt et al.,
1999). Decreased HRV has also been shown to be directly link to the risk of long-term
mortality (Laitio et al., 2000; 2002; 2004; Stein et al., 2001; Wu et al., 2005). Thus, a
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treatment of sudden cardiac death by strategically decrease tachycardia-induced
arrhythmias with little change of HRV is especially important for the sudden cardiac
death.
Here, we found that the inhibition of Src-mediated tyrosine phosphorylation by its
specific inhibitor PP2 can significantly decrease heart rate at a relatively low dose
without a significant alteration of HRV (in comparison with the effect of isoproterenol on
HRV). Thus, PP2, like ZD7288, may serve as a potential candidate in the treatment of
tachycardia-induced arrhythmias via inhibition of Src-mediated tyrosine phosphorylation
when at relatively low dosage.
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Results
Representative traces of ECG in the administration of different drugs
In Fig 1, high dose of PP2 (0.3 mg/kg) or ZD7288 (0.7 mg/kg) (lower panel) as well as
low dose of PP2 or ZD7288 (0.2 mg/kg) (upper panel) were applied and exhibit the
waveforms of ECG. At the high dose of PP2, multiple AV block can be induced. PVC
(dash arrow) or AV block (black line) can also be elicited at high dose of ZD 7288 (lower
panel). The identical low dose (0.2 mg/kg) of PP3 was applied as a negative control of
PP2. The dose of 0.4 μg/kg isoproterenol was used as the positive control of PP2 and
ZD7288 effects on heart rate and HRV.
The effects of different drugs on HRV
In Fig 2, the distribution pattern of HRV reveals bell shape distribution in the basal (the
first left and middle panel). HRV was slightly decreased by PP2 (the fourth panel) in
comparison to isoproterenol which significantly decreased HRV (the second panel). PP3
or ZD7288 reduces HRV very slightly in comparison to the basal. We also compared the
distribution pattern of heart rate and HRV. Interestingly, the distribution pattern of heart
rate in each drug is comparable (right panels) to that of HRV.
HRV analysis in Poincare Plot
Poincare plot is a geometric method normally used for dynamic analysis of HRV in
which the correlation between each RR interval and the preceding RR interval can be
plotted, indicating the degree of RR interval complexity. As indicated in Fig 3, Poincare
plot analysis includes the parameters of short-term HRV (SD1) and long-term HRV
(SD2), which slightly increase in PP2 (SD1=10.0, SD2=7.1) and ZD7288 (SD1=5.6,
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SD2=5.9), but significantly increased in isoproterenol (SD1=30.9, SD2=30.3) in
comparison to the basal (SD1=1.1, SD2=1.2). The values of SD1 and SD2 in PP3
(SD1=1.8, SD2=1.6) were more comparable to those in the basal, indicating that PP3 has
the similar beat-to-beat variability with the basal.
The fractal scaling exponent alpha 1 (α1) is the slope of the plot between logarithm of the
RR interval fluctuation and the logarithm of the size of time scale indicating selfsimilarity of heart rate dynamics, representing how random of heart rate dynamics is. In
PP3, the value of α1 was 0.605, which is comparable to that of basal level (0.640). The
values of α1 were slightly decreased in PP2 (0.328) and ZD7288 (0.144) at a relative low
dose of 0.2 mg/kg in comparison to the basal and isoproterenol (α1 slightly increase
(0.742)).
HRV results in the presence of different drugs administration
Table 1 is the summary of the representative values of different parameters for each drug.
We applied 0.2 mg/kg in PP2, PP3, and ZD 7288, and 0.4 μg/kg in isoproterenol. Each
experiment was repeated at least ten times (n=10-12). From this table, heart rate
significantly decreased 20% in PP2 and 35% in ZD7288 when compared with the basal.
PP3 can also decrease heart rate by 8%. The percentage decrease of heart rate is identical
to the percentage increase of mean RR. The longer the RR interval is, the slower the heart
rate will be. Standard deviation of R-R interval (STD RR) revealed slight increasing in
PP2 (8.7) and ZD7288 (5.7) whereas significantly increase in isoproterenol (30.6) in
comparison with PP3 (1.8) and the basal (1.1). SD1, SD2, and α1 have been analyzed in
Fig 3 where there is a slight change in PP2.
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Overall, our data strongly demonstrate that PP2 is able to reduce heart rate without a
significant alteration of HRV (in comparison to the effect of isoproterenol on HRV).
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normal

(0.4 µg/kg)

Iso

PP3

(0.2 mg/kg)

(0.2 mg/kg)
PP2

(0.3 mg/kg)

(0.2 mg/kg)
ZD7288

(0.7 mg/kg)
0.2sec

Fig 1. ECG in PP2, ZD7288, and controls.
Representative waveforms of ECG can be recorded in the presence of different drugs.
High dose of PP2 (0.3 mg/kg) or ZD7288 (0.7 mg/kg) as well as low dose of PP2 or
ZD7288 (0.2 mg/kg) were applied and the waveforms of ECG were exhibited. In PP2, the
upper panel represents the ECG in low dose application whereas in high dose application
in the lower panel. Multiple AV (black arrow) block can be induced at high dose
application of PP2. In ZD7288, high dose application (lower panel) can also elicit PVC
(dash arrow) or AV block (black arrow). PP3, a negative control of PP2, was applied at
the dose of 0.2 mg/kg for the comparison with low dose of PP2. 0.4 μg/kg isoproterenol
was applied for the positive control of PP2 and ZD7288. The ECG of the basal was also
shown in the first panel as the control (n=10).
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normal

Iso

PP3

PP2

ZD7288

Fig 2. HRV in PP2, ZD7288, and controls.
HRV reveals bell shape distribution pattern in the basal (the first left and middle panel).
Isoproterenol (the second panel) reveals significant whereas PP2 (the fourth panel)
indicates slight reduction of HRV. PP3 or ZD7288 reduces very slightly in HRV in
comparison with the basal. The distribution pattern of HR in each drug is in an inverse
trend (right panels) with that of HRV since HR is inversely proportional to HRV. The
figure shown above is the representative HRV for each drug (n=10-12).

38

normal

PP3

Iso

PP2

ZD7288

Fig 3. HRV analysis in Poincare Plot.
Poincare plot analysis also revealed that both of short-term HRV (SD1) and long-term
HRV (SD2) were slightly increased in PP2 and ZD7288, but significantly increased in
isoproterenol in comparison with the basal. The fractal scaling exponent alpha 1 (α1) in
basal level is 0.640, which is comparable with that of PP3 (0.605), but decrease in PP2
(0.328) and ZD7288 (0.144) at the low dose of 0.2 mg/kg.
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Drugs/Variable

Mean HR (bmp) Mean RR (ms) STD RR (ms) SD1 (ms) SD2 (ms)

α1

Basal

320

187.2

1.1

1.1

1.2

0.640

Iso

380

161.2

30.6

30.9

30.3

0.742

PP3

294

203.6

1.8

1.6

2.0

0.605

PP2

259

231.3

8.7

10.0

7.1

0.328

ZD7288

205

291.5

5.7

5.6

5.9

0.144

Table 1. HRV results with drugs.
The representative values of different parameters for each drug were calculated from the
kubios software. The applied dose of PP2, PP3 and ZD7288 was at 0.2 mg/kg whereas
isoproterenol was at 0.4 μg/kg. Each experiment was repeated at least ten times (n=1012). The values shown above were selected from the representative data.
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Discussion
Heart rate variability includes time domain and frequency domain which is normally used
to depict the effects of autonomic nervous system on the sinus node. Time domain
includes the parameters of RR interval, standard deviation of RR interval (STD RR).
Frequency domain includes the parameters of short-term HRV (SD1) and long-term HRV
(SD2) in Poincare plot as well as the fractal scaling exponent alpha 1 (α1) (Goldberger et
al., 2002; Peng et al., 1995; Pumprla et al., 2002; RajendraAcharya et at., 2006;
Thuraisingham et al., 2006).
Poincare plot is a geometric method normally used for dynamic analysis of HRV in
which the correlation between each RR interval and the preceding RR interval is plotted.
It represents the degree of RR interval complexity. There are two parameters used for
Poincare plot analysis: short-term HRV (SD1) and long-term HRV (SD2). SD1
represents the points vertical to the line of identity and reflects beat-to-beat variability.
SD2 represents the dispersion of the RR interval points along the line of identity and
reflects the long-term records of HRV (Brunetto et al., 2005; Smith et al., 2007). Our data
reveal slight increase of SD1 and SD2 in PP2 and ZD7288 indicating PP2 and ZD7288
will not significantly change the RR interval.
α1 is the slope of the plot between logarithm of the RR interval fluctuation and the
logarithm of the size of time scale, representing self-similarity of HR dynamics: how
random of the relationship between logarithm of the RR interval fluctuation and the
logarithm of the size of time scale. When compared with the control, the higher or lower
number indicates the random of RR interval dynamics (which means in less fractal
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pattern) (Peng et al., 1993; Weibel et al., 1991). The slight decrease of α1 in PP2 and
ZD7288 when compared with PP3 and the basal represented that these two drugs will not
significantly cause the loss of fractal correlation properties of HR dynamics toward more
random HR dynamics.
ZD7288, a selective blocker of HCN channel, has become a potent drug clinically used
for the treatment of tachycardia in Europe. Here, we test the effect of ZD7288 on HRV as
the comparison with PP2. Our results indicate that at the low dose (0.2 mg/kg) of
ZD7288 and PP2, heart rate was significantly reduced nearly 35% and 20%, respectively,
when compared with the basal (which inversely corresponds to the percentage change of
mean RR interval) with slight change of HRV. However, PP3, a negative control
compound of PP2, which does not inhibit the activity of Src kinases, can decrease heart
rate by 8%. Whether PP3 involves in signal cascades that contribute to the regulation of
heart rate is still unknown and need to be investigated. A β adrenergic receptor agonist,
isoproterenol, is also applied here as a positive control showing the increase of the heart
rate. Especially, the distribution pattern of the RR interval in ZD7288 and PP2 has a
slight change in comparison to that of the basal or PP3.
Our previous studies demonstrated that Src-mediated tyrosine phosphorylation plays a
pivotal role in the regulation of activities of HCN channels in HEK 293 cells. Reduced
Src-mediated tyrosine phosphorylation results in deceased activities of HCN channels
including reduction of surface expression and gating properties of the channels. PP2, a
specific Src kinase inhibitor, can reduce surface expression and gating properties of HCN
channels via decrease Src-mediated tyrosine phosphorylation in HEK 293 cells. In order
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to see whether PP2 can affect the heart rate through decrease of HCN channel activities,
we employ a whole animal rat in this study to investigate the potential role on the heart
rate regulation. Indeed, we found that the heart rate was significantly reduced after
applying PP2 within the time scale of minutes at a relative low dose.
The different percentage decrease of heart rate in ZD7288 and PP2 may be due to
intrinsically mechanistic difference. ZD7288 inhibits HCN channels by penetrating into
the cells and directly blocks the pore region of the channels. As HCN channels are the
pacemaker channels associated with the heart rate, inhibition of the channels by ZD7288
results in more efficient reduction of the heart rate than PP2. Src-mediated tyrosine
phosphorylation regulates gating properties of other ion channels and exchangers, which
can contribute to an increase in heart rate.
The association between Src and adrenergic receptors has been reported in the previous
study (Huang et al., 2004; Naohiro et al., 2007). The slight effect of PP2 on HRV may be
attributed to disruption of this association where the inhibition of Src kinases by PP2 may
somehow cause the change of adrenergic receptor-mediated signal cascades and slightly
influence HRV. Further studies are needed for the confirmation.
Atenolol (used to substitute the non-specific propranolol) and Metoprolol are the β1specific inhibitors used for the treatment of cardiac arrhythmias. However, side effects
caused by them implicate the potential problems. Through significant reduction of heart
rate by decreased Src-mediated tyrosine phosphorylation, our studies strongly indicate
that PP2 may serve as a potential candidate for the treatment of tachycardia-induced
arrhythmias without significant alteration of HRV.
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Chapter 2
Elucidate cellular mechanisms of tyrosine phosphorylation in
the regulation of heart rate and cardiac arrhythmias
The goal of this chapter is to elucidate the cellular mechanism of tyrosine
phosphorylation in the regulation of cardiac pacemaker channels that directly contribute
to the regulation of heart rate and their potential new role in cardiac arrhythmias. Two
parts are included. Part I summarizes the role of tyrosine phosphorylation in rescuing a
trafficking defective pacemaker channel mutant. Part II summarizes the role of tyrosine
phosphorylation in the modulation of pacemaker channels. The results in this chapter
have been published (J Biol Chem 284: 30433-30440, 2009).
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Part I: Rescue of a Trafficking Defective Human Pacemaker
Channel via a Novel Mechanism: Role of Src, Fyn, and Yes
Tyrosine Kinases
Abstract
Therapeutic strategies such as using channel blockers and reducing culture temperature
have been used to rescue some long QT-associated voltage-gated potassium Kv
trafficking defective mutant channels. A hyperpolarization-activated cyclic nucleotidegated HCN4 pacemaker channel mutant (D553N) has been recently found in a patient
associated with cardiac arrhythmias including long QT. D553N showed the defective
trafficking to the cell surface, leading to little ionic current expression (loss-of-function).
We show in this report that enhanced tyrosine phosphorylation mediated by Src, Fyn, and
Yes kinases was able to restore the surface expression of D553N for normal current
expression. Src or Yes, but not Fyn, significantly increased the current density and
surface expression of D553N. Fyn accelerated the activation kinetics of the rescued
D553N. Co-expression of D553N with Yes exhibited the slowest activation kinetics of
D553N. A combination of Src, Fyn, and Yes rescued the current expression and the
gating of D553N comparable with those of wild-type HCN4. In conclusion, we
demonstrate a novel mechanism using three endogenous Src kinases to rescue a
trafficking defective HCN4 mutant channel (D553N) by enhancing the tyrosine
phosphorylation of the mutant channel protein.
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Introduction
Defective trafficking leading to the reduced surface expression of ion channels is one of
the mechanisms responsible for a loss-of-function of the ion channel on the plasma
membrane (Delisle et al., 2004). Several methods have been developed to rescue the
voltage-gated potassium Kv trafficking defective channels: reducing the culture
temperature, applying the channel blockers, altering the molar ratio of glycerol, and using
the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase inhibitor thapsigargin (Delisle et
al., 2003; Furutani et al., 1999; Paulussen et al., 2002; Zhou et al., 1998; 1999;).
Hyperpolarizing-activated cyclic nucleotide-gated (HCN) pacemaker channels generate
time- and voltage-dependent inward currents, named Ih in neurons or If in the heart
(Robinson et al., 2003). They are important in various cell functions including
excitability, synapse transmission, and rhythmic activity (Robinson et al., 2003). The
most well studied regulation of If is its response to autonomic stimulation. β-Adrenergic
receptor activation increases and acetylcholine receptor activation decreases the
intracellular cAMP levels, which in turn increases/decreases If by binding to the cyclic
nucleotide-binding domain of the HCN channels, respectively (Robinson et al., 2003).
Other important mechanisms for the modulation of If/HCN channels have recently been
found including β-subunit (Yu et al., 2001), lipids (Fogle et al., 2007; Pian et al., 2006),
and p38 mitogen-activated protein kinase (Poolos et al., 2006).
Accumulating evidence has revealed tyrosine phosphorylation as an important
mechanism for modulation of HCN channel properties (Arinsburg et al., 2006; Li et al.,
2008; Wu et al., 2000; Yu et al., 2006; Zong et al., 2005). An acute increase in tyrosine
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phosphorylation of If or HCN channels increases the channel activity, including an
increase in the current amplitude, a positive shift of the voltage-dependent activation, an
acceleration of activation kinetics, and an increase in whole cell conductance (Arinsburg
et al., 2006; Li et al., 2008; Wu et al., 2000; Yu et al., 2006). Recently, we discovered
that the cell surface expression of HCN2 channels can be remarkably inhibited by
tyrosine dephosphorylation mediated by receptor-like protein tyrosine phosphatase α
(RPTPα) and increased by tyrosine phosphorylation via Src kinase after long term
treatment (Huang et al., 2008).
D553N, a missense HCN4 mutant, was recently identified in a patient with cardiac
arrhythmia associated with depressed HCN gating properties (Ueda et al., 2004).
Functional and structural assays revealed that D553N expresses little ionic currents,
which is possibly due to the defective channel trafficking so that the channels cannot
reach the plasma membrane for normal functions (Ueda et al., 2004).
The Src kinase family has nine members (Thomas et al., 1997). They are closely related
and share the same regulatory function. Three of them, Src, Fyn, and Yes, are
ubiquitously expressed in a variety of tissues including neurons and myocytes (Kalia et
al., 2004; Thomas et al., 1997). Without stimulation, they are inactive. However,
mutation of key tyrosine residue results in the constitutively active form of the kinase,
SrcY529F, FynY531F, and YesY537F, respectively (Barraclough et al., 2007; Kanda et
al., 2005). Using these Src kinases, we show in this report a novel approach that can
restore the surface expression of D553N for normal current expression via tyrosine
phosphorylation.
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Results
Inhibition of HCN4 Current Expression by RPTPα
We have recently demonstrated that RPTPα can inhibit the surface expression of HCN2
channels via tyrosine dephosphorylation (Huang et al., 2008). Given the high structural
homology between HCN2 and HCN4 (>80%) (Robinson et al., 2003), it was expected
that RPTPα may also inhibit the surface expression of HCN4. Fig. 1 shows a typical
current expression of HCN4 expressed in HEK293 cells (Fig. 1A). The expression was
dramatically suppressed across the test voltages (−65 to −135 mV) when HCN4 was coexpressed with RPTPα after 1 day of transfection (Fig. 1B). The reduction in current
expression was associated with a negative shift in threshold activation (Figs. 1, A and B,
arrows). After 2 days of transfection, RPTPα almost eliminated the current expression of
HCN4 (Fig. 1C). The effect of RPTPα on HCN4 current expression is similar to that on
HCN2 current expression (Huang et al., 2008). As a control, the empty vector, pRK5
(used to subclone RPTPα), did not affect the current expression of HCN4 (Fig. 1D). Each
of these results was confirmed in additional 5–7 cells.

Inhibited Surface Expression of HCN4 by RPTPα
To further seek supporting evidence that reduced ionic current expression of HCN4 is
caused by the suppressed surface expression of HCN4 channels, we tagged HCN4 with a
fluorescent protein, DsRed, and examined the distribution of HCN4 using fluorescent
confocal microscopy. Fig. 2A shows a typical fluorescent image of HCN4 expressed
alone in a HEK293 cell (left panel). When co-expressed with RPTPα, most HCN4
channels are retained in the cytosol (middle panel of Fig. 2A). On the other hand, Src529
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significantly enhanced the cell surface expression of HCN4 (Fig. 2A, right panel). As a
control, Fig. 2B shows the fluorescence (left panel) and bright field (right panel) images
of the empty DsRed vector expressed in HEK293 cells.

Rescuing D553N Current Expression by Src, Fyn, and Yes
D553N has been recently identified in a patient suffering from sinus node dysfunction,
long QT, ventricular tachycardia, and torsade de pointes (Ueda et al., 2004). In vitro
studies of the mutant channel revealed defective surface expression on plasma membrane,
leading to the loss of current expression (Ueda et al., 2004). Given the facts that the
HCN4 channel activity including the channel surface expression can be significantly
enhanced by Src-mediated tyrosine phosphorylation and the ubiquitous expression of
three Src kinase family members (Src, Fyn, and Yes), we set forth to test the hypothesis
that the current expression of the defective trafficking D553N can be restored by
constitutively active forms of Src kinases (Src529, Fyn531, and Yes537).
Fig. 3 provides a typical set of current recordings under different conditions. The current
expression of wild-type HCN4 is shown in Fig. 3A, as compared with the loss of current
expression for D553N (Fig. 3B). Fig. 3 (C–E) shows the effects of individual Src, Fyn,
and Yes on D553N current expression, respectively. Fig. 3 (F–H) also shows the effects
of Src+Fyn, Src+Yes, and Fyn+Yes on D553N current expression, respectively. Fig. 4I
shows the overall effects of combined Src+Fyn+Yes on D553N current expression.
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For effective comparison of the actions of Src kinases on D553N to HCN4, we calculated
the current density and the activation kinetics at −125 mV, which is near the fully
activated voltage. Current density at the voltage in which all channels are open is directly
related to our central interest of evaluating whether Src kinases can rescue the surface
expression of D553N. The current densities under different conditions are shown in Fig.
4A.
Src and Yes, but not Fyn, can significantly rescue D553N current expression. Different
combinations of three kinases all enhanced the current expression of D553N (Fig. 4A,
asterisk). All three Src kinases expressed together (Fig. 3I) can restore ∼68% current
expression of D553N as compared with the wild-type HCN4 expression (Fig. 4A, dark
bars, HCN4: 37.15 ± 3.21 pA/pF, n = 7; D553N+Src/Fyn/Yes: 25.25 ± 2.17 pA/pF, n =
10) (Fig. 4A).
The effects of Src/Fyn/Yes kinases on the current activation kinetics are also different
(Fig. 4B). The time constants for activation kinetics were obtained by fitting the onset
current with one-exponential function at −125 mV under different conditions. Fyn
accelerated but Yes slowed the activation kinetics of D553N, whereas Src had no effects
(p* values). The combinations of Src+Fyn and Fyn+Yes can accelerate D553N activation
kinetics, whereas the combination of Src+Yes cannot. A combination of all three Src
kinases can speed D553N activation kinetics at −125 mV (Fig. 4, B and D); the time
constants are 4.07 ± 0.59 s (n = 3) for D553N and 1.24 ± 0.05 s (n = 9) for
D553N/Src/Fyn/Yes, respectively (p = 0.01). It is worth pointing out that in 16 D553N
transfected cells we studied only three cells that expressed time-dependent inward
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currents at −125 mV and that were used for calculating current density and activation
kinetics shown in Fig. 4 (A and B). The other 13 cells expressed no currents at the test
potentials ranging from −75mV to −135mV. As a comparison, we also showed the
statistical analysis of comparing Src kinases on D553N to HCN4 indicated by p values in
Fig. 4B.
To assess the overall functional rescuing effects of Src/Fyn/Yes on D553N gating, we
examined the biophysical properties of D553N co-expressed with Src/Fyn/Yes (Fig. 3I)
in comparison with the wild-type HCN4 (Fig. 3A). The Boltzmann equation best fit from
the averaged activation curves obtained from tail currents showed a small depolarizing
shift of D553N+Src/Fyn/Yes compared with HCN4 with no altered slope factors(s).
However, statistical analysis from the means of two groups yielded no significant
difference (V0.5_HCN4: −86.1 ± 1.5 mV, n = 7; V0.5_D553N+Src/Fyn/Yes: −81.6 ± 1.4
mV, n = 9; p = 0.0724, s_HCN4: 8.2 ± 0.2 mV, n = 7; s_D553N+Src/Fyn/Yes: 8.4 ± 0.2
mV, n = 9, p = 0.577) (Fig. 4C). On the other hand, the effects of Src kinases on D553N
activation kinetics are complex. Compared with the wild-type HCN4, the averaged
activation kinetics for D553N+Src/Fyn/Yes were slowed at the beginning of the
activation curve, accelerated near the middle of the activation curve, but statistically
indistinguishable at the potentials after the half-activation point (Fig. 4D) (n = 7 for
HCN4, n = 9 for D553N+Src/Fyn/Yes).
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Enhanced Membrane Surface Expression of D553N by Src, Fyn, and Yes Tyrosine
Kinases
We have previously shown that Src-mediated tyrosine phosphorylation increases the
HCN2 and HCN4 channel activity via shifting the activation curve to depolarizing
potentials (short term effect) and enhancing the cell surface expression (long term effect)
(Arinsburg et al., 2006; Huang et al., 2008; Li et al., 2008; Yu et al., 2004). To seek
further supporting evidence for rescuing surface expression of D553N by three Src
kinases, we constructed the D553N-DsRed fusion protein and performed the confocal
imaging experiments. Fig. 5 shows that most wild-type HCN4 is expressed on the cell
surface (Fig. 5A). By contrast, most D553N cannot reach the cell surface (Fig. 5B). Coexpression with either Src (Fig. 5D) or Yes (Fig. 5F) can significantly enhance the
surface expression of D553N. However, Fyn has been much less significant on D553N
surface expression, as evidenced by a significant amount of D553N remaining in the
cytosol (Fig. 5E). DsRed vector itself was uniformly expressed across the cell (Fig. 5C)
and served as a negative control. These results, combined with the protein biochemistry
analysis, collectively provide the cellular evidence for the functional rescue of D553N
current expression at the plasma membrane by Src/Fyn/Yes kinases.
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Fig 1. RPTPα on HCN4 current expression in HEK293 cells.
A, HCN4 current expression in response to 15-s hyperpolarizing pulses from −65 to −135
mV in 10-mV increments. Tail currents were recorded at +20 mV. B, in a cell cotransfected with RPTPα after 1 day of incubation, HCN4 current expression in response
to 10-s hyperpolarizing pulses from −65 to −135 mV in 10-mV increments. C, in a cell
co-transfected with RPTPα after 2 days of incubation, HCN4 current expression in
response to 10-s hyperpolarizing pulses from −65 to −135 mV in 10-mV increments. D,
HCN4 current expression in HEK293 cells co-expressed with the empty vector, pRK5.
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Fig 2. Src/RPTPα on HCN4 cell surface expression in HEK293 cells.
A, fluorescence imaging of HCN4-DsRed, HCN4-DsRed+RPTPα, and HCN4DsRed+Src529. B, fluorescence (left panel) and bright field (right panel) images of cells
transfected with DsRed alone.
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Fig 3. Src/Fyn/Yes kinases on current expression of D553N at −125 mV.
Currents elicited by hyperpolarizing pulses in 10-mV increments are presented for HCN4
(A), D553N (B), D553N+Src529 (C), D553N+Fyn531 (D), D553N+Yes537 (E),
D553N+Src529+Fyn531 (F), D553N+Src529+Yes537 (G), D553N+Fyn531+Yes537
(H), and D553N+Src529+Fyn531+Yes537 (I). The test potentials are labeled in the
figures. The pulse durations were 15 s for A–C, E, and G; 12 s for F, H, and I; and 6 s for
D. The holding potential was −10 mV.
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Fig 4. Src/Fyn/Yes kinases on current density and gating of D553N compared with
HCN4. A, current density measured at −125 mV under different conditions. An asterisk
indicates a statistically significant difference in comparison with D553N current density.
B, time constants of activation kinetics at −125 mV under different conditions. p values
indicated statistical significance in comparing the effects of the kinases on D553N to
HCN4 (white bar). p* values indicated statistical significance in comparing the effects of
the kinases on D553N to D553N alone (gray bar). C, activation curves of HCN4 (WT)
and

D553N+Src/Fyn/Yes.

D,

activation

kinetics

of

HCN4

(WT)

and

D553N+Src/Fyn/Yes. All of the statistical results were from seven to nine cells for each
group except for D553N (only three cells expressed little currents of 16 cells tested).
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Fig 5. Src/Fyn/Yes kinases on D553N fluorescence imaging.
Fluorescence images of cells transfected with HCN4 (A), D553N (B), DsRed vector (C),
D553N+Src529 (D), D553N+Fyn531 (E), and D553N+Yes537 (F). All of the results
were repeated in an additional eight to ten cells.
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Discussion
Defective trafficking of mutant channels represents an important mechanism for Kv
channels causing long QT2 (Delisle et al., 2004). Studying long QT related Kv channel
modulation has led to the findings that lower temperature and channel blockers can
restore the surface and ionic current expression of the defective trafficking mutant
channels (Delisle et al., 2004). In this work, we showed for the first time that by
modulating the Src/Fyn/Yes kinase activity, a human HCN4 trafficking defective mutant
D553N (also linked to long QT (Ueda et al., 2004)) can be rescued for normal surface
and current expression. The corrected D553N exhibited the gating properties comparable
with those of the wild-type HCN4 channels.
Enhanced tyrosine phosphorylation increased the activity of the cardiac pacemaker
current, If, in the sinoatrial node cells (Wu et al., 2000). Using genistein, a nonspecific
tyrosine kinase inhibitor, we found a differential modulation of tyrosine phosphorylation
for HCN1, HCN2, and HCN4 expressed in Xenopus oocytes; genistein had no effects on
HCN1 but reduced HCN2 or HCN4 current expression (Yu et al., 2004). In the case of
HCN2, there was also a negative shift in the voltage dependence of activation that
accompanied the current reduction. These studies represent the acute effects of altered
tyrosine phosphorylation of HCN channel proteins on the gating properties of If.
To investigate the long term effects of specific tyrosine kinases on HCN channels in a
mammalian background, we studied the effects of Src kinase on HCN4 channel (the main
isoform in the heart) expressed in HEK293 cells. We focused on the Src kinases for two
reasons: it mediates epidermal growth factor receptor signaling (Thomas et al., 1997) and
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Src homology 3 domain was initially used to clone the first HCN channels (Santoro et al.,
1997). We found that Src associated with and phosphorylated the HCN4 channel
proteins, leading to the enhanced HCN4 current density near diastolic potentials
(Arinsburg et al., 2006). This was the first direct evidence showing that 1) HCN4
channels can be phosphorylated by Src-mediated tyrosine kinases and 2) long term
effects of tyrosine phosphorylation of HCN4 channels can induce the changes in the
current density, which directly correlates with the number of functional channels
expressed at the plasma membrane. Accompanying the increased current density were the
accelerated activation kinetics and a positive shift in the voltage-dependent activation,
which has been typically observed in the short term modulation of HCN4 channels. These
conclusions were confirmed by the subsequent investigation on the major tyrosine
residues that mediate Src actions (Li et al., 2008). Using PP2, a selective inhibitor of Src
kinase family, we found that the reduced Src kinase activity can indeed shift the voltagedependent activation to hyperpolarizing potentials, an effect mediated by HCN4 Tyr531
(Li et al., 2008). Another tyrosine residue, HCN4 Tyr554 previously reported by others
(Zong et al., 2005), also contributed to the slowing of activation kinetics by PP2 (Li et al.,
2008).
Work on the action of PP2 on HCN4 also resulted in two surprising observations. First,
the PP2-induced negative shift of HCN4 voltage-dependent activation is not in agreement
with our previous results with genistein. At least two factors can contribute to this
discrepancy: mammalian cell (HEK293) versus amphibian (Xenopus oocytes)
background and general (genistein) versus selective (PP2) inhibition of tyrosine kinases.
Second, we found that PP2 also reduced the whole cell channel conductance (Li et al.,
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2008). These results implied that even the short term effect of altered tyrosine
phosphorylation may affect the number of functional channels at the plasma membrane.
More recently in the investigation of the potential role the tyrosine phosphatase might
play in the modulation of HCN channel function, we found the dramatic inhibition of
HCN2 current expression by RPTPα (Huang et al., 2008). The inhibited HCN2 current
expression was due to the reduced surface expression of HCN2 channels via association
between RPTPα and the HCN2 channel proteins, resulting in the channel
dephosphorylation (Huang et al., 2008). The work demonstrated a previously
unrecognized feature of HCN channel modulation by tyrosine phosphorylation: the
tyrosine phosphorylation state of HCN channel proteins represents one important
regulatory mechanism for the cell surface expression of the functional channels, which
directly determines the current expression of functional HCN channels. This feature may
be utilized to enhance the surface and ionic current expression of HCN mutant channel
that cannot reach the plasma membrane for normal function.
Indeed, the evidence presented in this work showed that the enhanced tyrosine
phosphorylation mediated by Src kinases can rescue the surface expression of D553N for
normal channel function. What was unexpected, however, is the finding that three Src
kinases that were ubiquitously expressed in the heart have different functional effects on
D553N channel activity. In agreement with the previous studies, the Src kinase-mediated
tyrosine phosphorylation is associated with the acceleration of channel activation kinetics
(Arinsburg et al., 2006; Li et al., 2008; Zong et al., 2005). These differential effects by
Src/Fyn/Yes on enhancing D553N expression and function are summarized in Table 1.
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The differential phosphorylation of both wild-type HCN4 and D553N channels by three
Src kinases suggested that different tyrosine residues are involved in mediating each of
the kinases. These results also suggested a possibility that D553N may undergo a protein
misfolding that prevents the nearby tyrosine residues from being phosphorylated.
Association of Src tyrosine kinases appears to partially correct the protein folding that
leads to the exposure of key tyrosine residues for phosphorylation.
To understand the mechanism by which tyrosine phosphorylation used to restore the
surface expression of D553N, we proposed a model utilizing the three-dimensional
crystal structure of the C-linker region of HCN2 for the following three reasons. First,
D553N mutation occurred in the C-linker. Second, there is a high homology (91.6%)
between HCN2 and HCN4 in the C-linker. Third, HCN2 is the only protein in the HCN
family whose crystal structure of the C-linker has been solved (Zagotta et al., 2003).
HCN4 Asp553 corresponds to HCN2 Asp475. Among many potential mechanisms
responsible for the defective trafficking of HCN4-D553N, protein misfolding is an
attractive one. We hypothesized that there may exist a potential electrostatic interaction
between Asp475 and Lys472 of the B′ helix. The negatively charged Asp475 is spatially
close to the positively charged Lys472, similar to the relative spatial locations of Lys472
and Glu502 of the D′ helix, which have been demonstrated to form a salt bridge critical in
maintaining the local folding of C-linker (Zagotta et al., 2003). The putative D475N
(equivalent to D553N in HCN4) mutation can cause the loss of a negative charge, which
may change the intersubunit interaction between Lys472 and Glu502 to alter local folding
of the C-linker structure. We noted that Lys472 is changed to Arg550 in HCN4. With a
guanyl group, Arg550 is more capable than Lys472 in forming multiple electrostatic
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interactions with nearby residues having negative side chains. Therefore, in HCN4D553N mutant, the potential salt bridge of Asp553 with Arg550 could be disrupted, which
affected the interaction between Arg550 and Glu580 (Glu502 in HCN2) that is critical in
intersubunit contacts (Zagotta et al., 2003). Furthermore, the Src kinase-mediated
tyrosine phosphorylation at Tyr554 residue near Asp553 could introduce a negatively
charged phosphate group, which could mimic the effect of Asp553 to rebuild the salt
bridge interaction between Arg550 and Glu580, consistent with the previous studies
demonstrating the importance of Tyr554 (Li et al., 2008; Zong et al., 2005). For wild-type
HCN4, the existing negative charge on Asp553 might repel the entry of a phosphate group
and limit the phosphorylation on certain nearby tyrosine residues.
While presenting a novel mechanism to correct the surface expression of a trafficking
defective HCN4 mutant channel, we left at least three questions unanswered. First, what
are the tyrosine residue(s) in HCN4 channel proteins that mediate the actions of Fyn and
Yes? The same tyrosine residues (such as Tyr531 and Tyr554) are unlikely to be used by all
three kinases. Fyn, not Src, accelerated D553N activation kinetics (Fig. 5B). Fyn may
target the tyrosine residues in or near A′ and B′ helices of the C-linker. On the other hand,
Yes may phosphorylate different tyrosine residues that are located outside of the Clinker, which can explain its lack of acceleration in the activation kinetics. Second, what
is the correlation, if any, among the surface expression and activation kinetics and the
tyrosine phosphorylation state of HCN4 channels? Fyn showed acceleration of the
channel activation kinetics but little effect on promoting the channel surface expression.
Yes slowed the channel activation kinetics, but exhibited the most potency of promoting
the cell surface expression of D553N (Table 1). It might involve other unknown proteins
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yet to be identified. Third, will an increase in the endogenous Src/Fyn/Yes kinase activity
in myocytes help promote the surface expression of D553N in vivo? Addressing these
questions represents our future research endeavors, leading to the discovery of an
effective endogenous regulatory mechanism to correct cardiac arrhythmias caused by
HCN channel mutants.

64

Part
II:
Novel
mechanism
for
suppression
of
hyperpolarization-activated cyclic nucleotide-gated pacemaker
channels by receptor-like tyrosine phosphatase-alpha
Abstract
Tyrosine phosphorylation plays a pivotal role in the regulation of membrane trafficking
of HCN channels. Previous reports have demonstrated that both of the If densities and
gating properties were significantly enhanced by increase of tyrosine phosphorylation
level in rat myocytes (Wu et al., 2000). Here, we report that a member of receptor-type
tyrosine phosphatase, RPTPα, can abolish the current expression of HCN2. Our results
indicated that RPTPα plays the novel role in the regulation of HCN channel function via
tyrosine dephosphorylation of HCN channel protein.
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Introduction
Activated by membrane hyperpolarization, the HCN2 channels are important to rhythmic
activity in neurons and myocytes (Robinson et al., 2003; Santoro et al., 2003).
Accumulating evidence has also suggested an important role of tyrosine phosphorylation
in modulating HCN channels (Wu et al., 2000; Yu et al., 2004). We have recently shown
that increased tyrosine phosphorylation state of HCN4 by activated Src tyrosine kinase
can enhance the gating of HCN4 channels (Arinsburg et al., 2006). Given that the
efficacy of tyrosine phosphorylation is determined by the dynamic balance of tyrosine
kinases and tyrosine phosphatases, reduced tyrosine phosphatase activity is speculated to
increase HCN channel activity. Receptor-like protein-tyrosine phosphatases (RPTPs) are
transmembrane phosphatases critical in cell growth and cell adhesion (Stoker, 2005). One
member of RPTPs, RPTPα, has been proposed to be a positive regulator of Src tyrosine
kinases (Ponniah et al., 1999; Su et al., 1999). As a protein-tyrosine phosphatase, RPTPα
should also be able to dephosphorylate phosphotyrosines of channel proteins. This work
was designed to investigate whether RPTPα can inhibit the HCN channel activity by
decreasing the tyrosine phosphorylation state of HCN channel proteins.
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Results
RPTPα Inhibition of HCN2 Currents in HEK293 Cells
Our recent discovery showed that increased tyrosine phosphorylation of HCN4 channel
by activated Src tyrosine kinase can enhance the channel gating properties in HEK293
cells (Arinsburg et al., 2006; Li et al., 2008). We wondered whether increased tyrosine
dephosphorylation by RPTPα may inhibit the gating properties of HCN channels
expressed in HEK293 cells.
Functional expressions of HCN2 after 2 days (44–50 h) of transfection are shown in Fig
1. HCN2 currents were elicited by hyperpolarizing pulses detailed in the figure legends.
Typical biophysical properties of the expressed channels such as the threshold activation,
activation kinetics, and current densities are comparable with those reported previously
(Arinsburg et al., 2006; Li et al., 2008; Zong et al., 2005). Co-transfection with RPTPα,
however, resulted in a dramatic inhibition (Fig. 1B) or a surprising loss of HCN2 currents
(Fig. 1C). Similar results were reproduced in 10 additional cells for each HCN2 channel
co-expressed with RPTPα. As part of control experiments, the empty pRK5 vector did
not affect HCN2 expression from 1 to 4 days post-transfection. Fig. 1D shows the HCN2
recordings in a HEK293 cell co-transfected with HCN2 and pRK5 vector after 2 days.
Similar results were obtained in an additional five cells.
Interestingly, we found the degree by which RPTPα inhibited HCN2 current expression
changed with time. Fig. 2 shows HCN2 current expression recorded in HEK293 cells cotransfected with RPTPα after 1 day (24–30 h) (A), 2 days (44–50 h) (B), and 4 days (C)
post-transfection. Compared with HCN2 alone (Fig. 1A), co-transfection with RPTPα
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reduced HCN2 current density (pA/pF) measured at -125 mV by 64% after day 1 (HCN2
= 38.9 ± 1.7, n = 11; RPTPα = 1.37 ± 0.5, n = 10), by 96% after day 2 (RPTPα = 1.5 ±
0.5, n = 10), and by 80% after day 4 (RPTPα = 7.7 ± 0.7, n = 10) (Fig. 2D). The timedependent inhibition is not only significant as compared with the control, but also
significant among groups (e.g. day 1 and day 2; day 2 and day 4).
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Fig 1. RPTPα inhibition of HCN2 current expression.
HCN2 currents were recorded 2 days after cell transfection. A, HCN2 currents in a
HEK293 cell expressing HCN2 alone. Hyperpolarizing pulses (4 s) from -65 to -125 mV
were applied. B, hyperpolarization-activated currents in a HEK293 cell co-transfected
with HCN2 and RPTPα. Hyperpolarizing pulses (5 s) from -75 to -125 mV were applied.
C, hyperpolarization-activated currents in a HEK293 cell co-transfected with HCN2 and
RPTPα. Hyperpolarizing pulses (3 s) from -75 to -125 mV were applied. D, HCN2
currents in a HEK293 cell co-transfected with HCN2 and the empty pRK5 vector.
Hyperpolarizing pulses (5 s) from -65 to -125 mV were applied. The tail currents were
recorded at +20 mV. The holding potential was -10 mV. Arrows in A and D indicate the
threshold activation of HCN2 currents.
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Fig 2. RPTPα induced time-dependent inhibition of HCN2 current expression.
Hyperpolarizing pulses of 5 s ranging from -75 to -125 mV (A and B) or from 85 to -125
mV (C) in 10-mV increments were applied to elicit HCN2 currents in HEK293 cells cotransfected HCN2 with RPTPα after day 1 (A), day 2 (B), and day 4 (C). D, averaged
HCN2 current density at -125 mV for the corresponding time periods.

70

Discussion
In this study, we provided evidence showing dramatic inhibitory effects of tyrosine
dephosphorylation by RPTPα on HCN2 channels. Two mechanisms are likely involved
as follows: tyrosine dephosphorylation and membrane trafficking of HCN channels. Both
are mediated by RPTPα.
In HEK293 cells co-expressing HCN2 channels with RPTPα for 2 days yielded
surprising inhibition or even elimination of the current expression. There are two
plausible explanations as follows: the channels were retained in the cytoplasm leading to
little or no expression of functional channels on plasma membrane, or gating properties
of the channels on the plasma membrane were inhibited. In this study, we also performed
western blot analysis on the membrane fraction of cells and revealed that the
constitutively active Src, which increases the tyrosine phosphorylation level of the
channels, increased the surface expression of the channels. On the other hand, RPTPα,
which decreases the tyrosine phosphorylation level of the channels, retained most
channels in the cytoplasm.
It is surprising that the HCN2 channel expression was largely blocked by RPTPα after 2
days of transfection and reappeared after 4 days of transfection (Fig. 2B). It offers a likely
explanation to no measurable or much smaller time-dependent inward currents in
HEK293 cells co-transfected by HCN2 with RPTPα for the same time periods (Fig. 1, B
and C). It is worth noting that whole-cell patch clamp technique applied to individual
cells is more sensitive than Western blotting, which obtains the average result from batch
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of cells. Therefore, after transfection for 2 days we were able to detect small current
expression in some cells, but not in protein expression.
Protein-tyrosine phosphatases, like protein-tyrosine kinases, play a critical role in the
regulation of physiological events (Ponniah et al., 1999; Su et al., 1999). RPTPα has a
short extracellular domain (about 123–150 amino acids long) that contains eight potential
N-glycosylation sites (Daum et al., 1994; Kaplan et al., 1990). Following a
transmembrane region, there are two tandem domains having phosphatase catalytic
activity. RPTPα is expressed in two isoforms differing by nine residues (Kaplan et al.,
1990) that are highly glycosylated, p100 and p130 on SDS-PAGE (Daum et al., 1994).
The p100 form contains only N-linked glycosylation, whereas p130 contains both Nlinked and O-linked.
Our data have shown a critical role that RPTPα plays in the tyrosine dephosphorylation
of HCN2 channels. The short-term likely involves the tyrosine dephosphorylation, is the
reduced If activity in cardiac myocytes. The long-term effects (days) include the
inhibition of HCN channel surface expression and possibly channel biosynthesis.
Recently, HCN4 mutants have been linked to the bradycardia and long-QT arrhythmias
(Milanesi et al., 2006; Nof et al., 2007; Schulze et al., 2003; Ueda et al., 2004). The
common cellular mechanism was retaining membrane trafficking caused by the truncated
HCN4 protein lacking cyclic nucleotide binding domain (Schulze et al., 2003), D553N in
the C-linker between S6 and cyclic nucleotide binding domain (Ueda et al., 2004), and
G480R in the channel pore region (Nof et al., 2007). The evidence we presented in this
work provided a novel mechanism that may be used to enhance the surface expression of
mutant HCN channels for effecting normal cardiac pacemaker activity.
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Chapter 3
Inactivation of L-type calcium channel modulated by HCN2
channel
The goal of this chapter is to explore a new role of HCN serving as a regulatory protein
to regulate the Ca2+ influx via the control of L-type calcium channel (LTCC) inactivation.
The results in this chapter have been published (Am J Physiol Cell Physiol 298(5):
C1029-37, 2010).
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Abstract
Ca2+ entry is delicately controlled by inactivation of L-type calcium channel (LTCC)
composed of the pore-forming subunit α1C and the auxiliary subunits β1 and α2δ.
Calmodulin is the key protein that interacts with the COOH-terminal motifs of α1C,
leading to the fine control of LTCC inactivation. In this study we show evidence that a
hyperpolarization-activated cyclic nucleotide-gated channel, HCN2, can act as a
nonchannel regulatory protein to narrow the L-type Ca2+ channel current-voltage curve. In
the absence of LTCC auxiliary subunits, HCN2 can induce α1C inactivation. Without
α2δ, HCN2-induced fast inactivation of α1C requires calmodulin. With α2δ, the
α1C/HCN2/α2δ channel inactivation does not require calmodulin. In contrast, β1-subunit
plays a relatively minor role in the interaction of α1C with HCN2. The NH2 terminus of
HCN2 and the IQ motif of α1C subunit are required for α1C/HCN2 channel interaction.
Ca2+ channel inactivation is significantly slowed in hippocampus neurons (HNs)
overexpressing HCN2 mutant lacking NH2 terminus and accelerated in HNs
overexpressing the wild-type HCN2 compared with HN controls. Collectively, these
results revealed a potentially novel protection mechanism for achieving the LTCC
inactivation via interaction with HCN2.

74

Introduction
L-TYPE CALCIUM CHANNEL (LTCC) current inactivation is dependent on both Ca2+
ions and voltage (Cens et al., 2006; Liang et al., 2003). The β- and α2δ-subunits regulate
the membrane expression and the voltage-dependent inactivation of the α1C-subunit
(Arikkath et al., 2003). Calmodulin (CaM) plays a central role in both Ca2+-dependent
inactivation (CDI) and voltage-dependent inactivation (VDI) using Ba2+ as the charge
carrier (Kim et al., 2004; Liang et al., 2003). CaM is proposed to tether with the IQ motif
in the COOH terminus of α1C (Peterson et al., 1999; Pitt et al., 2001). Ca2+ influx
through LTCC activates apoCaM (Ca2+-free CaM)/IQ complex. The activated CaM/IQ
triggers a conformational change of the inactivation machinery consisting of α1C COOHterminal domains such as peptide A, peptide C (or CB), IQ motif, and CaM. As a result,
the inactivation machinery rapidly blocks the inner surface of the pore, leading to fast
CDI (Erickson et al., 2003; Pitt et al., 2001). CaM also has been proposed to interact with
the linker of the transmembrane I and II segments associated with the β1-subunit to
modulate VDI (Cens et al., 2006; Kim et al., 2004).
Hyperpolarization-activated, cyclic nucleotide-gated (HCN) channels are activated by
membrane hyperpolarization, generating a voltage- and time-dependent inward current
called Ih or If, which has been traditionally thought to permeate both Na+ and K+ ions
(DiFrancesco et al., 1993). Recently, we discovered that Ca2+ ions also can permeate
HCN channels, even in a small percentage of the total current (Yu et al., 2007).
Furthermore, activation of Ih and If can increase the synapse transmission in dorsal root
ganglion neurons (Yu et al., 2004) and shorten the action potential duration in ventricular
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myocytes (Yu et al., 2007), respectively. However, the underlying mechanisms are not
well understood. In the present work, we focus on a hypothesis that a closed HCN
channel can interact with LTCC at the plasma membrane, leading to the fast inactivation
of L-type Ca2+ current (ICaL).
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Results
CDI and VDI of α1C/α2δ/β1 and α1C/α2δ/β1/HCN2 channels in HEK-293 cells
Figure 1A exemplified a well-established difference between CDI and VDI: faster
inactivation for ICa (solid line) than for IBa (shaded line), recorded at +10 mV. This
difference, however, is largely diminished in the presence of HCN2 (Fig. 1B): like ICa, the
IBa of α1C/α2δ/β1/HCN2 can inactivate almost completely to the closed state. Figure 1C
summarizes the time constants of inactivation of ICa and IBa for α1C/α2δ/β1 and
α1C/α2δ/β1/HCN2. They are 25.0 ± 3.2 ms for ICa and 228.5 ± 24.2 ms for IBa of
α1C/α2δ/β1, and 58.3 ± 3.3 ms for ICa and 72.5 ± 5.6 ms for IBa of α1C/α2δ/β1/HCN2.
The difference between ICa and IBa of α1C/α2δ/β1/HCN2 inactivation kinetics was
diminished compared with that between ICa and IBa of α1C/α2δ/β1 inactivation kinetics,
indicating that HCN2 can help complete the IBa inactivation.
We also examined whether the current-voltage relationship curves of α1C/α2δ/β1 are
altered by HCN2. Representative ICa are shown for α1C/α2δ/β1 (Fig. 1D) and
α1C/α2δ/β1/HCN2 (Fig. 1E). In the presence of HCN2, there was a positive shift in the
threshold activation of ICaL and more reduced current amplitude at the depolarized end of
the bell shape near +50 mV (Fig. 1F, shaded line). All results were repeated in an
additional five to eight cells.
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Fast inactivation of α1C/HCN2 channels in HEK-293
To examine a possible hidden interaction between α1C and HCN2, we studied α1C
inactivation by coexpressing α1C and HCN2 in the absence of auxiliary subunits. With
the use of Ba2+ as the charge carrier, α1C exhibited little current inactivation when
expressed alone (Fig. 2A, top). The auxiliary subunit α2δ could limit the Ca2+ influx by
inducing a slow inactivation of α1C (Fig. 2A, top). Figure 2B, bottom, shows the absence
of endogenous time-dependent inward currents in HEK-293 cells without cDNA
transfection under our experimental conditions. These results are in agreement with the
previous reports (Felix et al., 1997; Yasuda et al., 2004). However, when HCN2 was
coexpressed with α1C, a fast inactivation of α1C/HCN2 was observed (Fig. 2B, top). This
new inactivation has a differential sensitivity for Ba2+ and Ca2+ ions, capable of coming
back to the closed state in the presence of Ca2+ (shaded line) but not Ba2+ (solid line), the
typical characteristics of the conventional LTCC inactivation (Kim et al., 2004; Zuhlke et
al., 1998). Adding α2δ did not significantly affect the α1C/HCN2 inactivation (Fig. 2A,
bottom). With Ba2+ as the charge carrier, time constants for inactivation of α1C/α2δ,
α1C/HCN2, and α1C/HCN2/α2δ were 156 ± 19, 26 ± 4, and 22 ± 2 ms, respectively (n =
8). The inactivation for α1C/α2δ channels was significantly slower than that for
α1C/HCN2 or α1C/HCN2/α2δ (P = 0.002, n = 8). There was no statistical difference
between α1C/HCN2 and α1C/HCN2/α2δ channel inactivation (P = 0.5, n = 8). To verify
that the current is via the conventional α1C channel, verapamil (10 µM) was applied to
block the current activation (Fig. 2, A, bottom, and B, top).
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To address the concern that the fast inactivation of α1C/HCN2 or α1C/HCN2/α2δ
channel was probably due to the contamination from the deactivation of HCN2 channels,
we studied current expression of HCN2 in the external solution normally used for
characterization of HCN2 and in the external solution used to record IBa inactivation (e.g.,
Fig. 2, A and B). The hyperpolarization-activated HCN2 channels permeate both Na+ and
K+ ions (DiFrancesco et al., 1993). The channel cannot be activated in the absence of
external Na+ and K+ ions (DiFrancesco et al., 1993). In the external solution containing
140 mM Na+ and 30 mM K+, a typical HCN2 current (the time-dependent inward current)
was recorded in response to a 3-s hyperpolarizing pulse to –125 mV (Fig. 2C), consistent
with the previous report (Yu et al., 2007). When the Na+ and K+ ions were removed from
the external solution, no time-dependent inward current was recorded (Fig. 2C).
HCN2 channels are closed at membrane depolarization that is used to activate LTCC
(DiFrancesco et al., 1993). In response to a depolarization to +10 mV from the holding
potential of –90 mV, there was no HCN2 activation current in the solution containing 140
mM Na+ and 30 mM K+ (Fig. 2D). The inactivation of α1C/HCN2/α2δ channel in the
Na+- and K+-free solution was used as a comparison (Fig. 2D). These data strongly
indicate that the closed HCN2 channels can act as the nonfunction channel to induce a
fast inactivation of α1C.
Role of Ca2+-free CaM in α1C/HCN2 channel inactivation
Given the pivotal role CaM plays in the Ca2+ channel inactivation, we tested the idea that
CaM may be involved in the fast inactivation of α1C/HCN2 channel for two reasons:
CaM is endogenously present in HEK-293 cells, and apoCaM (no Ca2+-bound CaM) is
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tethered to structural domains in the COOH terminus of α1C subunit (Erickson et al.,
2003; Pitt et al., 2001).
We first used two structurally different calmodulin inhibitors, W-7 [N-(6-aminohexyl)-5chloro-1-naphthalenesulfonamide] (Hidaka et al., 1981) and trifluoperazine (TFP)
(Reinhart et al., 1980), to study their potential effects on α1C/HCN2 channel inactivation.
After binding Ca2+ ions, CaM undergoes a conformational change leading to the exposure
of its hydrophobic activation site for binding to its substrate, CaM-dependent kinase
(CaMK). Both W-7 and TFP block CaM actions by occupying the hydrophobic site to
prevent binding of CaMK (Hidaka et al., 1981; Osawa et al., 1998). Figure 3A shows that
both drugs at 15 µM eliminated the fast inactivation of α1C/HCN2 channels within 15–20
min, consistent with the time course of inhibiting CaM activity by both drugs. The effect
of the drug was observed in the same cell. The similar results were obtained in an
additional five to seven cells.
We then employed a dominant negative calmodulin mutant, CaM(1,2,3,4) (Xia et al., 1998).
Compared with the current expression of α1C/HCN2 coexpressed with a wild-type
calmodulin, CaM(WT), overexpression of CaM(1,2,3,4) eliminated the fast inactivation of
α1C/HCN2 (Fig. 3B, shaded line). These pharmacological and mutant CaM data strongly
suggested that the interaction of α1C and HCN2 is partially mediated by CaM.
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Role of α2δ in α1C/HCN2 channel inactivation
Nearly all studies of CaM-mediated α1C inactivation, carried out in either Xenopus
oocytes or mammalian cells (HEK-293, Chinese hamster ovary, COS), have been
performed with coexpression of β1- and α2δ-subunits. This is due to the important roles
of β1- and α2δ-subunits in expression of α1C on plasma membrane and Ca2+ channel
function (Arikkath et al., 2003). Previous studies also have demonstrated a significant
role of α2δ in initiating the inactivation of α1C expressed in HEK-293 cells (Felix et al.,
1997; Yasuda et al., 2004). Wondering whether CaM would have the similar impact on
the α1C/HCN2 channel inactivation in the presence of the α2δ subunit, we tested the
effects of W-7 and TFP on the current expression of α1C/HCN2/α2δ channels.
Surprisingly, neither W-7 (left) nor TFP (right) affected the inactivation of
α1C/HCN2/α2δ channels (Fig. 3C, shaded lines). To further confirm this observation, we
overexpressed either CaM(WT) or CaM(1,2,3,4) with α1C/HCN2/α2δ channels (Fig. 3D,
shaded lines). Neither of them affected the inactivation of α1C/HCN2/α2δ channels.
Compared with its dominant effect in α1C/HCN2 channel inactivation (Fig. 3, A and B),
CaM plays a minor role in α1C/HCN2/α2δ channel inactivation (Figs. 3, C and D),
indicating a potential role of α2δ-subunit in the α1C/HCN2 channel inactivation.
α1C/HCN2 channel interaction requires NH2 terminus of HCN2 and IQ motif of
α1C
The fact that the fast inactivation of α1C/HCN2 is Ca2+ independent (since we used Ba2+
as a charge carrier) suggested that CaM may not be the only mechanism for α1C/HCN2
channel interaction. To explore an unconventional idea that HCN2 may also interact with
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α1C, we studied the current expression of 1) the wild-type α1C with a HCN2 mutant
lacking the NH2 terminus [HCN2(-N)] and 2) the wild-type HCN2 with an α1C mutant
lacking the IQ motif in the COOH terminus [α1C∆(1623-1666)] (Gao et al., 2000). Figure
4A shows that the inactivation of α1C/HCN2 (solid line) was eliminated by either HCN2(N) or α1C∆(1623-1666) (shaded lines).
We next examined how α1C and HCN2 channel mutants interact in the presence of the
α2δ subunit. Figure 4B shows that compared with the α1C/HCN2/α2δ channel
inactivation (solid line), both α1C/HCN2(-N)/α2δ and α1C∆(1623-1666)/HCN2/ 2
channels dramatically slowed the inactivation process (shaded lines). We also observed
biphasic inactivation of α1C/HCN2(-N)/α2δ (Fig. 4B, shaded line) with its first fast
inactivation phase close to the wild type but with a second phase almost linear that cannot
be fitted by an exponential function.
We finally studied the effects of HCN2 and α1C mutants on α1C/HCN2 inactivation in
the presence of both α2δ- and β1-subunits. Compared with the wild-type
α1C/α2δ/β1/HCN2 channel (solid line), the significant slowing of α1C/HCN2 channel
inactivation by either HCN2(-N) or α1C∆(1623-1666) (shaded lines) still persisted in the
presence of α2δ- and β1-subunits (Fig. 4C). At +10 mV, the time constants of IBa
inactivation were 72.5 ± 5.6 ms for α1C/α2δ/β1/HCN2, 108 ± 13 ms for
α1C/α2δ/β1/HCN2(-N), and 498 ± 43 ms for α1C∆(1623-1666)/α2δ/β1/HCN2,
respectively (n = 5–7) (Fig. 4D). Together, these results suggest that the NH2 terminus of
HCN2 and the IQ motif of α1C are the structural elements required for the inactivation of
the α1C/HCN2 channel.
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Relative roles of CaM, α2δ, and β1 in the inactivation of α1C/HCN2 channels
To examine the relative contribution of α2δ and CaM to the inactivation of α1C/HCN2
channels, we compared the inactivation time constants for different combinations of α1C,
HCN2, α2δ, and CaM, including their respective mutants, except for α1C 1905x/HCN2.
α1C 1905x is a distal COOH-terminal truncated form of α1C, which is used as a control
for α1C∆(1623-1666) function (Gao et al., 2000). We found that α1C∆(1623-1666) and
HCN2(-N) are the two most significant structural motifs that contribute to the inactivation
of α1C/HCN2 channels independently of α2δ (Fig. 4D). We also found, surprisingly, that
overexpression of CaM(WT) did not accelerate (as one would expect), but slowed, the
inactivation of α1C/HCN2/α2δ or α1C 1905x/HCN2/α2δ channels (Fig. 4D).
In the absence of α2δ, there was a distinct difference between CDI and VDI for
α1C/HCN2 channels (Fig. 2B). In the presence of α2δ, however, the difference between
CDI and VDI disappeared (Fig. 4E). Combined with the diminished difference between
CDI and VDI for α1C/α2δ/β1/HCN2 (Fig. 1B), the results provide additional evidence for
a major role of α2δ in the inactivation of α1C/HCN2 channels. In comparing Fig. 4, C
and E, β1 helped complete the IBa inactivation of α1C/HCN2/α2δ channels, which are
consistent with the results shown in Fig. 1B.
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Slowing Ca2+ inactivation by disrupting α1C/HCN2 association in hippocampus
neurons
NH2 terminus of HCN2 was reported to be essential in the formation of the homo- and
heteromeric channels at the plasma membrane (Proenza et al., 2002). Shown in Fig. 5A,
formation of the rat hippocampal neuron network was visualized after 5–6 days in
culture. After 24- to 48-h transfection of HCN2(-N) with GFP, the expression of HCN2(N) was indicated by the fluorescent image (Fig. 5B) compared with the brightfield image
of the same region (Fig. 5A). The fluorescent neurons were subject to the patch-clamp
recordings. Shown in Fig. 5C, overexpression of HCN2(-N) induced a remarkably slow
inactivation component (light shaded line) that was not present in the control neurons or
in neurons transfected with the empty vector (solid line, as a transfection control). On the
other hand, transfection with the full-length HCN2 accelerated the IBa inactivation (dark
shaded line in Fig. 5C). Currents were verified by verapamil (10 µM) blockade (Fig. 5C).
At +10 mV, time constants of IBa inactivation were 26.5 ± 2.9 ms (n = 9) for control
hippocampal neurons (HN), 35.1 ± 3.5 ms (n = 6) for HN + vector, 66.1 ± 3.3 ms (n = 7)
for HN + HCN2(-N), and 19.0 ± 2.2 ms (n = 10) for HN + HCN2 (Fig. 5D). The altered
time constants for channel inactivation were marked with statistical significance
compared with the control HN or HN transfected with vector (Fig. 5D).
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Fig 1. Ca2+-dependent inactivation (CDI) and voltage-dependent inactivation (VDI)
of α1C/α2δ/β1 and α1C/α2δ/β1/HCN2 in HEK-293. A: Ca2+ current (ICa; solid line) and
Ba2+ current (IBa; shaded line) of α1C/α2δ/β1 recorded at +10 mV. B: ICa (solid line) and
IBa (shaded line) of α1C/α2δ/β1/HCN2 recorded at +10 mV. C: time constants (τ) for
inactivation of ICa and IBa at +10 mV for α1C/α2δ/β1 and α1C/α2δ/β1/HCN2,
respectively. For simplicity of comparison, we best fit the currents with one exponential
function. P values shown are the statistical results of comparing ICa and IBa inactivation.
D and E: ICa currents recorded in the test pulses ranging from –50 to +50 mV in 10-mV
increments for α1C/α2δ/β1 (D) and α1C/α2δ/β1/HCN2 (E), respectively. A 400-ms
depolarizing pulse was used. Holding potential was –90 mV. F: current-voltage
relationship curves for α1C/α2δ/β1 and α1C/α2δ/β1/HCN2.
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Fig 2. α1C/HCN2 channel inactivation in HEK-293 cells. A, top: current expression of
α1C and α1C/α2δ, respectively. Bottom, current inactivation of α1C/HCN2/α2δ that was
blocked by 10 µM verapamil. Pulse duration was 200 ms. B, top: α1C/HCN2 inactivation
using 2 mM Ba2+ (solid line) or 2 mM Ca2+ (shaded line) as the charge carrier, which was
blocked by 10 µM verapamil. Pulse duration was 400 ms. Bottom, absence of timedependent inward current expressions in HEK-293 cells without plasmid transfection.
Pulse duration was 300 ms. In A, the current inactivation was normalized for better
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comparison of the inactivation kinetics. C: hyperpolarizing pulse control experiments. In
cells expressing only HCN2, IHCN2 was elicited by a 3-s hyperpolarizing pulse to –125
mV from the holding potential of –10 mV in modified Tyrode solution containing 140
mM Na+ and 30 mM K+; in cells coexpressing α1C/HCN2/α2δ, the same hyperpolarizing
pulse could not detect IHCN2 in the external and internal solutions used to record IBa.
Although the leak current varies from cell to cell, we chose a leak current that closely
aligned with the HCN2 time-dependent inward current for better comparison. The pulse
protocol is shown in the inset. The dashed line shows the holding current. D: depolarizing
pulse control experiments. In solutions without Na+ and K+ ions (0 Na+, 0 K+), IBa was
recorded only in cells coexpressing α1C/HCN2/α2δ, not in cells expressing only HCN2.
The pulse protocol is shown in the inset.
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Fig 3. Role of calmodulin (CaM) in α1C/HCN2 channel inactivation. A: α1C/HCN2
channel inactivation (solid line) and lost inactivation in the presence of the CaM inhibitor
W-7 or trifluoperazine (TFP) (shaded lines). B: α1C/HCN2/CaM(WT) channel inactivation
(solid line) and lost inactivation of α1C/HCN2/CaM(1,2,3,4) channels (shaded line).
CaM(WT), wild-type calmodulin; CaM(1,2,3,4), a dominant negative calmodulin mutant. C:
α1C/HCN2/α2δ channel inactivation in the absence (solid line) and presence of W-7
(shaded line; left) or TFP (shaded line; right). D: α1C/HCN2/α2δ channel inactivation in
the absence (solid line) and presence of CaM(1,2,3,4) (shaded line).
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Fig 4. α1C/HCN2 interaction requires NH2 terminus of HCN2 and IQ motif of α1C.
A: α1C/HCN2 channel inactivation for wild-type (solid line), α1C∆(1623-1666)/HCN2
(shaded line), and α1C/HCN2(-N) channels (shaded line). B: α1C/HCN2/α2δ channel
inactivation for wild-type (solid line), α1C∆(1623-1666)/HCN2/α2δ (shaded line), and
α1C/HCN2(-N)/α2δ channels (shaded line). C: inactivation of α1C/α2δ/β1/HCN2 (solid
line), α1C∆(1623-1666)/α2δ/β1/HCN2 (shaded line), and α1C/α2δ/β1/HCN2(-N) (shaded
line). D: inactivation time constants measured at +10 mV for showing the significant role
of HCN2(-N) [α1C/HCN2/α2δ, α1C/HCN2(-N)/α2δ, α1C/HCN2/α2δ/CaM(WT), and
α1C/HCN2/α2δ/CaM(1,2,3,4); solid bars] and the significant role of α1C∆(1623-1666)
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α1C1905x/HCN2,

α1C1905x/HCN2/α2δ,

α1C1905x/HCN2/α2δ/CaM(WT),

and

α1C∆(1623-1666)/HCN2/α2δ; shaded bars]. Results are expressed as means ± se. *P <
0.0001, statistically significant difference compared with α1C/HCN2/α2δ; P = 0.07 for
α1C/HCN2/α2δ/CaM(WT) and P = 0.08 for α1C/HCN2/α2δ/CaM(1,2,3,4) (n = 6–12). &P <
0.0001,

statistically

significant

difference

compared

with

α1C/HCN2/α2δ

or

α1C1905x/HCN2/α2δ; P = 0.006 for α1C1905x/HCN2/α2δ/CaM(WT) and P = 0.0003 for
α1C∆(1623-1666)/HCN2/α2δ (n = 5–12). E: inactivation of α1C/HCN2/α2δ channel in
the presence of Ba2+ (solid line) and Ca2+ (shaded line), respectively.
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Fig 5. Altered L-type Ca2+ channel (LTCC) inactivation in rat hippocampal neurons
(HN) overexpressing HCN2(-N) and the full-length HCN2. A brightfield image (A)
and fluorescence image (B) of the region is shown 48 h posttransfection of HCN2(-N) or
HCN2 with GFP. C: Ca2+ current inactivation using Ba2+ as a charge carrier in a control
neuron and in neurons transfected with the empty vector (HN + vector), in a neuron
transfected with HCN2(-N) [HN + HCN2(-N)], and in a neuron transfected with HCN2
(HN + HCN2). IBa currents were recorded at +10 mV. The holding potential was at –90
mV. Pulse duration was 400 ms. P4 protocol was used. The HN + vector trace was
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moved up by 60 pA for clear illustration of currents under different conditions. D:
inactivation time constants in HN, HN transfected with HCN2, HN transfected with the
vector, and HN transfected with HCN2(-N). Results are expressed as means ± se. P
values indicate statistical significance compared with either HN or HN + vector group.
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Fig 6. A schematic model depicting the potential roles of HCN2 and δ-subunit in the
inactivation of LTCC. Mechanism 1 summarizes the mechanisms for CDI and VDI of
LTCC. Mechanism 2 proposes a potential CaM-mediated interaction between the NH2
terminus of HCN2 and the IQ motif of α1C. Mechanism 3 proposes a potential interaction
between the COOH tail of the δ-subunit and the NH2 terminus of HCN2 within the
COOH-terminal inactivation machinery of α1C-subunit. AID, α1-interaction domain.
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Discussion
Both α1C- and δ-subunits are transmembrane proteins with NH2 and COOH tails of α1C
and COOH tail of δ located intracellularly. CaM and β1-subunit are intracellular proteins
attached to the α1C near the inner surface of the membrane. These four proteins constitute
the inactivation machinery for the fine control of Ca2+ influx through LTCC in both VDI
and CDI (Erickson et al., 2003; Kim et al., 2004; Peterson et al., 1999; Xia et al., 1998).
Our previous studies showed possible involvement of HCN in the modulation of myocyte
action potential duration (Yu et al., 2007). In the present work, we evaluated the
hypothesis that inactivation of LTCC can be modulated via interaction with HCN
channels under the experimental conditions that prevent HCN2 channel opening. We
showed here that HCN2 can act as a nonchannel regulatory protein to induce a fast
inactivation of α1C. To further investigate the possible associated mechanisms involved
in the interaction between α1C and HCN2 channel proteins, we proposed a model shown
in Fig 6. Mechanism 1 represents our current understanding of interactions among βsubunits, which are bound to the α1-interaction domain (AID), apoCaM, and inactivation
motifs in the COOH-terminal region of α1C. The majority of this conceptual
understanding was provided from studies in either Xenopus oocytes or HEK-293 cells
coexpressing α1C with β1- and α2δ-subunits (Erickson et al., 2003; Peterson et al., 1999,
Pitt et al., 2001; Wang et al., 2007; Zuhlke et al., 1998; 1999). Our present study revealed
several new concepts.
First, in the absence of β1- and α2δ-subunits, HCN2 can induce a faster inactivation of
α1C than α2δ as measured by IBa (compare Fig 2, A and B). This interaction of HCN2 and
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α1C requires CaM (mechanism 2 in Fig 6), since two CaM inhibitors (W-7 and TFP) and
the dominant negative CaM(1,2,3,4) all eliminated the inactivation of α1C/HCN2 channel
(Fig 3, A and B).
Second, in the presence of the α2δ-subunit, HCN2 can still induce fast inactivation of
α1C. However, the impact of CaM in affecting the inactivation of α1C/HCN2/α2δ
channel is diminished compared with that for α1C/HCN2 channel, suggesting a prevalent
role of the α2δ-subunit in α1C and HCN2 interaction (mechanism 3 in Fig 6).
Third, mutants of HCN2 (with the NH2 terminus deleted) and α1C (without IQ motif)
revealed a critical role of these two structural elements in mediating the fast inactivation
of α1C/HCN2 channels (Fig 4). It is worth noting that the short COOH terminus of the δsubunit is located in the intracellular space. Analysis of amino acids in the NH2 terminus
of HCN2 showed an overall positive charge, which can potentially interact with the
negatively charged COOH terminus of δ-subunit. Although previous studies have
suggested a vital role for the δ-subunit in accelerating α1C inactivation (Felix et al., 1997;
Yasuda et al., 2004), there is limited mechanistic insight into how this process occurs.
Our data suggested that a key contributor to this accelerated inactivation may be a
dynamic, coordinated interaction among the COOH terminus of the δ-subunit, the IQ
motif of α1C, and the NH2 terminus of HCN2. Alternatively, it is also possible that β1subunit can interfere with the inactivation of α1C∆(1623-1666)/HCN2/α2δ and
α1C/α2δ/HCN2(-N), as well (Fig 4C). This may be a logical possibility, since the β1subunit is attached to the linker of I-II domains and has been reported to interact with the
IQ motif either directly or possibly through the actions of CaM (Zhang et al., 2005).
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Finally, we have demonstrated that an interaction of α1C and HCN2 is present in native
tissues, as evidenced by association of the two channel proteins in the hippocampus and
dramatic slowing of IBa in hippocampal neurons overexpressing HCN2(-N) (Fig 5). It
should be noted that the currents we recorded in hippocampal neurons are not pure
LTCCs, since N- and P/Q-calcium channels are present in hippocampal neurons, and
verapamil can also inhibit N- and P/Q-type calcium currents (Dobrev et al., 1999).
Nevertheless, the fact that overexpression of HCN2(-N) mutant in HNs induced a
significant slowing of inactivation supports the hypothesis that dynamic interaction
between α1C and HCN2 exists in the native tissue.
Unusual features of α1C/HCN2 and α1C/HCN2/α2δ channel inactivation
Dissecting VDI and CDI often has been carried out by using Ba2+ and Ca2+, respectively
(Kim et al., 2004; Peterson et al., 1999; Xia et al., 1998; Zuhlke et al., 1998), yielding
intriguing results. Not only is CDI about 6–10 times faster than VDI (Kim et al., 2004;
Liang et al., 2003), but CDI also can come back to the closed state whereas VDI cannot.
The CDI index, measured by the residual fraction of the currents that remains at the end
of the test pulse, is much smaller for Ca2+ than for Ba2+ (Erickson et al., 2003; Kim et al.,
2004; Peterson et al., 1999; Zuhlke et al., 1998). Interestingly, the speed of VDI can be
increased to that of CDI if the IQ motif is deleted (Zuhlke et al., 1998). Furthermore, a
single mutation of I to A or E in the IQ motif could eliminate the difference in CDI index
for Ca2+ and Ba2+ (Zuhlke et al., 1999). Recently, using a fluorescence resonance energy
transfer (FRET) two-hybrid mapping technique, preassociation of apoCaM and a 73amino acid segment containing IQ motif was found to be critical for the slow VDI
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(Erickson et al., 2003). Disruption of this preassociation significantly accelerated the VDI
and removed the difference between CDI and VDI (Erickson et al., 2003).
Both α1C/HCN2 and α1C/HCN2/α2δ channels have exhibited VDI rates that are faster
than that reported following the disruption of preassociation of IQ motif and apoCaM
(Erickson et al., 2003). Our data suggest that HCN2, via its NH2 terminus, can interrupt
the preassociation of apoCaM with the IQ motif of α1C and that this may contribute to the
accelerated VDI inactivation. The requirement of CaM for α1C/HCN2 inactivation in the
absence of α2δ subunit is supported by the facts that inhibiting CaM activity using either
pharmacological inhibitors or overexpression of CaM(1,2,3,4) all eliminated the inactivation
of α1C/HCN2 (Fig 3, A and B). On the other hand, α1C/HCN2/α2δ channel inactivation
is largely independent of CaM (Fig 3, C and D). One possible scenario for this difference
may be that the conformational change of CaM resulted from the interaction between the
IQ motif and HCN2 is different from that resulted from the interaction between the IQ
motif and HCN2/α2δ. The interaction between the IQ motif and HCN2 may lead CaM to
undergo a conformational change that exposes its hydrophobic activation site to the CaM
blockers, whereas the interaction between the IQ motif and HCN2/α2δ may induce a
different CaM conformational change that does not make its blockers accessible to the
activation site. This possibility would explain the fast VDI of α1C/HCN2/α2δ channel
(solid lines in Fig 3, C and D), the insensitivity of W-7 and TFP to the α1C/HCN2/α2δ
currents (Fig 3C), and the lack of a difference between CDI and VDI for the
α1C/HCN2/α2δ channel (Fig 4E).
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Potential implications of α1C and HCN2 interaction
In this study, although we have presented evidence demonstrating the interaction of α1Csubunit (Cav1.2) with HCN2, interactions of this type might also occur in other types of
Ca2+ channels that undergo CDI, such as Cav2 channels, as a common mechanism. Use of
CaM as the key element for Ca2+ channel inactivation has been reported for Cav1 and
Cav2 channels (Liang et al., 2003).
Increased Ca2+ influx is associated with a number of neuronal disorders, including
neuropathic pain (Altier et al., 2004). Gabapentin, a GABA analog, is an antiepileptic
drug that has been used recently to relieve neuropathic pain and is believed to bind the
α2δ1-subunit, leading to decreased Ca2+ influx (Altier et al., 2004; Hendrich et al., 2008).
The mechanism of how gabapentin binding of α2δ1-subunit decreased Ca2+ influx
remains elusive, since the gabapentin action is acute (Altier et al., 2004). The α2δsubunits have been known to enhance the surface expression of α1C and Ca2+ current
amplitude (Felix et al., 1997; Yasuda et al., 2004). A recent study demonstrated that
chronic treatment with gabapentin was associated with a reduction in the surface
expression of α2δ2 and Cav2.1 subunits (Hendrich et al., 2008). On the other hand, the
α2δ-subunits also promote inactivation of Cav1.2 (α1C) or Cav2.2 (N-type) (Yasuda et
al., 2004), and inhibition of the α2δ subunit should, in principle, slow the α1C
inactivation, resulting in an increased Ca2+ influx. The interaction of α1C with HCN2 may
provide an alternative mechanism to prevent an increase in Ca2+ influx under the
conditions in which the α2δ-subunit expression is reduced.
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Study limitations
Although we report for the first time a novel and potentially important mechanism for
modulation of Ca2+ current inactivation by HCN2 channel, there are many unanswered
questions. For instance, we noticed that the activation of ICaL also seems to be altered by
HCN2 (e.g., Fig. 1F). In addition, whether HCN2 may also modulate other Ca2+ channels
that share similar inactivation machinery to α1C is unknown. More importantly, under
various physiological and especially pathological conditions, the importance of
interaction between HCN2 and LTCC requires further investigation, since the expression
levels of HCN2, α1C, and α2δ1 may be altered.
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Chapter 4
Trafficking mechanism of HCN4 and its mutant and the novel
role of HCN2 in modulation of Ca2+ influx
This chapter contains two parts showing unpublished work. Part 1 aims to understand the
trafficking mechanisms of HCN4 as well as how tyrosine phosphorylation may help
rescue the defective membrane trafficking of HCN4 mutants identified in patients. Part II
aims to further understand the dynamic interaction between HCN and calcium channels.
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Part I: Trafficking mechanisms of HCN4 and its mutants
identified in patient
Abstract
D553N is a missense mutation in the C-linker of HCN4 channel protein. It was found in a
patient with severe cardiac arrhythmias including long QT syndrome, ventricular
tachycardia polymorphisms, and bradycardia induced by sinus node dysfunction.
Although it has been implicated that the cardiac arrhythmia caused by this mutant was
due to its trafficking defect, no analysis reveals the underlying mechanism in the
subcellular level. Here, we demonstrated that the trafficking defective mutant HCN4
D553N is restricted in the endoplasmic reticulum (ER) and perinuclear region. Two days
after transfection D553N with the ER maker KKXX in the HEK293 cells, colocalization
of these two proteins could be observed. Further, we employed the membrane surface dye
FMI34 to show that D553N cannot colocalize with the membrane dye FMI34. On the
contrary, wild type HCN4 channels colocalized with the dye FMI34 on the cell
membrane which serves as the control for the comparison. In conclusion, our data further
demonstrate the subcellular mechanism that the D553N mutant is retained in the ER,
resulting in loss-of-function of this mutant at the cell membrane.
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Introduction
HCN4 channels play an important role in the regulation of pacemaker activity of
sinoatrial nodes. They are responsible for making the “U” turn of maximal diastolic
potential (phase 4) for the next cycle of the action potential in sinoatrial nodes. Previous
studies have revealed that the abnormality of HCN4 channels in patients is the cause for
cardiac arrhythmias such as long QT syndromes, cardiac tachycardia, and sinoatrial
nodes dysfunction. So far, several HCN4 mutants have been found in patients that are
correlated with cardiac arrhythmias (Milanesi et al., 2006; Schulze et al., 2003; Ueda et
al., 2004). Recently, a patient with the severe cardiac arrhythmias was indicated as HCN4
D553N mutant. The electrocardiogram (ECG) also revealed the relative flat “P” wave
accompany with long QT interval (0.64s versus 0.44s for the normal people) followed by
ventricular tachycardia polymorphisms (Ueda et al., 2004). When the cellular
mechanisms were further analyzed, they found that this mutant was the dominant
negative mutant, which will dominate the phenotype when coexisting with the wild type
HCN4 channels.
By using the electrophysiology and imaging, their results indicated that the membrane
expression or current expression can nearly be eliminated or significantly reduced after
transfection of D553N alone or cotransfection of D553N with wild type HCN4 in COS7
cells (Ueda et al., 2004). The results strongly indicated that the underlying mechanism
contributing to loss-of function of D553N mutant is due to defective membrane
trafficking. However, what is the subcellular level that this mutant could be trapped
during the trafficking process remains obscure. Here we employed the ER maker KKXX
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to investigate the possible colocalization between D553N mutant and this marker using
the live-cell confocal imaging. Interestingly, we found that the D553N mutant can
colocalize with KKXX whereas it cannot colocalize with a membrane dye FM1-34 which
is exclusively expressed on the cell membrane. The control experiment also revealed the
colocalization between FM1-34 and wild type HCN4 channels. Overall, our data
uncovered the subcellular localization of HCN4 mutant D553N, which may provide the
further subcellular evidence indicating the trafficking defect of this mutant.
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Results
In Fig 1, we co-transfect the D553N mutant carried with DsRed with ER marker KKXX
carried with GFP into HEK293 cells. Two days after, the result showed that D553N
mutant with DsRed clustered in the centric region of HEK293 cells in which the
colocalization with the ER marker KKXX carried with GFP can be observed under the
confocal microscope. As ER is distributed around the nucleus, the localization of D553N
represented as red can also be observed to surround the region nearby the nucleus and is
matched to the KKXX represented as green.
However, the D553N cannot colocalize with the membrane dye FM1-43 (Audrey et al.,
2004) which distributes well on the cell membrane as indicated in Fig 2.
Fig 3 is the positive control showing that the wild type HCN4 distributes on the cell
membrane in which the colocalization can be detected under the microscope. This result
indicated that the D553N mutant is trapped in the ER and fails to localize in the cell
membrane.
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Fig 1. Colocalization between D553N mutant and the ER marker KKXX.
Left up panel shows the D553N carried with DsRed as indicated in the red color. Right
up panel represents the expression of the fusion protein KKXX carried with GFP as
indicated in green color. Right down panel reveals the colocalization between D553N and
KKXX after merge the previous two panels, which indicates as yellow color. Left down
panel shows the HEK293 cell in the bright field.
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Fig 2. Non-colocalization of wild type HCN4 channels and the ER marker KKXX.
Left up panel shows the subcellular distribution of wild type HCN4 channels, which
express throughout the plasma membrane of HEK 293 cells as indicated in red color.
Right up panel reveals the expression of KKXX as indicated in green color. Right down
panel represents the merged result of the previous two panels. There is no colocalization
between the wild type HCN4 channels and the KKXX. Left down panel shows the bright
field of the HEK293 cell.
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Fig 3. Colocalization between wild type HCN4 channels and the membrane dye
FM1-43. Left up panel shows the membrane dye FM1-43 as indicated in the green color.
Left down panel represents the distribution of wild type HCN4 channels carried with
DsRed as indicated in red color. Right down panel indicates the merged result of the
previous two panels and shows the colocalization between the wild type HCN4 channels
and FM1-43 as indicated in yellow color. Right up panel shows the whole HEK293 cell
in the bright field.
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Discussion
Our results indicated that the impairment of the membrane expression of single mutation
D553N is resulted from trapping in the ER in the process of the trafficking (Fig1-3).
These results are consistent with previous reports and may explain why this mutant
expresses little current when studied with whole-cell patch clamp.
This membrane trafficking defective D553N mutant has been proposed to cause cardiac
arrhythmias such as long QT syndromes accompany with the dysfunction of sinoatrial
node (Ueda et al., 2004). As D553N is a single amino acid mutation of HCN4 channels
from Asp to Asn, which removes the negative charge, it may thus cause the abnormal
folding of the channel protein in the protein synthesis. The disruption of the negative
charge may alter the interaction among amino acid residues and results in conformation
change of this mutant. Interestingly, ER is a key subcellular organelle for quality control
of the channel proteins (Ibba et al., 1999; Wickner et al., 1999). The abnormal folding of
D553N mutant may retain the channel in ER, which is subsequently through endosomallysosomal pathway for degradation (Cole et al., 1992; Koh et al., 2005). This may
provide us the possible explanation for our results showing the subcellular localization of
D553N mutant in ER.
KKXX is the double mutant fusion protein that retains in the ER and serves as an ER
marker. We take this advantage and transfect D553N mutant with this marker fusion
protein KKXX to study whether they colocalize in the ER in order to elucidate the
subcellular localization of D553N. Our results suggest that the trafficking defective
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D553N mutant is attributed to the trapping in the ER and this may make us understand
the subcellular mechanism about this mutant induced cardiac arrhythmias.
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Part II: Association between HCN2 and L-type calcium
channels by using fluorescence recovery after photobleaching
(FRAP)
Abstract
Calcium influx via L-type calcium channels (LTCCs) plays the critical role in the
regulation of intracellular calcium homeostasis. Inactivation of LTCCs is one of the most
important mechanisms to modulate calcium influx and prevents the calcium overload
induced diseases such as cardiac arrhythmias. Thus, how to delicately regulate the
inactivation of LTCCs is directly linked to the intracellular calcium amount and the
calcium-based diseases prevention. In the previous studies, using electrophysiology and
immunoprecipitation, we have demonstrated that the association between the pore
forming subunit α1C of L-type calcium channels (LTCCs) and HCN2 channels can
induce the fast inactivation of LTCCs to restrict the calcium influx.
Here, we employed another technique (FRAP) to investigate the dynamic association
between α1C and HCN2 channels in HEK293 cells. Consistently, the results indicated
that the half life (t1/2) of fluorescent recovery was significantly slower in the HEK293
cells co-transfected with α1C-GFP and HCN2 (t1/2=14.04±3.51(s)) than those of Nterminal deletion of HCN2 with α1C-GFP (t1/2=7.83±2.15(s)) or wild type HCN2-GFP
with IQ motif deletion of α1C (t1/2=1.12±0.09(s)). The cells co-transfected with α1C and
HCN2-GFP also reveals the relatively slower half life (t1/2 =10±1.23(s)). Our studies
strongly demonstrate that HCN2 channels are capable of cross-talking with LTCCs at the
cell membrane via the association between N-terminus of HCN2 channels and IQ motif
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of α1C in a dynamic manner. These results may provide us supporting evidence of how
HCN2 channels can induce the fast inactivation of LTCCs and regulate the calcium
influx.
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Introduction
Inactivation of L-type calcium channels (LTCCs) plays a pivotal role to delicately
regulate calcium influx in cardiomyocytes, which is closely linked to cardiac
contractility, and if abnormal, leads to calcium-based diseases such as cardiac
arrhythmias. The underlying cellular mechanism of inactivation of LTCCs has been
wildly studied. It is generally believed that the interaction among the IQ motif on the Cterminal of α1C (the pore region of LTCCs), calmodulin (CaM), and I-II loop near the
pore region is involved in the regulation of inactivation of LTCCs. Based on the different
mechanisms, the inactivation of LTCCs can be divided into calcium-dependent fast
inactivation (CDI) (using Ca2+ as the charge carrier) as well as the voltage-dependent
slow inactivation (VDI) (using Ba2+ as the charge carrier). The CDI is dependent on the
influx of calcium ions which can interact with CaM, IQ motif, and I-II loop and induce
the fast inactivation by closing the pore region of LTCCs. On the other hand, VDI is not
calcium dependent (Cens et al., 2006; Kim et al., 2004; Pitt et al., 2001); it is only
responsible for the voltage change on the cell membrane in which the slow inactivation
will be induced by the conformation change of the CaM, IQ motif, and I-II loop.
Our previous studies have indicated that the inactivation of LTCCs can be fast induced by
another ion channel, HCN2, on the cell membrane approached by electrophysiology in
the HEK293 cells co-transfected HCN2 channels with the pore subunit α1C and the
different recombinant accessory β subunits of LTCCs (Lin et al., 2010).
Electrophysiology and immunoprecipitation results further indicated that the underlying
mechanism is via the association between N-terminus of HCN2 and IQ motif of α1C
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subunit of LTCCs. In this study, using FRAP to examine the mobility of the wild type
HCN2 or α1C subunit and its mutants tagged with GFP in HEK293 cells, we further
confirmed the association between N-terminal of HCN2 and IQ motif of α1C subunit.
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Results
In order to investigate whether α1C and HCN2 channels associate with each other, we
use the FRAP technique to examine the half-time (t1/2) in the HEK293 cells expressing
the different recombinant proteins such as α1C-GFP and HCN2, α1C and HCN2-GFP, Nterminal deletion of HCN2 and α1C-GFP, as well as wild type HCN2-GFP and IQ motif
deletion of α1C.
During the FRAP experiment, photobleaching with high energy light creates a dark and
bleached region within the sample, named region of interest (ROI), which is indicated by
the arrow in Fig 1. The neighboring molecules, in this case the GFP-labeled proteins,
subsequently diffuse into the ROI and replace the bleached molecules to reach a steady
state. How fast this steady state is achieved is measured by the half-time (t1/2), which is
correlated with how heavy the GFP-labeled proteins are. For example, if the protein is
associated with another protein as a complex, the molecular weight is heavier than the
protein by itself; therefore the diffusion rate is slower, resulting in a longer t1/2. The
calculation of t1/2 is shown in Fig 1.
Fig 2 indicated that the half-time (t1/2) of α1C-GFP and HCN2 reveals as 14.04±3.51(s)
(n=3) after subtracting the background and analyzing by the software Igor. When
comparing with N-terminal deletion of HCN2 with α1C-GFP (indicated as Fig 3) or wild
type HCN2-GFP with IQ motif deletion of α1C (indicated as Fig 4), the half-time is
significantly slower in cells co-transfected α1C-GFP with HCN2 (t1/2=7.83±2.15(s) <
t1/2=14.04±3.51(s) and t1/2 =1.12±0.09(s) < t1/2=14.04±3.51(s), respectively) (n=3). The
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half-time of the cells co-transfected α1C with HCN2-GFP indicated in Fig5 is equal to
10±1.23(s) (n=3), which is still slower than those of mutants.
These results indicated the dynamic association of HCN2 between α1C possibly through
N-terminus of HCN2 and IQ motif of α1C.
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Fig 1. Fluorescence recovery after photobleaching (FRAP).
Red arrows indicate region of interest (ROI) generated by photobleaching. The bleached
molecules in ROI are gradually replaced by adjacent molecules (GFP-labeled proteins)
and reach the steady state. The half-time t1/2 represents the time required for the bleach
region to recover half of its initial intensity. The calculation of t1/2 is shown at the bottom.
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Fig 2. Half-time (t1/2) of HEK293 cells co-transfected α1C-GFP with HCN2.
The recovery half-time (t1/2) of α1C-GFP and HCN2 reveals as 14.04±3.51(s) after
subtracting the background and analyzing by the software LM510 and Igor (n=3). Figure
2 indicated the representative figure in HEK293 cells co-transfected HCN2 with α1C
tagged with GFP.
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Fig 3. Half-time (t1/2) of HEK293 cells co-transfected N-terminal deletion HCN2
with α1C-GFP. The recovery half-time is revealed as 7.83±2.15(s) after analysis by the
software LSM510 and Igor (n=3). Figure 3 indicated the representative figure in HEK293
cells co-transfected N-terminal deletion HCN2 with α1C-GFP.
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Fig 4. Half-time (t1/2) of HEK293 cells co-transfected wild type HCN2-GFP with IQ
motif deletion of α1C. The recovery half-time is revealed as 1.12±0.09(s) after analysis
by the software LSM510 and Igor (n=3). Figure 4 indicated the representative figure in
HEK293 cells co-transfected wild type HCN2-GFP with IQ motif deletion of α1C.
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Fig 5. Half-time (t1/2) of HEK293 cells co-transfected α1C with HCN2-GFP. The
recovery half-time is revealed as 10±1.23(s) after analysis by the software LSM510 and
Igor (n=3). Figure 5 indicated the representative figure in HEK293 cells co-transfected
α1C with HCN2-GFP.
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Discussion
FRAP is an optical technique that can be used to quantify two dimensionally molecular
diffusion. The photobleaching of ROI allows adjacent molecules diffuse toward ROI in
which the dynamic protein-protein interaction can be quantified by this approach. In the
previous study, we have demonstrated that association between N-terminus of HCN2 and
C-terminus of LTCC (Lin et al., 2010). In order to further confirm this association in a
dynamic manner, we employed FRAP here to test the half-time of fluorescence recovery
in HEK293 cells transfected with different recombinant proteins. If one protein is
associated with another protein as a complex, the diffusion rate of the protein complex is
slower than the protein by itself due to increase of the molecular weight. Our results
revealed that the half-time in HEK293 cells co-expressed with the mutant (either Nterminal mutant of HCN2 or C-terminal mutant of LTCC) is significantly faster than that
of the wild type, indicating N-terminus of HCN2 and C-terminus of LTCC are key
contributors for the association between LTCC and HCN2.
It is worth to notice here that although the half-time of cells cotransfected α1C with
HCN2-GFP indicated in Fig 5 revealed faster a little bit when compared with α1C-GFP
and HCN2 (Fig 2) (t1/2=10±1.23(s) < t1/2=14.04±3.51(s), n=3), the value is significantly
slower than those of the mutants. This may be due to the larger molecular weight of α1C
(~150KD) than HCN2 (~100KD) (Huang et al., 2008; Lin et al., 2010). Our results
strongly demonstrated that HCN2 associate with α1C via the N-terminus of HCN2 and
IQ motif of α1C, indicating the crosstalk between these two channels on the cell
membranes.
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Overall Summary
Up till now, several approaches have been developed to establish animal models for the
study of arrhythmias. These include: (1) Aorta bandage to induce ischemic condition
(Billman et al., 2005), (2) Installation of pacemakers to induce heart failure (Timek et al.,
2003), and (3) Genetic ablation (Benkusky et al., 2007). Although widely used in many
different studies, these model systems are all associated with structural remodeling,
which results in ectopic automaticity or reentrant excitation and therefore induces cardiac
arrhythmias.
However, structural remodeling is not the only mechanism for arrhythmias. It is known
that SCD can also occur acutely (in several seconds) without structural remodeling
(MacAlpin, 1993; Zipes et al., 1998), indicating that short-term dysregulation can also be
an important arrhythmogenic mechanism. Therefore, it is of great value to establish an
animal arrhythmic model for in the absence of structural remodeling. In Chapter 1, we
successfully established a new rat arrhythmia model without structural remodeling,
enabling research on mechanisms leading to short-term cardiac dysfunction.
Alteration of cardiac rhythm by tyrosine phosphorylation
In this study, we found that increasing tyrosine phosphorylation by applying tyrosine
phosphatase inhibitor, sodium orthovanadate, led to different types of ventricular
arrhythmias. Furthermore, reducing tyrosine phosphorylation by Src kinase inhibitor,
PP2, significantly decreased heart rate as well as HRV. These results let us conclude that
the endogenous tyrosine phosphorylation and dephosphorylation levels in the cardiac
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system delicately modulate the rhythm of the heart via balancing with each other in the
physiological condition: Src-mediated tyrosine phosphorylation is dominant in atria
whereas phosphatase-mediated tyrosine dephosphorylation is dominant in ventricles.
That may explain why PP2 can reduce heart rate at a low dose (0.2 mg/kg) and induce
AV block at a higher dose administration (0.3 mg/kg); whereas sodium orthovanadate
can induce different types of ventricular arrhythmias at different doses (3.8 mg/kg and
5.5 mg/kg).
Although our main purpose of using PP2 is to decrease tyrosine phosphorylation (we
have PP3 as the negative control), we cannot exclude the possibility that PP2 may
directly affect other signal pathways, such as the pathways mediated by phosphatidyl
inositol 3′-kinase (PI3K) and p38 mitogen-activated protein kinase (MAPK), the
downstream of epidermal growth factor (EGF) receptor-mediated pathways (Kumar et
al., 2003). Whether these kinases may also involve in the regulation of cardiac rhythm
need further investigated.
The observed changes of cardiac rhythm and HRV by reducing tyrosine phosphorylation
after administration of PP2 could be a result of 1) altered activity of autonomic nervous
system (ANS), and/or 2) altered sensitivity of sinus node responding to ANS. Previous
studies have demonstrated that Src family tyrosine kinases are associated with β
adrenergic receptors and regulate the internalization of these receptors (Huang et al.,
2004). It is possible that Src kinases mediate G protein activation and alter the
intracellular cAMP level leading to downstream signaling events. Therefore, inhibition of
Src kinases by PP2 may interfere with and reduce the activity of ANS pathway. However,
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reducing ANS activity may not be the only explanation. The other possibility could be
due to a reduced sensitivity of SA node to the ANS involving the alteration of ion
channel activities. Previous studies showed that EGF increases heart rate and channel
currents through tyrosine phosphorylation in the isolated heart system (Nair et al., 1993).
Since HCN4 channels express dominantly in the sinus node contributing to the “U” turn
in the phase 4 of sinus node action potential, one possible scenario is that HCN channel
activities can be altered by tyrosine phosphorylation, thus mediating the change observed
in the heart rate and HRV.
Modulation of HCN channel activities by tyrosine phosphorylation
To elucidate the possibility that the change of cardiac rhythm by tyrosine phosphorylation
is due to the alteration of HCN channel activities, in chapter 2, we employed HEK293
cells co-expressing HCN channel proteins and other regulators. The advantage of using
HEK293 cells is because this is a well-established expressing system without endogenous
channel proteins, providing a clean platform to study channel proteins of our interest.
Using this in vitro system combined with techniques of electrophysiology and confocal
imaging, we were able to dissect the mechanism of phosphorylation-dependent regulation
of heart rate and HRV.
Our results indicated that the increase of Src-mediated tyrosine phosphorylation
dramatically enhanced surface expression and gating properties of HCN channels;
conversely, RPTPα, a tyrosine phosphatase, led to the decrease of surface expression and
gating properties of channels by reducing tyrosine phosphorylation. In accordance with
these results in HEK293 cells, our previous in vivo data using adult rat ventricular
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myocytes also revealed that increased tyrosine phosphorylation by sodium orthovanadate
(a tyrosine phosphatase inhibitor) could enhance the current amplitude and gating
properties of HCN channels (decrease the activation threshold from -135 mv to -90 mv)
in comparison with that in the absence of sodium orthovanadate (Huang et al., 2008).
These data suggest that changed sensitivity of SA node to the ANS could indeed be a key
contributor to the changed heart rate/ HRV when the phosphorylation level is altered.
Since HCN4 channels are dominantly expressed on atria whereas HCN2 channels on
ventricles, altered activities of HCN channels increase the risk of ectopic automaticity by
changing the slope in the phase 4 of atrial or ventricular action potential. If the
automaticity of sinus node (primary pacemaker) is replaced by other regions of atriums or
ventricles, atrial or ventricular arrhythmias could occur. This may explain why different
types of ventricular arrhythmias can be induced as a response to the increased tyrosine
phosphorylation by sodium orthovanadate.
On the other hand, reduced tyrosine phosphorylation state by PP2 may associate
reduction of HCN4 channel activities and thus decrease the cardiac rhythm. However,
there are still some questions that are not entirely understood, such as: 1) why Src kinases
differentially modulate atrial activities whereas phosphatases dominantly regulate
ventricular activities; 2) whether HCN4 channels can be downregulated on atrium by
reduced tyrosine phosphorylation after administration of PP2; 3) whether HCN2 channels
can be upregulated by increased tyrosine phosphorylation followed by application of
sodium orthovanadate. These open questions acquire further investigations.
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Under pathological conditions, we also demonstrated that enhancement of tyrosine
phosphorylation by three Src kinases, Src, Fyn, and Yes, can rescue the membrane
trafficking defect mutant HCN4 D553N that has been found in a patient with long QT
symptom

followed

by

polymorphic

ventricular

tachycardia.

By

employing

electrophysiology and confocal imaging, we found that not only membrane surface
expression but gating properties and kinetics of this mutant can also be rescued after
cotransfection of these three Src kinases. One possible explanation is that this single
amino acid mutant (from D to N) causes the loss of negative charges at the residue 553,
which leads to conformation change (misfolding) and therefore interfering with
trafficking and/or localizing to the surface membrane. These three Src kinases can
provide phosphate, which is negatively charged, to tyrosine residues of this mutant and
possibly prevent misfolding. Furthermore, our results also demonstrated that the
subcellular location of HCN4 D553N mutant was at endoplasmic reticulum (ER),
confirming that this mutant has membrane trafficking defect (Ueda et al., 2004).
Our biochemical results also showed that these three Src kinases have different tyrosine
phosphorylation effects on the D553N mutant: Fyn has the highest whereas Yes has the
lowest (Lin et al., 2009). It may explain why these three Src kinases have differential
results: Yes and Src can rescue the surface expression whereas Fyn can accelerate the
kinetics of this mutant. Nevertheless, the exact relationships among tyrosine
phosphorylation, surface expression, and kinetics of the channel protein are not
understood completely. Therefore, further studies are also needed in cardiac myocytes.
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Calcium influx limitation of LTCC by HCN2
We have also found a novel role of HCN2 in the regulation of LTCC inactivation. LTCCs
contribute to the plateau phase of action potentials and delicately regulate the calcium
influx. Since calcium homeostasis is pivotal for the maintenance of normal cardiac
function, abnormal calcium handling can be directly linked to cardiac arrhythmias.
Excessive calcium influx is known to lead to long QT interval and induce DAD-related
tachyarrhythmias ((Burashnikov et al., 2003; Nattel et al., 1988; Satoh et al., 1998).
EADs can also be induced if plateau potentials become abnormally prolonged (Chen et
al., 2001; Coutu et al., 2006; Stambler et al., 2003).
In chapter 3, we found a new mechanism to restrict calcium influx via facilitation of
inactivation of LTCCs. By electrophysiology after the cotransfection of α1C (core
subunit of LTCC) with HCN2 in HEK 293 cells, we concluded that HCN2 can induce
faster inactivation of LTCCs when compared with the control. In order to investigate
whether CaM is involved in this regulation, we used two structurally different CaM
inhibitors, W-7 and TFP. Surprisingly, either W-7 or TFP can totally eliminate this fast
inactivation of LTCCs triggered by HCN2. Similar results were also observed when we
employed a CaM dominant negative mutant, CaM(1,2,3,4). These data demonstrated that
CaM is necessary in this HCN2-triggered fast inactivation, which is consistent with
previous studies where CaM played the critical roles in the regulation of both VDI and
CDI of LTCCs (Cens et al., 2006; Erickson et al., 2003; Kim et al., 2004; Pitt et al.,
2001). The inhibitory time period of these two drugs is also comparable to that of
previous studies (Reinhart et al., 1980; Hidaka et al., 1981). However, in the presence of
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α2δ subunit, the role of CaM is compromised since neither W-7 nor TFP affected this fast
inactivation regulated by HCN2 any more, indicating the potential role of α2δ in this
regulation. One possibility is that the negative charges in the N-terminus of HCN2 may
associate with the positive charges in the C-terminus of α2δ and interfere with its
interaction with CaM. Besides, previous studies also revealed that α2δ is pivotal to
regulate the surface expression and gating properties of LTCCs (Arikkath et al., 2003;
Felix et al., 1997; Yasuda et al., 2004), which is consistent with the reported finding here.
In order to test the hypothesis that the fast inactivation of LTCCs initiated by HCN2 may
depend on the interaction between N-terminus of HCN2 and IQ motif of α1C, we
employed two mutants: N-terminal deleted HCN2 and IQ motif deleted α1C. Our results
indicate that either of these two mutants could abolish or slow down this fast inactivation
regulated by HCN2, suggesting that N-terminus of HCN2 and IQ motif of α1C are two
key domains responsible for this regulation. Consistently, our results in FRAP further
demonstrated the dynamic association between these two key domains, confirming the
interaction between N-terminus of HCN2 and IQ motif of α1C.
Conclusions
In chapter 1 and chapter 2, the in vivo and in vitro results from my thesis work strongly
indicated that tyrosine phosphorylation played a crucial role in the regulation of heart rate
and cardiac arrhythmogenesis possibly through modulation of HCN channels. In chapter
3, we have demonstrated that the inactivation of LTCC, facilitated by HCN2 through the
association of the two channels, leads to a reduced calcium influx. This provides
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scientific basis for potential therapeutic strategy for the treatment of cardiac arrhythmias
(such as long QT syndrome) caused by excessive calcium homeostasis.
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Rescue of a Trafficking Defective Human Pacemaker Channel
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Defective trafficking leading to the reduced surface expression of ion channels is one of the mechanisms responsible for a
loss-of-function of the ion channel on the plasma membrane
(1). Several methods have been developed to rescue the voltagegated potassium Kv trafficking defective channels: reducing the
culture temperature, applying the channel blockers, altering
the molar ratio of glycerol, and using the sarcoplasmic/endoplasmic reticulum Ca2⫹-ATPase inhibitor thapsigargin (2– 6).
Hyperpolarizing-activated cyclic nucleotide-gated (HCN)3
pacemaker channels generate time- and voltage-dependent
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inward currents, named Ih in neurons or If in the heart (7). They
are important in various cell functions including excitability,
synapse transmission, and rhythmic activity (7). The most well
studied regulation of If is its response to autonomic stimulation.
␤-Adrenergic receptor activation increases and acetylcholine
receptor activation decreases the intracellular cAMP levels,
which in turn increases/decreases If by binding to the cyclic
nucleotide-binding domain of the HCN channels, respectively
(7). Other important mechanisms for the modulation of
If/HCN channels have recently been found including ␤-subunit
(8), lipids (9, 10), and p38 mitogen-activated protein kinase
(11).
Accumulating evidence has revealed tyrosine phosphorylation as an important mechanism for modulation of HCN channel properties (12–16). An acute increase in tyrosine phosphorylation of If or HCN channels increases the channel activity,
including an increase in the current amplitude, a positive shift
of the voltage-dependent activation, an acceleration of activation kinetics, and an increase in whole cell conductance (12–
15). Recently, we discovered that the cell surface expression of
HCN2 channels can be remarkably inhibited by tyrosine
dephosphorylation mediated by receptor-like protein tyrosine
phosphatase ␣ (RPTP␣) and increased by tyrosine phosphorylation via Src kinase after long term treatment (17).
D553N, a missense HCN4 mutant, was recently identified in
a patient with cardiac arrhythmia associated with depressed
HCN gating properties (18). Functional and structural assays
revealed that D553N expresses little ionic currents, which is
possibly due to the defective channel trafficking so that the
channels cannot reach the plasma membrane for normal functions (18).
The Src kinase family has nine members (19). They are
closely related and share the same regulatory function. Three of
them, Src, Fyn, and Yes, are ubiquitously expressed in a variety
of tissues including neurons and myocytes (19, 20). Without
stimulation, they are inactive. However, mutation of key tyrosine residue results in the constitutively active form of the
kinase, SrcY529F, FynY531F, and YesY537F, respectively (15,
21, 22). Using these Src kinases, we show in this report a novel
approach that can restore the surface expression of D553N for
normal current expression via tyrosine phosphorylation.

EXPERIMENTAL PROCEDURES
cDNA Plasmids—The human version of HCN4-pcDNA1.1
was kindly provided by Dr. U. B. Kaupp and subcloned into
pcDNA3.1 vector. HCN4-D553N-pcDNA3 was made by subJOURNAL OF BIOLOGICAL CHEMISTRY
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Therapeutic strategies such as using channel blockers and
reducing culture temperature have been used to rescue some long
QT-associated voltage-gated potassium Kv trafficking defective
mutant channels. A hyperpolarization-activated cyclic nucleotidegated HCN4 pacemaker channel mutant (D553N) has been
recently found in a patient associated with cardiac arrhythmias
including long QT. D553N showed the defective trafficking to the
cell surface, leading to little ionic current expression (loss-of-function). We show in this report that enhanced tyrosine phosphorylation mediated by Src, Fyn, and Yes kinases was able to restore the
surface expression of D553N for normal current expression. Src or
Yes, but not Fyn, significantly increased the current density and
surface expression of D553N. Fyn accelerated the activation kinetics of the rescued D553N. Co-expression of D553N with Yes exhibited the slowest activation kinetics of D553N. Src, Fyn, and Yes
significantly enhanced the tyrosine phosphorylation of D553N. A
combination of Src, Fyn, and Yes rescued the current expression
and the gating of D553N comparable with those of wild-type
HCN4. In conclusion, we demonstrate a novel mechanism using
three endogenous Src kinases to rescue a trafficking defective
HCN4 mutant channel (D553N) by enhancing the tyrosine phosphorylation of the mutant channel protein.
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recorded using the whole cell patch clamp technique with an
Axopatch-200B amplifier. The current amplitude of HCN4 or
D553N current is defined as the amplitude of the onset timedependent inward current elicited by the hyperpolarizing pulse,
excluding the instant jump at the beginning of the pulse. The
current density is the current amplitude divided by the cell
capacitance measured in each cell studied. The pipettes had a
resistance of 2– 4 M⍀ when filled with internal solution: 6 mM
NaCl, 130 mM potassium aspartate, 2 mM MgCl2, 5 mM CaCl2,
11 mM EGTA, and 10 mM HEPES; pH was adjusted to 7.2 by
KOH. The external solution contained 120 mM NaCl, 1 mM
MgCl2, 5 mM HEPES, 30 mM KCl, 1.8 mM CaCl2; pH was
adjusted to 7.4 by NaOH. The Ito blocker, 4-aminopyridine (2
mM), was added to the external solution to inhibit the endogenous transient potassium current, which can overlap with and
obscure IHCN4 tail currents recorded at ⫹20 mV. The data were
acquired by CLAMPEX and analyzed by CLAMPFIT (pClamp
8; Axon).
The data are shown as the means ⫾ S.E. The threshold activation of IHCN4 is defined as the first hyperpolarizing voltage
at which the first time-dependent inward current can be
observed. Student’s t test was used for statistical analysis with
p ⬍ 0.05 being considered statistically significant. Time constants were obtained by using Boltzmann best fit with one exponential function on current traces that reach steady state.
HCN4 activates slowly, and the cells would not tolerate pulses
sufficiently long to reach the steady state. We therefore used the
following approach to obtain an accurate estimate of the steady
state activation (15). The onset current traces were fitted with a
single exponential function to 30 – 40 s to allow estimates of
steady state current levels. The fitted current amplitudes were
then divided by the driving force (the difference between test
pulses and the reversal potential that was measured in each cell)
to obtain the conductance at each test pulse. The activation
curves were constructed by normalizing the conductance to its
maximal value in response to the most negative test pulse.
Confocal Fluorescent Imaging of HEK293 Cells—HEK293
cells transfected with HCN4-DsRed or HCN4-DsRed-D553N
were incubated on coverslips and fixed in 4% paraformaldehyde/PBS for 15 min and then washed with PBS (10 mM phosphate buffer, 150 mM NaCl, pH 7.4) for 5 min for three times,
followed by blocking in 1% bovine serum albumin/PBS, pH 7.4,
for 60 min. After washing six times in PBS, the coverslips were
mounted on slide glasses using Fluoromount G (Southern Biotechnology). The cells were imaged by a LSM510 confocal
microscopy using a Plan-Neofluar 40⫻/0.75 objective or a
Plan-Apochromat 63⫻/1.4 Oil differential interference contrast M27 objective. For DsRed imaging, a 1.2-milliwatt 543-nm
HeNe laser was used for excitation, and a 560 – 615-nm BP
emission filter was used for emission.

RESULTS
Inhibition of HCN4 Current Expression by RPTP␣—We have
recently demonstrated that RPTP␣ can inhibit the surface
expression of HCN2 channels via tyrosine dephosphorylation
(17). Given the high structural homology between HCN2 and
HCN4 (⬎80%) (7), it was expected that RPTP␣ may also inhibit
the surface expression of HCN4. Fig. 1 shows a typical current
VOLUME 284 • NUMBER 44 • OCTOBER 30, 2009

Downloaded from www.jbc.org at WEST VIRGINIA UNIV, on May 23, 2011

stituting aspartic acid with asparagine using PCR. HCN4D553N-DsRed was made by subcloning HCN4-D553N into the
DsRed vector. RPTP␣ was a generous gift from Dr. Jan Sap
(University of Copenhagen, Copenhagen, Denmark). The constitutively active form of Fyn, FynY531F, in pcDNA3.1 vector,
was kindly provided by Dr. Shigeru Kanda (Nagasaki University, Nagasaki, Japan). The constitutively active form of Yes
(YesY537F) was kindly provided by Dr. Arkadiusz Welman
(Edinburgh Cancer Research Center), and we subcloned it into
the pcDNA3.1 vector. Src529 (SrcY529F) was purchased from
Upstate Biotechnology (Millipore). For simplicity, we also use
Src, Fyn, and Yes and Src529, Fyn531, and Yes537 in the text for
interchangeable use with the constitutively active form of each
kinase: SrcY529F, FynY531F, and YesY537F.
Cell Culture and Plasmids Transfection—HEK293 cells were
grown in Dulbecco’s modified Eagle’s medium (Invitrogen),
supplemented with 10% fetal bovine serum, 100 IU/ml penicillin, and 100 g/liter streptomycin. Cells with 50 –70% confluence
in 6-well plates were used for plasmid transfection using Lipofectamine2000 (Invitrogen).
Cell Lysis, Immunoprecipitation, and Western Blot Analysis—
Total protein extracts were prepared from cells transfected for
24 – 48 h using CelLytic cell lysis reagent (Sigma) supplemented
with protease inhibitors. For membrane fraction preparations,
we used a membrane protein extraction kit (Pierce). The protein concentration of the lysate was determined using the Bradford or BCA assay. Equal amounts of total protein (0.5–1 mg)
were incubated with a specific antibody for 1 h at 4 °C, and
protein A/G Plus-agarose (Santa Cruz) was then added and
incubated overnight with gentle rocking. The beads were
washed three times with cold PBS buffer and resuspended in
2⫻ sample buffer. The immune complexes were separated by
SDS-PAGE and analyzed by Western blot using the specific
antibody of interest. Total protein of 5–20 g/sample was subjected to SDS-PAGE using 4 –12% gradient gels (Invitrogen)
and then transferred to nitrocellulose membranes (Amersham
Biosciences) and incubated with proper antibodies. After washing and incubating with horseradish peroxidase-conjugated
secondary antibody, immunoreactive proteins were visualized
with the SuperSignal威 West Pico kit (Pierce).
Cell Surface Biotinylation—Cell surface biotinylation experiments were performed by following the manufacturer’s
instruction (Pierce). Briefly, HEK293 cells transfected with
desired plasmids were first treated with EZ-link Sulfo-NHS-SSBiotin to label cell surface proteins. The cells were subsequently
lysed with lysis buffer containing protease inhibitor mixture
(Sigma). The labeled proteins were then isolated with immobilized NeutrAvidin-agarose. After washing three times, the
bound proteins were released by incubating with SDS-PAGE
sample buffer containing 50 mM dithiothreitol and then analyzed by Western blotting. All of the protein experiments were
repeated at least three times.
Whole Cell Patch Clamp Recordings—For recording IHCN4,
day 1 (24 –30 h) up to day 4 (90 –98 h) post-transfection
HEK293 cells with green fluorescence were selected for patch
clamp studies. The HEK293 cells were placed in a Lucite bath in
which the temperature was maintained at 25 ⫾ 1 °C by a temperature controller (Cell MicroControls). IHCN4 currents were
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expression of HCN4 expressed in HEK293 cells (Fig. 1A). The
expression was dramatically suppressed across the test voltages
(⫺65 to ⫺135 mV) when HCN4 was co-expressed with RPTP␣
after 1 day of transfection (Fig. 1B). The reduction in current
expression was associated with a negative shift in threshold
activation (Figs. 1, A and B, arrows). After 2 days of transfection,
RPTP␣ almost eliminated the current expression of HCN4 (Fig.
1C). The effect of RPTP␣ on HCN4 current expression is similar to that on HCN2 current expression (17). As a control, the
empty vector, pRK5 (used to subclone RPTP␣), did not affect
the current expression of HCN4 (Fig. 1D). Each of these results
was confirmed in an additional 5–7 cells.
Inhibited Surface Expression and Reduced Tyrosine Phosphorylation of HCN4 by RPTP␣—Wondering whether HCN4 current inhibition of RPTP␣ is due to the suppressed membrane
expression of the channel proteins, we examined the HCN4
channel membrane preparation (Fig. 2A). The left triplet shows
HCN4 expression. The split bands indicate unglycosylated and
glycosylated forms, similar to HCN2 membrane expression
(17). The glycosylated form of HCN4 was significantly inhibited
by RPTP␣ (middle triplet) and enhanced by Src529 (a constitutively active form of Src) (right triplet).
Using the phosphotyrosine-specific antibody 4G10, Fig. 2B
shows that the tyrosine phosphorylation of HCN4 channel protein (middle lane) was significantly enhanced by Src529 (second
lane from the right) but inhibited by RPTP␣ (left lane). These
results suggested that the altered membrane expression of
HCN4 is possibly caused by the increased or decreased tyrosine
OCTOBER 30, 2009 • VOLUME 284 • NUMBER 44

FIGURE 3. Src/RPTP␣ on HCN4 cell surface expression in HEK293 cells.
A, fluorescence imaging of HCN4-DsRed, HCN4-DsRed⫹RPTP␣, and HCN4DsRed⫹Src529. B, fluorescence (left panel) and bright field (right panel)
images of cells transfected with DsRed alone.

phosphorylation of the channel protein by Src tyrosine kinase
and RPTP␣ tyrosine phosphatase, respectively.
To further seek supporting evidence that reduced ionic current expression of HCN4 is caused by the suppressed surface
expression of HCN4 channels, we tagged HCN4 with a fluorescent protein, DsRed, and examined the distribution of HCN4
using fluorescent confocal microscopy. Fig. 3A shows a typical
fluorescent image of HCN4 expressed alone in a HEK293 cell
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 1. RPTP␣ on HCN4 current expression in HEK293 cells. A, HCN4
current expression in response to 15-s hyperpolarizing pulses from ⫺65 to
⫺135 mV in 10-mV increments. Tail currents were recorded at ⫹20 mV. B, in a
cell co-transfected with RPTP␣ after 1 day of incubation, HCN4 current
expression in response to 10-s hyperpolarizing pulses from ⫺65 to ⫺135 mV
in 10-mV increments. C, in a cell co-transfected with RPTP␣ after 2 days of
incubation, HCN4 current expression in response to 10-s hyperpolarizing
pulses from ⫺65 to ⫺135 mV in 10-mV increments. D, HCN4 current expression in HEK293 cells co-expressed with the empty vector, pRK5.

FIGURE 2. Src/RPTP␣ on HCN4 membrane protein expression and tyrosine phosphorylation in HEK293 cells. A, immunoblots (IB) on membrane
fraction for HCN4, HCN4⫹ RPTP␣, and HCN4⫹Src529. ␤-Actin was used as a
loading control. B, tyrosine phosphorylation of HCN4 by Src529 and RPTP␣.
The total protein samples were first immunoprecipitated (IP) using 4G10 antibody and then immunoblotted using an HCN4 antibody. Weak phosphorylation signals of HCN4 and HCN4⫹RPTP␣ can be seen in long exposed film (1
min). The immunoblot of HCN4 (right lane) was used as a size marker.
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sion for D553N (Fig. 4B). Fig. 4
(C–E) shows the effects of individual Src, Fyn, and Yes on D553N
current expression, respectively.
Fig. 4 (F–H) also shows the effects
of Src⫹Fyn, Src⫹Yes, and Fyn⫹Yes
on D553N current expression, respectively. Fig. 4I shows the overall
effects of combined Src⫹Fyn⫹Yes
on D553N current expression.
For effective comparison of the
actions of Src kinases on D553N to
HCN4, we calculated the current
density and the activation kinetics
at ⫺125 mV, which is near the fully
activated voltage. Current density at
the voltage in which all channels are
open is directly related to our central interest of evaluating whether
Src kinases can rescue the surface
expression of D553N. The current
densities under different conditions
are shown in Fig. 5A.
Src and Yes, but not Fyn, can significantly rescue D553N current
expression. Different combinations
of three kinases all enhanced the
current expression of D553N (Fig.
FIGURE 4. Src/Fyn/Yes kinases on current expression of D553N at ⴚ125 mV. Currents elicited by
hyperpolarizing pulses in 10-mV increments are presented for HCN4 (A), D553N (B), D553N⫹Src529 (C), 5A, asterisk). All three Src kinases
D553N⫹Fyn531 (D), D553N⫹Yes537 (E), D553N⫹Src529⫹Fyn531 (F), D553N⫹Src529⫹Yes537 (G), expressed together (Fig. 4I) can
D553N⫹Fyn531⫹Yes537 (H), and D553N⫹Src529⫹Fyn531⫹Yes537 (I). The test potentials are labeled in restore ⬃68% current expression of
the figures. The pulse durations were 15 s for A–C, E, and G; 12 s for F, H, and I; and 6 s for D. The holding
D553N as compared with the wildpotential was ⫺10 mV.
type HCN4 expression (Fig. 5A,
(left panel). An approximately equal amount of HCN4 is dis- dark bars, HCN4: 37.15 ⫾ 3.21 pA/pF, n ⫽ 7; D553N⫹Src/Fyn/
tributed on the plasma membrane and in the cytosol, consistent Yes: 25.25 ⫾ 2.17 pA/pF, n ⫽ 10) (Fig. 5A).
The effects of Src/Fyn/Yes kinases on the current activation
with the membrane protein expression results (Fig. 2A). When
co-expressed with RPTP␣, most HCN4 channels are retained in kinetics are also different (Fig. 5B). The time constants for actithe cytosol (middle panel of Fig. 3A). On the other hand, Src529 vation kinetics were obtained by fitting the onset current with
significantly enhanced the cell surface expression of HCN4 one-exponential function at ⫺125 mV under different condi(Fig. 3A, right panel). As a control, Fig. 3B shows the fluores- tions. Fyn accelerated but Yes slowed the activation kinetics of
cence (left panel) and bright field (right panel) images of the D553N, whereas Src had no effects (p* values). The combinations of Src⫹Fyn and Fyn⫹Yes can accelerate D553N activaempty DsRed vector expressed in HEK293 cells.
Rescuing D553N Current Expression by Src, Fyn, and Yes— tion kinetics, whereas the combination of Src⫹Yes cannot. A
D553N has been recently identified in a patient suffering from combination of all three Src kinases can speed D553N activasinus node dysfunction, long QT, ventricular tachycardia, and tion kinetics at ⫺125 mV (Fig. 5, B and D); the time constants
torsade de pointes (18). In vitro studies of the mutant channel are 4.07 ⫾ 0.59 s (n ⫽ 3) for D553N and 1.24 ⫾ 0.05 s (n ⫽ 9) for
revealed defective surface expression on plasma membrane, D553N/Src/Fyn/Yes, respectively (p ⫽ 0.01). It is worth pointleading to the loss of current expression (18). Given the facts ing out that in 16 D553N transfected cells we studied only three
that the HCN4 channel activity including the channel surface cells that expressed time-dependent inward currents at ⫺125
expression can be significantly enhanced by Src-mediated tyro- mV and that were used for calculating current density and actisine phosphorylation and the ubiquitous expression of three vation kinetics shown in Fig. 5 (A and B). The other 13 cells
Src kinase family members (Src, Fyn, and Yes), we set forth to expressed no currents at the test potentials ranging from
test the hypothesis that the current expression of the defective ⫺75mV to ⫺135mV. As a comparison, we also showed the
trafficking D553N can be restored by constitutively active statistical analysis of comparing Src kinases on D553N to
HCN4 indicated by p values in Fig. 5B.
forms of Src kinases (Src529, Fyn531, and Yes537).
To assess the overall functional rescuing effects of Src/Fyn/
Fig. 4 provides a typical set of current recordings under different conditions. The current expression of wild-type HCN4 is Yes on D553N gating, we examined the biophysical properties
shown in Fig. 4A, as compared with the loss of current expres- of D553N co-expressed with Src/Fyn/Yes (Fig. 4I) in compari-
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altered slope factors(s). However, statistical analysis from the means of two
groups yielded no significant difference (V0.5_HCN4: ⫺86.1 ⫾ 1.5 mV,
n ⫽ 7; V0.5_D553N⫹Src/Fyn/Yes:
⫺81.6 ⫾ 1.4 mV, n ⫽ 9; p ⫽ 0.0724,
s_HCN4: 8.2 ⫾ 0.2 mV, n ⫽ 7;
s_D553N⫹Src/Fyn/Yes: 8.4 ⫾ 0.2
mV, n ⫽ 9, p ⫽ 0.577) (Fig. 5C). On
the other hand, the effects of Src
kinases on D553N activation
kinetics are complex. Compared
with the wild-type HCN4, the
averaged activation kinetics for
D553N⫹Src/Fyn/Yes were slowed
at the beginning of the activation
curve, accelerated near the middle
of the activation curve, but statistically indistinguishable at the
potentials after the half-activation
point (Fig. 5D) (n ⫽ 7 for HCN4,
n ⫽ 9 for D553N⫹Src/Fyn/Yes).
Enhanced Tyrosine PhosphorylaFIGURE 5. Src/Fyn/Yes kinases on current density and gating of D553N compared with HCN4. A, current
tion
and Membrane Surface Expresdensity measured at ⫺125 mV under different conditions. An asterisk indicates a statistically significant difference in comparison with D553N current density. B, time constants of activation kinetics at ⫺125 mV under sion of D553N by Src, Fyn, and Yes
different conditions. p values indicated statistical significance in comparing the effects of the kinases on D553N
Tyrosine Kinases—We have previto HCN4 (white bar). p* values indicated statistical significance in comparing the effects of the kinases on
D553N to D553N alone (gray bar). C, activation curves of HCN4 (WT) and D553N⫹Src/Fyn/Yes. D, activation ously shown that Src-mediated
kinetics of HCN4 (WT) and D553N⫹Src/Fyn/Yes. All of the statistical results were from seven to nine cells for tyrosine phosphorylation increases
each group except for D553N (only three cells expressed little currents of 16 cells tested).
the HCN2 and HCN4 channel activity via shifting the activation curve
to depolarizing potentials (short term effect) and enhancing the
cell surface expression (long term effect) (12, 14, 15, 17). We
have now demonstrated that reduced tyrosine phosphorylation
by RPTP␣ (Fig. 2B) can lead to the suppressed surface expression of HCN4 (Fig. 2A). To investigate whether tyrosine phosphorylation is involved in rescuing actions of Src, Fyn, and Yes
on D553N current expression, we studied the tyrosine phosphorylation state of D553N by Src, Fyn, and Yes kinase, respectively. Fig. 6 shows the tyrosine phosphorylation of HCN4 (Fig.
6A) and D553N (Fig. 6B) by three Src kinases in HEK293 cells.
HCN4 background phosphorylation was weak and significantly
increased by Src529 and Fyn531, but not by Yes537. D553N
background phosphorylation was barely detectable but dramatically increased by Src529, Fyn531, and Yes537. It was
noticed that Src529 increased most significantly the phosphorylation of the wild-type HCN4, but Fyn531 induced the highest
phosphorylation of D553N channel proteins.
FIGURE 6. Src/Fyn/Yes kinases on tyrosine phosphorylation and surface
We next examined the effects of Src kinases on D553N surexpression of D553N. A, tyrosine phosphorylation of HCN4, HCN4⫹Src529,
HCN4⫹Fyn531, and HCN4⫹Yes537, respectively. B, tyrosine phosphoryla- face expression using biotinylation approach (see “Experimention of D553N, D553N⫹Src529, D553N⫹Fyn531, and D553N⫹Yes537, tal Procedures” for details). Fig. 6C shows that the surface
respectively. Samples for A and B were immunoprecipitated (IP) with 4G10
antibody prior to the detection by HCN4 antibody. C, Src/Fyn/Yes effects on expression of D553N was barely detected. Src, Fyn, and Yes
each significantly enhanced the surface expression to various
surface expression of D553N using a biotinylation method. IB, immunoblot.
degrees. Yes had a larger effect than Src and Fyn in promoting
son with the wild-type HCN4 (Fig. 4A). The Boltzmann equa- the surface expression of D553N. The HCN4 wild-type surface
tion best fit from the averaged activation curves obtained from expression (Fig. 6C, second lane from the left) was used as a
tail currents (see “Experimental Procedures” for details in the positive control.
To seek further supporting evidence for rescuing surface
construction of the activation curve) showed a small depolarizing shift of D553N⫹Src/Fyn/Yes compared with HCN4 with no expression of D553N by three Src kinases, we constructed the
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D553N-DsRed fusion protein and performed the confocal
imaging experiments. Fig. 7 shows that most wild-type HCN4 is
expressed on the cell surface (Fig. 7A). By contrast, most D553N
cannot reach the cell surface (Fig. 7B). Co-expression with
either Src (Fig. 7D) or Yes (Fig. 7F) can significantly enhance the
surface expression of D553N. However, Fyn has been much less
significant on D553N surface expression, as evidenced by a significant amount of D553N remaining in the cytosol (Fig. 7E).
DsRed vector itself was uniformly expressed across the cell (Fig.
7C) and served as a negative control. These results, combined
with the protein biochemistry analysis, collectively provide the
cellular evidence for the functional rescue of D553N current
expression at the plasma membrane by Src/Fyn/Yes kinases.

DISCUSSION
Defective trafficking of mutant channels represents an
important mechanism for Kv channels causing long QT2 (1).
Studying long QT related Kv channel modulation has led to the
findings that lower temperature and channel blockers can
restore the surface and ionic current expression of the defective
trafficking mutant channels (1). In this work, we showed for the
first time that by modulating the Src/Fyn/Yes kinase activity, a
human HCN4 trafficking defective mutant D553N (also linked
to long QT (18)) can be rescued for normal surface and current
expression. The corrected D553N exhibited the gating properties comparable with those of the wild-type HCN4 channels.
Enhanced tyrosine phosphorylation increased the activity of
the cardiac pacemaker current, If, in the sinoatrial node cells
(13). Using genistein, a nonspecific tyrosine kinase inhibitor, we
found a differential modulation of tyrosine phosphorylation for
HCN1, HCN2, and HCN4 expressed in Xenopus oocytes; genistein had no effects on HCN1 but reduced HCN2 or HCN4 current expression (12). In the case of HCN2, there was also a
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FIGURE 7. Src/Fyn/Yes kinases on D553N fluorescence imaging. Fluorescence images of cells transfected with HCN4 (A), D553N (B), DsRed vector (C),
D553N⫹Src529 (D), D553N⫹Fyn531 (E), and D553N⫹Yes537 (F). All of the
results were repeated in an additional eight to ten cells.

negative shift in the voltage dependence of activation that
accompanied the current reduction. These studies represent
the acute effects of altered tyrosine phosphorylation of HCN
channel proteins on the gating properties of If.
To investigate the long term effects of specific tyrosine
kinases on HCN channels in a mammalian background, we
studied the effects of Src kinase on HCN4 channel (the main
isoform in the heart) expressed in HEK293 cells. We focused on
the Src kinases for two reasons: it mediates epidermal growth
factor receptor signaling (19) and Src homology 3 domain was
initially used to clone the first HCN channels (23). We found
that Src associated with and phosphorylated the HCN4 channel
proteins, leading to the enhanced HCN4 current density near
diastolic potentials (15). This was the first direct evidence
showing that 1) HCN4 channels can be phosphorylated by Srcmediated tyrosine kinases and 2) long term effects of tyrosine
phosphorylation of HCN4 channels can induce the changes in
the current density, which directly correlates with the number
of functional channels expressed at the plasma membrane.
Accompanying the increased current density were the accelerated activation kinetics and a positive shift in the voltage-dependent activation, which has been typically observed in the
short term modulation of HCN4 channels. These conclusions
were confirmed by the subsequent investigation on the major
tyrosine residues that mediate Src actions (14). Using PP2, a
selective inhibitor of Src kinase family, we found that the
reduced Src kinase activity can indeed shift the voltage-dependent activation to hyperpolarizing potentials, an effect mediated
by HCN4 Tyr531 (14). Another tyrosine residue, HCN4 Tyr554
previously reported by others (16), also contributed to the slowing of activation kinetics by PP2 (14). Work on the action of PP2
on HCN4 also resulted in two surprising observations. First, the
PP2-induced negative shift of HCN4 voltage-dependent activation is not in agreement with our previous results with genistein. At least two factors can contribute to this discrepancy:
mammalian cell (HEK293) versus amphibian (Xenopus oocytes)
background and general (genistein) versus selective (PP2) inhibition of tyrosine kinases. Second, we found that PP2 also
reduced the whole cell channel conductance (supplemental Fig.
3 in Ref. 14). These results implied that even the short term
effect of altered tyrosine phosphorylation may affect the number of functional channels at the plasma membrane.
More recently in the investigation of the potential role the
tyrosine phosphatase might play in the modulation of HCN
channel function, we found the dramatic inhibition of HCN2
current expression by RPTP␣ (17). The inhibited HCN2 current expression was due to the reduced surface expression of
HCN2 channels via association between RPTP␣ and the HCN2
channel proteins, resulting in the channel dephosphorylation
(17). The work demonstrated a previously unrecognized feature of HCN channel modulation by tyrosine phosphorylation:
the tyrosine phosphorylation state of HCN channel proteins
represents one important regulatory mechanism for the cell
surface expression of the functional channels, which directly
determines the current expression of functional HCN channels.
This feature may be utilized to enhance the surface and ionic
current expression of HCN mutant channel that cannot reach
the plasma membrane for normal function.
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TABLE 1
Relative roles of Src, Fyn, and Yes on D553N surface/current
expression and activation kinetics
⫺, no or little expression or little effect or decrease; ⫹, increase; ⫹⫹, significant
increase or acceleration.

D553N
⫹Src
⫹Fyn
⫹Yes
a

Surface
expressiona

Current
density

Activation
kinetics

⫺
ⴙⴙ
ⴙ
ⴙⴙ

⫺
ⴙⴙ
⫺
ⴙⴙ

⫺
ⴙⴙ
⫺

Combined results of biotinylation and fluorescence imaging.
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L-TYPE CALCIUM CHANNEL (LTCC) current inactivation is dependent on both Ca2⫹ ions and voltage (3, 13). The ␤- and
␣2␦-subunits regulate the membrane expression and the voltage-dependent inactivation of the ␣1C-subunit (2). Calmodulin
(CaM) plays a central role in both Ca2⫹-dependent inactivation
(CDI) and voltage-dependent inactivation (VDI) using Ba2⫹ as
the charge carrier (12, 13). CaM is proposed to tether with the
IQ motif in the COOH terminus of ␣1C (15, 16). Ca2⫹ inﬂux
through LTCC activates apoCaM (Ca2⫹-free CaM)/IQ complex. The activated CaM/IQ triggers a conformational change
of the inactivation machinery consisting of ␣1C COOH-terminal domains such as peptide A, peptide C (or CB), IQ motif,
and CaM. As a result, the inactivation machinery rapidly
blocks the inner surface of the pore, leading to fast CDI (6, 16).
CaM also has been proposed to interact with the linker of the
transmembrane I and II segments associated with the ␤1subunit to modulate VDI (3, 12).
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Hyperpolarization-activated, cyclic nucleotide-gated (HCN)
channels are activated by membrane hyperpolarization, generating a voltage- and time-dependent inward current called Ih or
If, which has been traditionally thought to permeate both Na⫹
and K⫹ ions (4). Recently, we discovered that Ca2⫹ ions also
can permeate HCN channels, even in a small percentage of the
total current (24, 25). Furthermore, activation of Ih and If can
increase the synapse transmission in dorsal root ganglion
neurons (25) and shorten the action potential duration in
ventricular myocytes (24), respectively. However, the underlying mechanisms are not well understood. In the present work,
we focus on a hypothesis that a closed HCN channel can
interact with LTCC at the plasma membrane, leading to the fast
inactivation of L-type Ca2⫹ current (ICaL).
MATERIALS AND METHODS

cDNA constructs. Various full-length cDNA plasmids were generous gifts from other investigators as detailed in the Supplemental
Material. (Supplemental data for this article is available online at the
American Journal of Physiology-Cell Physiology website.)
Cell culture and plasmids transfection. Human embryonic kidney
(HEK)-293 cells were grown on poly-D-lysine-coated coverslips in
Dulbecco’s modiﬁed Eagle’s medium (Invitrogen) supplemented with
10% fetal bovine serum, 100 IU/ml penicillin, and 100 g/l streptomycin. Cells with 50 –70% conﬂuence in a six-well plate were used for
plasmid transfection (2–5 g for each plasmid) using Lipofectamine2000 (Invitrogen).
An HEK-293 cell line stably expressing ␣2␦/␤1 was kindly provided by Dr. Richard Tsien (Stanford University). Culture of these
cells was similar to that described above except for addition of
antibiotics, G418 (0.5 mM/ml) and 5 mM L-glutamine, to the DMEM.
Preparation of hippocampus tissue. Adult rats (300 –350 g) were
euthanized by intraperitoneal injection of pentobarbital sodium (1.2
g/kg). After euthanasia, the adult rats were decapitated. The protocol
was approved by the Institutional Animal Care and Use Committee of
the Health Sciences Center at West Virginia University. Hippocampal
tissues were cut out and quickly frozen in liquid nitrogen.
Cell lysis, immunoprecipitation, and Western blot analysis. Coimmunoprecipitation and Western blot experiments were the same as
previously reported (11). Details are provided in the Supplemental
Material.
Hippocampus neuron culture, transfection, and imaging. Primary
embryonic day 18 rat hippocampus neurons were used for studying
the interaction between ␣1C and HCN2. Neuron culture and plasmid
transfection were completed following the instruction manual (Invitrogen). Live-cell images of hippocampal neurons were visualized
using an inverted Nikon TE2000S epiﬂuorescent microscope with
Prior ﬁlter wheels and a Photometrics Coolsnap HQ charge-coupled
device camera. More details are provided in the Supplemental Material.
Whole cell patch-clamp recordings. Patch-clamp recordings are the
same as previously reported (11). The pipettes had a resistance of 2–5
M⍀ when ﬁlled (in mM): 108 CsCl, 4 MgCl2, 9 EGTA, and 9
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Lin Y, Huang J, Zhang Q, Hollander JM, Frisbee JC, Martin
KH, Nestor C, Goodman R, Yu H. Inactivation of L-type calcium
channel modulated by HCN2 channel. Am J Physiol Cell Physiol
298: C1029 –C1037, 2010. First published February 17, 2010;
doi:10.1152/ajpcell.00355.2009.—Ca2⫹ entry is delicately controlled by inactivation of L-type calcium channel (LTCC) composed
of the pore-forming subunit ␣1C and the auxiliary subunits ␤1 and
␣2␦. Calmodulin is the key protein that interacts with the COOHterminal motifs of ␣1C, leading to the ﬁne control of LTCC inactivation. In this study we show evidence that a hyperpolarizationactivated cyclic nucleotide-gated channel, HCN2, can act as a nonchannel regulatory protein to narrow the L-type Ca2⫹ channel currentvoltage curve. In the absence of LTCC auxiliary subunits, HCN2 can
induce ␣1C inactivation. Without ␣2␦, HCN2-induced fast inactivation of ␣1C requires calmodulin. With ␣2␦, the ␣1C/HCN2/␣2␦
channel inactivation does not require calmodulin. In contrast, ␤1subunit plays a relatively minor role in the interaction of ␣1C with
HCN2. The NH2 terminus of HCN2 and the IQ motif of ␣1C subunit
are required for ␣1C/HCN2 channel interaction. Ca2⫹ channel inactivation is signiﬁcantly slowed in hippocampus neurons (HNs) overexpressing HCN2 mutant lacking NH2 terminus and accelerated in
HNs overexpressing the wild-type HCN2 compared with HN controls.
Collectively, these results revealed a potentially novel protection
mechanism for achieving the LTCC inactivation via interaction with
HCN2.
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HEPES. The bath solution contained (in mM) 2 BaCl2, 1 MgCl2, 10
HEPES, 40 tetraethylammonium, 10 glucoses, and 65 CsCl. Both
solutions were adjusted with CsOH to pH 7.2. Unless speciﬁcally
mentioned in the text, the Ba2⫹ currents (IBa) were recorded at ⫹10
mV from a holding potential of ⫺90 mV. IBa current inactivation was
sometimes normalized for better comparison of kinetics in different
combinations of plasmids coexpressed in different HEK-293 cells
(e.g., Figs. 2, A and D, and 3, A–C). Normalization is indicated
without vertical scales; where vertical scales are present, P/4 protocols
were used to remove the leak currents. The capacitive currents were
minimized with 75– 85% series resistance compensation. More details
are provided in the Supplemental Material.
RESULTS

Fig. 1. Ca2⫹-dependent inactivation (CDI)- and voltage-dependent inactivation (VDI) of ␣1C/␣2␦/␤1 and ␣1C/␣2␦/␤1/HCN2 in HEK-293. A: Ca2⫹ current (ICa;
solid line) and Ba2⫹ current (IBa; shaded line) of ␣1C/␣2␦/␤1 recorded at ⫹10 mV. B: ICa (solid line) and IBa (shaded line) of ␣1C/␣2␦/␤1/HCN2 recorded
at ⫹10 mV. C: time constants () for inactivation of ICa and IBa at ⫹10 mV for ␣1C/␣2␦/␤1 and ␣1C/␣2␦/␤1/HCN2, respectively. For simplicity of comparison,
we best ﬁt the currents with one exponential function. P values shown are the statistical results of comparing ICa and IBa inactivation. D and E: ICa currents
recorded in the test pulses ranging from ⫺50 to ⫹50 mV in 10-mV increments for ␣1C/␣2␦/␤1 (D) and ␣1C/␣2␦/␤1/HCN2 (E), respectively. A 400-ms
depolarizing pulse was used. Holding potential was ⫺90 mV. F: current-voltage relationship curves for ␣1C/␣2␦/␤1 and ␣1C/␣2␦/␤1/HCN2.
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CDI and VDI of ␣1C/␣2␦/␤1 and ␣1C/␣2␦/␤1/HCN2 channels in HEK-293 cells. Figure 1A exempliﬁed a well-established difference between CDI and VDI: faster inactivation
for ICa (solid line) than for IBa (shaded line), recorded
at ⫹10 mV. This difference, however, is largely diminished in
the presence of HCN2 (Fig. 1B): like ICa, the IBa of ␣1C/␣2␦/
␤1/HCN2 can inactivate almost completely to the closed state.
Figure 1C summarizes the time constants of inactivation of ICa
and IBa for ␣1C/␣2␦/␤1 and ␣1C/␣2␦/␤1/HCN2. They are
25.0 ⫾ 3.2 ms for ICa and 228.5 ⫾ 24.2 ms for IBa of ␣1C/␣2␦/␤1,
and 58.3 ⫾ 3.3 ms for ICa and 72.5 ⫾ 5.6 ms for IBa of
␣1C/␣2␦/␤1/HCN2. The difference between ICa and IBa of
␣1C/␣2␦/␤1/HCN2 inactivation kinetics was diminished compared with that between ICa and IBa of ␣1C/␣2␦/␤1 inactivation
kinetics, indicating that HCN2 can help complete the IBa
inactivation.
We also examined whether the current-voltage relationship
curves of ␣1C/␣2␦/␤1 are altered by HCN2. Representative ICa

are shown for ␣1C/␣2␦/␤1 (Fig. 1D) and ␣1C/␣2␦/␤1/HCN2
(Fig. 1E). In the presence of HCN2, there was a positive shift
in the threshold activation of ICaL and more reduced current
amplitude at the depolarized end of the bell shape near ⫹50
mV (Fig. 1F, shaded line). All results were repeated in an
additional ﬁve to eight cells.
Fast inactivation of ␣1C/HCN2 channels in HEK-293. To
examine a possible hidden interaction between ␣1C and
HCN2, we studied ␣1C inactivation by coexpressing ␣1C and
HCN2 in the absence of auxiliary subunits. With the use of
Ba2⫹ as the charge carrier, ␣1C exhibited little current inactivation when expressed alone (Fig. 2A, top). The auxiliary
subunit ␣2␦ could limit the Ca2⫹ inﬂux by inducing a slow
inactivation of ␣1C (Fig. 2A, top). Figure 2B, bottom, shows
the absence of endogenous time-dependent inward currents in
HEK-293 cells without cDNA transfection under our experimental conditions. These results are in agreement with the
previous reports (7, 23). However, when HCN2 was coexpressed with ␣1C, a fast inactivation of ␣1C/HCN2 was
observed (Fig. 2B, top). This new inactivation has a differential
sensitivity for Ba2⫹ and Ca2⫹ ions, capable of coming back to
the closed state in the presence of Ca2⫹ (shaded line) but not
Ba2⫹ (solid line), the typical characteristics of the conventional
LTCC inactivation (12, 28). Adding ␣2␦ did not signiﬁcantly
affect the ␣1C/HCN2 inactivation (Fig. 2A, bottom). With
Ba2⫹ as the charge carrier, time constants for inactivation of
␣1C/␣2␦, ␣1C/HCN2, and ␣1C/HCN2/␣2␦ were 156 ⫾ 19, 26 ⫾ 4,
and 22 ⫾ 2 ms, respectively (n ⫽ 8). The inactivation for
␣1C/␣2␦ channels was signiﬁcantly slower than that for ␣1C/
HCN2 or ␣1C/HCN2/␣2␦ (P ⫽ 0.002, n ⫽ 8). There was no
statistical difference between ␣1C/HCN2 and ␣1C/HCN2/␣2␦
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channel inactivation (P ⫽ 0.5, n ⫽ 8). To verify that the
current is via the conventional ␣1C channel, verapamil (10
M) was applied to block the current activation (Fig. 2, A,
bottom, and B, top).
To address the concern that the fast inactivation of ␣1C/
HCN2 or ␣1C/HCN2/␣2␦ channel was probably due to the
contamination from the deactivation of HCN2 channels, we
studied current expression of HCN2 in the external solution
normally used for characterization of HCN2 and in the external
solution used to record IBa inactivation (e.g., Fig. 2, A and B).
The hyperpolarization-activated HCN2 channels permeate
both Na⫹ and K⫹ ions (4). The channel cannot be activated in
the absence of external Na⫹ and K⫹ ions (4). In the external
solution containing 140 mM Na⫹ and 30 mM K⫹, a typical
AJP-Cell Physiol • VOL

HCN2 current (the time-dependent inward current) was recorded in response to a 3-s hyperpolarizing pulse to ⫺125 mV
(Fig. 2C), consistent with the previous reports (e.g., Ref. 24). When
the Na⫹ and K⫹ ions were removed from the external solution, no
time-dependent inward current was recorded (Fig. 2C).
HCN2 channels are closed at membrane depolarization that
is used to activate LTCC (4). In response to a depolarization to
⫹10 mV from the holding potential of ⫺90 mV, there was no
HCN2 activation current in the solution containing 140 mM
Na⫹ and 30 mM K⫹ (Fig. 2D). The inactivation of ␣1C/
HCN2/␣2␦ channel in the Na⫹- and K⫹-free solution was used
as a comparison (Fig. 2D). These data strongly indicate that the
closed HCN2 channels can act as the nonfunction channel to
induce a fast inactivation of ␣1C.
Role of Ca2⫹-free CaM in ␣1C/HCN2 channel inactivation.
Given the pivotal role CaM plays in the Ca2⫹ channel inactivation, we tested the idea that CaM may be involved in the fast
inactivation of ␣1C/HCN2 channel for two reasons: CaM is
endogenously present in HEK-293 cells, and apoCaM (no
Ca2⫹-bound CaM) is tethered to structural domains in the
COOH terminus of ␣1C subunit (6, 16).
We ﬁrst used two structurally different calmodulin inhibitors, W-7 [N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide] (10) and triﬂuoperazine (TFP) (18), to study their
potential effects on ␣1C/HCN2 channel inactivation. After
binding Ca2⫹ ions, CaM undergoes a conformational change
leading to the exposure of its hydrophobic activation site for
binding to its substrate, CaM-dependent kinase (CaMK). Both
W-7 and TFP block CaM actions by occupying the hydrophobic site to prevent binding of CaMK (10, 14). Figure 3A shows
that both drugs at 15 M eliminated the fast inactivation of
␣1C/HCN2 channels within 15–20 min, consistent with the
time course of inhibiting CaM activity by both drugs. The
effect of the drug was observed in the same cell. The similar
results were obtained in an additional ﬁve to seven cells.
We then employed a dominant negative calmodulin mutant,
CaM(1,2,3,4) (22). Compared with the current expression of
␣1C/HCN2 coexpressed with a wild-type calmodulin, CaM(WT),
overexpression of CaM(1,2,3,4) eliminated the fast inactivation of
␣1C/HCN2 (Fig. 3B, shaded line). These pharmacological and
mutant CaM data strongly suggested that the interaction of ␣1C
and HCN2 is partially mediated by CaM.
Role of ␣2␦ in ␣1C/HCN2 channel inactivation. Nearly all
studies of CaM-mediated ␣1C inactivation, carried out in
either Xenopus oocytes or mammalian cells (HEK-293, Chinese hamster ovary, COS), have been performed with coexpression of ␤1- and ␣2␦-subunits. This is due to the important
roles of ␤1- and ␣2␦-subunits in expression of ␣1C on plasma
membrane and Ca2⫹ channel function (2). Previous studies
also have demonstrated a signiﬁcant role of ␣2␦ in initiating
the inactivation of ␣1C expressed in HEK-293 cells (7, 23).
Wondering whether CaM would have the similar impact on the
␣1C/HCN2 channel inactivation in the presence of the ␣2␦
subunit, we tested the effects of W-7 and TFP on the current
expression of ␣1C/HCN2/␣2␦ channels. Surprisingly, neither
W-7 (left) nor TFP (right) affected the inactivation of ␣1C/
HCN2/␣2␦ channels (Fig. 3C, shaded lines). To further conﬁrm this observation, we overexpressed either CaM(WT) or
CaM(1,2,3,4) with ␣1C/HCN2/␣2␦ channels (Fig. 3D, shaded
lines). Neither of them affected the inactivation of ␣1C/HCN2/
␣2␦ channels. Compared with its dominant effect in ␣1C/
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Fig. 2. ␣1C/HCN2 channel inactivation in HEK-293 cells. A, top: current
expression of ␣1C and ␣1C/␣2␦, respectively. Bottom, current inactivation of
␣1C/HCN2/␣2␦ that was blocked by 10 M verapamil. Pulse duration was
200 ms. B, top: ␣1C/HCN2 inactivation using 2 mM Ba2⫹ (solid line) or 2 mM
Ca2⫹ (shaded line) as the charge carrier, which was blocked by 10 M
verapamil. Pulse duration was 400 ms. Bottom, absence of time-dependent
inward current expressions in HEK-293 cells without plasmid transfection.
Pulse duration was 300 ms. In A, the current inactivation was normalized for
better comparison of the inactivation kinetics. C: hyperpolarizing pulse control
experiments. In cells expressing only HCN2, IHCN2 was elicited by a 3-s
hyperpolarizing pulse to ⫺125 mV from the holding potential of ⫺10 mV in
modiﬁed Tyrode solution containing 140 mM Na⫹ and 30 mM K⫹; in cells
coexpressing ␣1C/HCN2/␣2␦, the same hyperpolarizing pulse could not detect
IHCN2 in the external and internal solutions used to record IBa. Although the
leak current varies from cell to cell, we chose a leak current that closely aligned
with the HCN2 time-dependent inward current for better comparison. The
pulse protocol is shown in the inset. The dashed line shows the holding current.
D: depolarizing pulse control experiments. In solutions without Na⫹ and K⫹
ions (0 Na⫹, 0 K⫹), IBa was recorded only in cells coexpressing ␣1C/HCN2/
␣2␦, not in cells expressing only HCN2. The pulse protocol is shown in the
inset.
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Fig. 3. Role of calmodulin (CaM) in ␣1C/
HCN2 channel inactivation. A: ␣1C/HCN2
channel inactivation (solid line) and lost inactivation in the presence of the CaM inhibitor
W-7 or triﬂuoperazine (TFP) (shaded lines).
B: ␣1C/HCN2/CaM(WT) channel inactivation
(solid line) and lost inactivation of ␣1C/HCN2/
CaM(1,2,3,4) channels (shaded line). CaM(WT),
wild-type calmodulin; CaM(1,2,3,4), a dominant
negative calmodulin mutant. C: ␣1C/HCN2/
␣2␦ channel inactivation in the absence (solid
line) and presence of W-7 (shaded line; left) or
TFP (shaded line; right). D: ␣1C/HCN2/␣2␦
channel inactivation in the absence (solid line)
and presence of CaM(1,2,3,4) (shaded line).

a HCN2 mutant lacking the NH2 terminus [HCN2(-N)] and 2)
the wild-type HCN2 with an ␣1C mutant lacking the IQ motif
in the COOH terminus [␣1C⌬(1623-1666)] (8). Figure 4A
shows that the inactivation of ␣1C/HCN2 (solid line) was
eliminated by either HCN2(-N) or ␣1C⌬(1623-1666) (shaded
lines).
We next examined how ␣1C and HCN2 channel mutants
interact in the presence of the ␣2␦ subunit. Figure 4B shows
that compared with the ␣1C/HCN2/␣2␦ channel inactivation
(solid line), both ␣1C/HCN2(-N)/␣2␦ and ␣1C⌬(1623-1666)/
HCN2/␣2␦ channels dramatically slowed the inactivation pro-

Fig. 4. ␣1C/HCN2 interaction requires NH2 terminus of HCN2 and IQ motif of ␣1C. A: ␣1C/
HCN2 channel inactivation for wild-type (solid line),
␣1C⌬(1623-1666)/HCN2 (shaded line), and ␣1C/
HCN2(-N) channels (shaded line). B: ␣1C/HCN2/
␣2␦ channel inactivation for wild-type (solid line),
␣1C⌬(1623-1666)/HCN2/␣2␦ (shaded line), and
␣1C/HCN2(-N)/␣2␦ channels (shaded line). C: inactivation of ␣1C/␣2␦/␤1/HCN2 (solid line),
␣1C(1623-1666)/␣2␦/␤1/HCN2 (shaded line), and
␣1C/␣2␦/␤1/HCN2(-N) (shaded line). D: inactivation time constants measured at ⫹10 mV for
showing the signiﬁcant role of HCN2(-N) [␣1C/
HCN2/␣2␦, ␣1C/HCN2(-N)/␣2␦, ␣1C/HCN2/␣2␦/
CaM(WT), and ␣1C/HCN2/␣2␦/CaM(1,2,3,4); solid
bars] and the signiﬁcant role of ␣1C⌬(16231666) [␣1C1905x/HCN2, ␣1C1905x/HCN2/␣2␦,
␣1C1905x/HCN2/␣2␦/CaM(WT), and ␣1C⌬(16231666)/HCN2 /␣2␦; shaded bars]. Results are expressed as means ⫾ SE. *P ⬍ 0.0001, statistically
signiﬁcant difference compared with ␣1C/HCN2/
␣2␦; P ⫽ 0.07 for ␣1C/HCN2/␣2␦/CaM(WT) and
P ⫽ 0.08 for ␣1C/HCN2/␣2␦/CaM(1,2,3,4) (n ⫽
6–12). &P ⬍ 0.0001, statistically signiﬁcant difference compared with ␣1C/HCN2/␣2␦ or ␣1C1905x/
HCN2/␣2␦; P ⫽ 0.006 for ␣1C1905x/HCN2/␣2␦/
CaM(WT) and P ⫽ 0.0003 for ␣1C⌬(1623-1666)/
HCN2/␣2␦ (n ⫽ 5–12). E: inactivation of ␣1C/
HCN2/␣2␦ channel in the presence of Ba2⫹ (solid
line) and Ca2⫹ (shaded line), respectively.
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HCN2 channel inactivation (Fig. 3, A and B), CaM plays a
minor role in ␣1C/HCN2/␣2␦ channel inactivation (Figs. 3, C
and D), indicating a potential role of ␣2␦-subunit in the
␣1C/HCN2 channel inactivation.
␣1C/HCN2 channel interaction requires NH2 terminus of
HCN2 and IQ motif of ␣1C. The fact that the fast inactivation
of ␣1C/HCN2 is Ca2⫹ independent (since we used Ba2⫹ as a
charge carrier) suggested that CaM may not be the only
mechanism for ␣1C/HCN2 channel interaction. To explore an
unconventional idea that HCN2 may also interact with ␣1C,
we studied the current expression of 1) the wild-type ␣1C with
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On the other hand, HCN2 bands were seen with an HA
antibody in the sample immunoprecipitated using an antibody
speciﬁc to ␣1C (Fig. 5C, bottom). However, the signals were
very weak in cells expressing ␣1C⌬(1623-1666)/HCN2 and
undetectable in cells expressing HCN2(-N)/␣1C (Fig. 5C,
bottom).
To investigate the relative contribution of ␣2␦ and CaM to
the association of ␣1C and HCN2, Fig. 5D shows the coimmunoprecipitation results in HEK-293 cells overexpressing the
respective combinations of cDNAs. In the presence of ␣2␦, the
association of ␣1C and HCN2 was not signiﬁcantly enhanced
by CaM compared with CaM(1,2,3,4). In the absence of ␣2␦,
however, the association of ␣1C and HCN2 was more significantly enhanced by CaM than by CaM(1,2,3,4), as evidenced by
much stronger signals detected by either ␣1C antibody (top) or
HCN2 antibody (bottom). Although one should not expect a
linear correlation between the protein chemistry result and
whole cell patch-clamp data due to the technical difference,
these results are consistent with the functional roles of ␣2␦ and
CaM in the interaction of ␣1C and HCN2 (Fig. 3).
To demonstrate the existence of such an association in native
tissues, we chose rat hippocampus as a test model due to the
technical feasibility and rich expression of LTCC (21) and
HCN2 (19) in the hippocampus. We used fresh rat hippocampus tissues for the abundant amount of proteins to facilitate the
coimmunoprecipitation experiments. In Fig. 5E, the ␣1C signals were readily detectable when the sample was ﬁrst immunoprecipitated by an HCN2 antibody (left). On the other hand,
the HCN2 band was also evident in the sample immunoprecipitated ﬁrst by ␣1C antibody (right). For negative control of
coimmunoprecipitation in hippocampal neurons, the samples
were immunoprecipitated with a GFP antibody and then blotted by either an HCN2 antibody or an ␣1C antibody. No
expected signals were detected (Fig. 5F).
Slowing Ca2⫹ inactivation by disrupting ␣1C/HCN2 association in hippocampus neurons. NH2 terminus of HCN2 was
reported to be essential in the formation of the homo- and
heteromeric channels at the plasma membrane (17). Overexpression of HCN2 lacking NH2 terminus in the hippocampal
neurons, in which the endogenous expression levels of both
␣1C and HCN2 channel proteins are comparable and the two
proteins are associated (Fig. 5E), may disrupt the association.
Shown in Fig. 6A, formation of the rat hippocampal neuron
network was visualized after 5– 6 days in culture. After 24- to
48-h transfection of HCN2(-N) with GFP, the expression of
HCN2(-N) was indicated by the ﬂuorescent image (Fig. 6B)
compared with the brightﬁeld image of the same region (Fig.
6A). The ﬂuorescent neurons were subject to the patch-clamp
recordings. Shown in Fig. 6C, overexpression of HCN2(-N)
induced a remarkably slow inactivation component (light
shaded line) that was not present in the control neurons or in
neurons transfected with the empty vector (solid line, as a
transfection control). On the other hand, transfection with the
full-length HCN2 accelerated the IBa inactivation (dark shaded
line in Fig. 6C). Currents were veriﬁed by verapamil (10 M)
blockade (Fig. 6C). At ⫹10 mV, time constants of IBa inactivation were 26.5 ⫾ 2.9 ms (n ⫽ 9) for control hippocampal
neurons (HN), 35.1 ⫾ 3.5 ms (n ⫽ 6) for HN ⫹ vector, 66.1 ⫾ 3.3
ms (n ⫽ 7) for HN ⫹ HCN2(-N), and 19.0 ⫾ 2.2 ms (n ⫽ 10) for
HN ⫹ HCN2 (Fig. 6D). The altered time constants for channel
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cess (shaded lines). We also observed biphasic inactivation of
␣1C/HCN2(-N)/␣2␦ (Fig. 4B, shaded line) with its ﬁrst fast
inactivation phase close to the wild type but with a second
phase almost linear that cannot be ﬁtted by an exponential
function.
We ﬁnally studied the effects of HCN2 and ␣1C mutants on
␣1C/HCN2 inactivation in the presence of both ␣2␦- and
␤1-subunits. Compared with the wild-type ␣1C/␣2␦/␤1/HCN2
channel (solid line), the signiﬁcant slowing of ␣1C/HCN2
channel inactivation by either HCN2(-N) or ␣1C⌬(1623-1666)
(shaded lines) still persisted in the presence of ␣2␦- and
␤1-subunits (Fig. 4C). At ⫹10 mV, the time constants of IBa
inactivation were 72.5 ⫾ 5.6 ms for ␣1C/␣2␦/␤1/HCN2, 108 ⫾ 13
ms for ␣1C/␣2␦/␤1/HCN2(-N), and 498 ⫾ 43 ms for
␣1C⌬(1623-1666)/␣2␦/␤1/HCN2, respectively (n ⫽ 5–7)
(Fig. 4D). Together, these results suggest that the NH2 terminus of HCN2 and the IQ motif of ␣1C are the structural elements
required for the inactivation of the ␣1C/HCN2 channel.
Relative roles of CaM, ␣2␦, and ␤1 in the inactivation of
␣1C/HCN2 channels. To examine the relative contribution of
␣2␦ and CaM to the inactivation of ␣1C/HCN2 channels, we
compared the inactivation time constants for different combinations of ␣1C, HCN2, ␣2␦, and CaM, including their respective mutants, except for ␣1C1905x/HCN2. ␣1C1905x is a
distal COOH-terminal truncated form of ␣1C, which is used as
a control for ␣1C⌬(1623-1666) function (8). We found that
␣1C⌬(1623-1666) and HCN2(-N) are the two most signiﬁcant
structural motifs that contribute to the inactivation of ␣1C/
HCN2 channels independently of ␣2␦ (Fig. 4D). We also
found, surprisingly, that overexpression of CaM(WT) did not accelerate (as one would expect), but slowed, the inactivation of
␣1C/HCN2/␣2␦ or ␣1C1905x/HCN2/␣2␦ channels (Fig. 4D).
In the absence of ␣2␦, there was a distinct difference
between CDI and VDI for ␣1C/HCN2 channels (Fig. 2B). In
the presence of ␣2␦, however, the difference between CDI and
VDI disappeared (Fig. 4E). Combined with the diminished
difference between CDI and VDI for ␣1C/␣2␦/␤1/HCN2 (Fig.
1B), the results provide additional evidence for a major role of
␣2␦ in the inactivation of ␣1C/HCN2 channels. In comparing
Fig. 4, C and E, ␤1 helped complete the IBa inactivation of
␣1C/HCN2/␣2␦ channels, which are consistent with the results
shown in Fig. 1B.
Association of ␣1C and HCN2 channel proteins in HEK-293
and hippocampus. Whether the interaction of ␣1C and HCN2
is mediated by CaM (for ␣1C/HCN2 channels) or by ␦-subunit
(for ␣1C/HCN2/␣2␦ channels), ␣1C and HCN2 channel proteins should be physically close. Fig 5A shows that in HEK293 cells expressing ␣1C and HCN2, ␣1C signal could indeed
be detected with an ␣1C antibody after the samples were
immunoprecipitated by an HCN2 antibody (left lane). Immunoblots using an ␣1C antibody for cells expressing ␣1C/␣2␦
and cells with no cDNA transfection (NT) served as positive
and negative controls, respectively. Figure 5B shows that
HCN2 signal could also be detected with its antibody after the
samples were immunoprecipitated by an ␣1C antibody. Figure
5C shows that in HEK-293 cells expressing ␣1C and a hemagglutinin (HA)-tagged HCN2 cDNA plasmid, the ␣1C signal
was detected using an anti-␣1C antibody after the sample was
immunoprecipitated with an anti-HA antibody (Fig. 5C, top).
The signal was, however, undetected in cells expressing
␣1C⌬(1623-1666)/HCN2 or HCN2(-N)/␣1C (Fig. 5C, top).
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inactivation were marked with statistical signiﬁcance compared
with the control HN or HN transfected with vector (Fig. 6D).
DISCUSSION

Both ␣1C- and ␦-subunits are transmembrane proteins with
NH2 and COOH tails of ␣1C and COOH tail of ␦ located
intracellularly. CaM and ␤1-subunit are intracellular proteins
attached to the ␣1C near the inner surface of the membrane.
These four proteins constitute the inactivation machinery for
the ﬁne control of Ca2⫹ inﬂux through LTCC in both VDI and
CDI (6, 12, 15, 22).
Our previous studies showed possible involvement of HCN
in the modulation of myocyte action potential duration (24). In
AJP-Cell Physiol • VOL

the present work, we evaluated the hypothesis that inactivation
of LTCC can be modulated via interaction with HCN channels
under the experimental conditions that prevent HCN2 channel
opening. We showed here that HCN2 can act as a nonchannel
regulatory protein to induce a fast inactivation of ␣1C. To
further investigate the possible associated mechanisms involved in the interaction between ␣1C and HCN2 channel
proteins, we proposed a model shown in Fig. 7. Mechanism 1
represents our current understanding of interactions among
␤-subunits, which are bound to the ␣1-interaction domain
(AID), apoCaM, and inactivation motifs in the COOH-terminal
region of ␣1C. The majority of this conceptual understanding
was provided from studies in either Xenopus oocytes or HEK-
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Fig. 5. Association of ␣1C and HCN2 proteins in HEK-293 cells and in the hippocampus. A: cells expressing ␣1C and HCN2 were immunoprecipitated (IP) using
an HCN2 antibody, followed by signal detection (IB) using an ␣1C antibody (left lane). Cells expressing ␣1C and ␣2␦ were blotted by an ␣1C antibody (middle
lane), serving as a positive control. Cells without cDNA transfection (NT) were blotted using an ␣1C antibody (right lane), serving as a negative control. B: cells
expressing ␣1C and HCN2 were immunoprecipitated using an ␣1C antibody, followed by signal detection using an HCN2 antibody. Cells without cDNA
transfection served as a negative control. C, top: in cells coexpressing ␣1C and HA-HCN2, ␣1C signal was detected using an anti-␣1C antibody after the sample
was immunoprecipitated by a speciﬁc anti-hemagglutinin (HA) antibody. Signals were not detected in cells expressing HCN2(-N)/␣1C or HCN2/␣1C⌬(16231666). Bottom, in cells coexpressing ␣1C and HCN2, HCN2 signals were detected by an HA antibody in the sample immunoprecipitated with an ␣1C antibody.
Very weak signal was seen in cells expressing HCN2/␣1C⌬(1623-1666) but not in cells expressing HCN2(-N)/␣1C. D: effect of CaM and ␣2␦ on association
of ␣1C and HCN2. Top, samples were immunoprecipitated using an HCN2 antibody, followed by signal detection with an ␣1C antibody. Bottom, samples were
immunoprecipitated using an ␣1C antibody, followed by signal detection with an HCN2 antibody. IgG bands were included as controls. E: coimmunoprecipitation of ␣1C and HCN2 in the hippocampus. Left, sample was immunoprecipitated with an HCN2 antibody and blotted by an ␣1C antibody. Right, sample was
immunoprecipitated with an ␣1C antibody and blotted by an HCN2 antibody. F: negative control for coimmunoprecipitation in the rat hippocampus. Samples
were immunoprecipitated using a green ﬂuorescent protein (GFP) antibody, followed by immunoblots using an HCN2 antibody (left lane) and an ␣1C antibody
(right lane), respectively.
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293 cells coexpressing ␣1C with ␤1- and ␣2␦-subunits (6, 15,
16, 20, 27, 28). Our present study revealed several new
concepts.
First, in the absence of ␤1- and ␣2␦-subunits, HCN2 can
induce a faster inactivation of ␣1C than ␣2␦ as measured by
IBa (compare Fig. 2, A and B). This interaction of HCN2 and
␣1C requires CaM (mechanism 2 in Fig. 7), since two CaM
inhibitors (W-7 and TFP) and the dominant negative
CaM(1,2,3,4) all eliminated the inactivation of ␣1C/HCN2 channel (Fig. 3, A and B).

Second, in the presence of the ␣2␦-subunit, HCN2 can still
induce fast inactivation of ␣1C. However, the impact of CaM
in affecting the inactivation of ␣1C/HCN2/␣2␦ channel is
diminished compared with that for ␣1C/HCN2 channel, suggesting a prevalent role of the ␣2␦-subunit in ␣1C and HCN2
interaction (mechanism 3 in Fig. 7).
Third, mutants of HCN2 (with the NH2 terminus deleted)
and ␣1C (without IQ motif) revealed a critical role of these two
structural elements in mediating the fast inactivation of ␣1C/
HCN2 channels (Fig. 4). It is worth noting that the short

Fig. 7. A schematic model depicting the
potential roles of HCN2 and ␦-subunit in the
inactivation of LTCC. Mechanism 1 summarizes the mechanisms for CDI and VDI of
LTCC. Mechanism 2 proposes a potential
CaM-mediated interaction between the NH2
terminus of HCN2 and the IQ motif of ␣1C.
Mechanism 3 proposes a potential interaction between the COOH tail of the ␦-subunit
and the NH2 terminus of HCN2 within the
COOH-terminal inactivation machinery of
␣1C-subunit. AID, ␣1-interaction domain.
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Fig. 6. Altered L-type Ca2⫹ channel (LTCC) inactivation in rat
hippocampal neurons (HN) overexpressing HCN2(-N) and the
full-length HCN2. A brightﬁeld image (A) and ﬂuorescence
image (B) of the region is shown 48 h posttransfection of
HCN2(-N) or HCN2 with GFP. C: Ca2⫹ current inactivation
using Ba2⫹ as a charge carrier in a control neuron and in
neurons transfected with the empty vector (HN ⫹ vector), in a
neuron transfected with HCN2(-N) [HN ⫹ HCN2(-N)], and in
a neuron transfected with HCN2 (HN ⫹ HCN2). IBa currents
were recorded at ⫹10 mV. The holding potential was at ⫺90
mV. Pulse duration was 400 ms. P4 protocol was used. The HN ⫹
vector trace was moved up by 60 pA for clear illustration of currents
under different conditions. D: inactivation time constants in HN, HN
transfected with HCN2, HN transfected with the vector, and HN
transfected with HCN2(-N). Results are expressed as means ⫾ SE.
P values indicate statistical signiﬁcance compared with either HN or
HN ⫹ vector group.

C1036

HCN2 MODULATION OF LTCC INACTIVATION

AJP-Cell Physiol • VOL

requirement of CaM for ␣1C/HCN2 inactivation in the absence
of ␣2␦ subunit is supported by the facts that inhibiting CaM
activity using either pharmacological inhibitors or overexpression of CaM(1,2,3,4) all eliminated the inactivation of ␣1C/
HCN2 (Fig. 3, A and B). On the other hand, ␣1C/HCN2/␣2␦
channel inactivation is largely independent of CaM (Fig. 3, C
and D). One possible scenario for this difference may be that
the conformational change of CaM resulted from the interaction between the IQ motif and HCN2 is different from that
resulted from the interaction between the IQ motif and HCN2/
␣2␦. The interaction between the IQ motif and HCN2 may lead
CaM to undergo a conformational change that exposes its
hydrophobic activation site to the CaM blockers, whereas the
interaction between the IQ motif and HCN2/␣2␦ may induce a
different CaM conformational change that does not make its
blockers accessible to the activation site. This possibility
would explain the fast VDI of ␣1C/HCN2/␣2␦ channel (solid
lines in Fig. 3, C and D), the insensitivity of W-7 and TFP to
the ␣1C/HCN2/␣2␦ currents (Fig. 3C), and the lack of a
difference between CDI and VDI for the ␣1C/HCN2/␣2␦
channel (Fig. 4E).
Potential implications of ␣1C and HCN2 interaction. In this
study, although we have presented evidence demonstrating the
interaction of ␣1C-subunit (Cav1.2) with HCN2, interactions
of this type might also occur in other types of Ca2⫹ channels that
undergo CDI, such as Cav2 channels, as a common mechanism.
Use of CaM as the key element for Ca2⫹ channel inactivation has
been reported for Cav1 and Cav2 channels (13).
Increased Ca2⫹ inﬂux is associated with a number of neuronal disorders, including neuropathic pain (1). Gabapentin, a
GABA analog, is an antiepileptic drug that has been used
recently to relieve neuropathic pain and is believed to bind the
␣2␦1-subunit, leading to decreased Ca2⫹ inﬂux (1, 9). The
mechanism of how gabapentin binding of ␣2␦1-subunit decreased Ca2⫹ inﬂux remains elusive, since the gabapentin
action is acute (1). The ␣2␦-subunits have been known to
enhance the surface expression of ␣1C and Ca2⫹ current
amplitude (7, 23). A recent study demonstrated that chronic
treatment with gabapentin was associated with a reduction in
the surface expression of ␣2␦2 and Cav2.1 subunits (9). On the
other hand, the ␣2␦-subunits also promote inactivation of
Cav1.2 (␣1C) or Cav2.2 (N-type) (23), and inhibition of the
␣2␦ subunit should, in principle, slow the ␣1C inactivation,
resulting in an increased Ca2⫹ inﬂux. The interaction of ␣1C
with HCN2 may provide an alternative mechanism to prevent
an increase in Ca2⫹ inﬂux under the conditions in which the
␣2␦-subunit expression is reduced.
Study limitations. Although we report for the ﬁrst time a
novel and potentially important mechanism for modulation of
Ca2⫹ current inactivation by HCN2 channel, there are many
unanswered questions. For instance, we noticed that the activation of ICaL also seems to be altered by HCN2 (e.g., Fig. 1F).
In addition, whether HCN2 may also modulate other Ca2⫹
channels that share similar inactivation machinery to ␣1C is
unknown. More importantly, under various physiological and
especially pathological conditions, the importance of interaction between HCN2 and LTCC requires further investigation,
since the expression levels of HCN2, ␣1C, and ␣2␦1 are
altered.
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COOH terminus of the ␦-subunit is located in the intracellular
space. Analysis of amino acids in the NH2 terminus of HCN2
showed an overall positive charge, which can potentially interact with the negatively charged COOH terminus of ␦-subunit. Although previous studies have suggested a vital role for
the ␦-subunit in accelerating ␣1C inactivation (7, 23), there is
limited mechanistic insight into how this process occurs. Our
data suggested that a key contributor to this accelerated inactivation may be a dynamic, coordinated interaction among the
COOH terminus of the ␦-subunit, the IQ motif of ␣1C, and the
NH2 terminus of HCN2. Alternatively, it is also possible that
␤1-subunit can interfere with the inactivation of ␣1C⌬(16231666)/HCN2/␣2␦ and ␣1C/␣2␦/HCN2(-N), as well (Fig. 4C).
This may be a logical possibility, since the ␤1-subunit is
attached to the linker of I-II domains and has been reported to
interact with the IQ motif either directly or possibly through
the actions of CaM (26). Our results for HCN2(-N) and
␣1C⌬(1623-1666) (Fig. 5C) also are consistent with previous
reports that the NH2 terminus of HCN2 and IQ motif of ␣1C
are important structural elements for the respective channel
surface expression (8, 17). Thus it is possible that the altered
channel trafﬁcking leading to the reduced surface expression of
either HCN2 or ␣1C provides a potential mechanism for the
roles of NH2 terminus of HCN2 and IQ motif of ␣1C in the
interaction of the two channels.
Finally, we have demonstrated that an interaction of ␣1C
and HCN2 is present in native tissues, as evidenced by association of the two channel proteins in the hippocampus and
dramatic slowing of IBa in hippocampal neurons overexpressing HCN2(-N) (Fig. 6). It should be noted that the currents we
recorded in hippocampal neurons are not pure LTCCs, since Nand P/Q-calcium channels are present in hippocampal neurons,
and verapamil can also inhibit N- and P/Q-type calcium currents (5). Nevertheless, the fact that overexpression of
HCN2(-N) mutant in HNs induced a signiﬁcant slowing of
inactivation supports the hypothesis that dynamic interaction
between ␣1C and HCN2 exists in the native tissue.
Unusual features of ␣1C/HCN2 and ␣1C/HCN2/␣2␦ channel inactivation. Dissecting VDI and CDI often has been
carried out by using Ba2⫹ and Ca2⫹, respectively (12, 15, 22,
28), yielding intriguing results. Not only is CDI about 6 –10
times faster than VDI (12, 13), but CDI also can come back to
the closed state whereas VDI cannot. The CDI index, measured
by the residual fraction of the currents that remains at the end
of the test pulse, is much smaller for Ca2⫹ than for Ba2⫹ (6, 12,
15, 28). Interestingly, the speed of VDI can be increased to that
of CDI if the IQ motif is deleted (28). Furthermore, a single
mutation of I to A or E in the IQ motif could eliminate the
difference in CDI index for Ca2⫹ and Ba2⫹ (27). Recently,
using a ﬂuorescence resonance energy transfer (FRET) twohybrid mapping technique, preassociation of apoCaM and a
73-amino acid segment containing IQ motif was found to be
critical for the slow VDI (6). Disruption of this preassociation
signiﬁcantly accelerated the VDI and removed the difference
between CDI and VDI (6).
Both ␣1C/HCN2 and ␣1C/HCN2/␣2␦ channels have exhibited VDI rates that are faster than that reported following the
disruption of preassociation of IQ motif and apoCaM (6). Our
data suggest that HCN2, via its NH2 terminus, can interrupt the
preassociation of apoCaM with the IQ motif of ␣1C and that
this may contribute to the accelerated VDI inactivation. The
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